Table S1: Unique studies reported in EWAS Atlas 
Stage,Platform,Sample size,Male(%),Age(min),Age(max),Age(mean),Age(sd),Tissue,Cohort name,Full name,Description,Ancestry,Tissue
Initial,27K,10,0.4,null,null,29.7,29.7,alveolar macrophage,,,never smokers,Not reported,alveolar macrophage
Initial,27K,10,1,26,71,50,null,epidermis,,,,Not reported,epidermis
Initial,27K,1006,0,35,76,null,null,whole blood,,Sister Study,Sister Study,Not reported,whole blood
Initial,27K,108,0.52,0,84,19,null,prefrontal cortex,,,Cerebrotendinous xanthomatosis,Not reported,prefrontal cortex
Initial,27K,109,0.39,15,15,15,0,buccal epithelium,,,,Not reported,buccal epithelium
Initial,27K,11,0.45,null,null,58,15,whole blood,,,symptomatic HDM,Not reported,whole blood
Initial,27K,11,1,null,null,57.2,15.2,pancreatic islet,,,control,European,pancreatic islet
Initial,27K,113,0,50,84,null,null,whole blood,UKOPS,United Kingdom Ovarian Cancer Population Study,Ovarian cancer before treatment,Not reported,whole blood
Initial,27K,113,0,null,null,null,null,whole blood,,,pre-treatment ovarian cancer cases,Not reported,whole blood
Initial,27K,114,0.7,16,96,44,null,cerebellum,,,,Not reported,cerebellum
Initial,27K,12,0.58,null,null,39.3,3.81,alveolar macrophage,,,heavy smokers,African American or Afro-Caribbean;Not reported,alveolar macrophage
Initial,27K,123,0.5,8,78,43,17.2,tumor tissue,ENS@T,European Network for the Study of Adrenal Tumors,24 metastatic,European,tumor tissue
Initial,27K,125,0.7,15,100,43,null,caudal pons,,,,Not reported,caudal pons
Initial,27K,127,0.67,15,100,44,null,frontal cortex,,,,Not reported,frontal cortex
Initial,27K,131,0.99,21,55,29,null,saliva,,,,Not reported,saliva
Initial,27K,132,0,33,82,60,12,whole blood,,,Batch 1,European,whole blood
Initial,27K,133,0.68,16,100,43,null,frontal cortex,,,,Not reported,frontal cortex
Initial,27K,14,0,6,73,20,null,dermal fibroblast,,,,Not reported,dermal fibroblast
Initial,27K,146,0,28,91,63.3,12.8,leukocyte,,,case,European,leukocyte
Initial,27K,148,0,52,78,null,null,whole blood,UKOPS,United Kingdom Ovarian Cancer Population Study,Healthy women,Not reported,whole blood
Initial,27K,148,0,null,null,null,null,whole blood,,,healthy,Not reported,whole blood
Initial,27K,149,0.52,18,30,21,null,leukocyte,PAPA,Poblogaeth Asthma Prifysgol Abertawe,,European,leukocyte
Initial,27K,15,0.47,null,null,38.1,11.05,whole blood,,,healthy controls,Not reported,whole blood
Initial,27K,153,0,null,null,63,11.1,leukocyte,,,,European,leukocyte
Initial,27K,16,0.62,21,85,52,null,bone marrow,,,,Not reported,bone marrow
Initial,27K,160,0.5,5,79,29,null,leukocyte,SLSJ,Saguenay‚ÄìLac-SaintJean region,,European,leukocyte
Initial,27K,168,null,20,70,45,null,cerebellum,,,,Not reported,cerebellum
Initial,27K,17,0.59,16,68,55,null,apical left ventricular,,,,Not reported,apical left ventricular
Initial,27K,172,0,32,80,57.2,8.2,whole blood,TwinsUK,,"33 MZ pairs, 43 DZ pairs, and 20 singletons",European,whole blood
Initial,27K,176,0,27,89,62.9,12.7,leukocyte,,,control,European,leukocyte
Initial,27K,19,0.54,null,null,60.1,7.9,whole blood,COPDGene,,Current smokers,European,whole blood
Initial,27K,196,0,null,null,62.9,12.7,tumor tissue,,,Case,European,tumor tissue
Initial,27K,202,0,null,null,62.8,12.4,ovarian,,,Control,European,ovarian
Initial,27K,216,0.49,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,27K,23,0,19,75,46,null,breast,,,,Not reported,breast
Initial,27K,24,0.42,51,77,66,null,lung,,,,Not reported,lung
Initial,27K,26,null,null,null,null,null,whole blood,,,narcoleptic patients,East Asian,whole blood
Initial,27K,27,0.85,52,83,69,null,lung,,,,Not reported,lung
Initial,27K,279,null,null,null,null,null,blood,TCGA,,,Asian unspecified,blood
Initial,27K,28,0,0,0,0,0,placenta,,,,Not reported,placenta
Initial,27K,296,0,27,91,63,13,whole blood,,,Batch 2,European,whole blood
Initial,27K,344,0,null,null,57.1,8.8,whole blood,Sister Study,National Institute of Environmental Health Sciences (NIEHS) Sister Study,Former smoker,European,whole blood
Initial,27K,35,0.37,43,90,74,null,colon,,,,Not reported,colon
Initial,27K,355,0.52,2,61,28,null,leukocyte,MRCA,Medical Research Council Asthma,,Not reported,leukocyte
Initial,27K,41,0.49,43,87,69,null,stomach,,,,Not reported,stomach
Initial,27K,41,0.51,40,79,66,null,cartilage,,,,Not reported,cartilage
Initial,27K,496,0,null,null,55.1,9.1,whole blood,Sister Study,National Institute of Environmental Health Sciences (NIEHS) Sister Study,Never-smoker,European,whole blood
Initial,27K,5,1,null,null,64.4,5.3,pancreatic islet,,,Type 2 diabetes,European,pancreatic islet
Initial,27K,51,0.24,15,81,43,null,tumor tissue,,,Carcinomas,Not reported,tumor tissue
Initial,27K,52,null,25,88,68,null,gastric tissue,,,,Not reported,gastric tissue
Initial,27K,55,0.35,15,15,15,0,buccal epithelium,,,,European,buccal epithelium
Initial,27K,56,0.48,50,60,54,3,peripheral blood,ESTHER,,"Never smoker: lifetime smoking <= 100 cigarettes, never regularly smoking",Not reported,peripheral blood
Initial,27K,56,0.5,50,60,54,3,peripheral blood,ESTHER,,"Former smoker: abstinent for past 10+ years, but smoking >= 20 cigarettes per day before",Not reported,peripheral blood
Initial,27K,57,0.86,20,79,51,null,liver,,,,Not reported,liver
Initial,27K,65,0.54,50,60,54,3,peripheral blood,ESTHER,,Heavy smoker: smoking >= 20 cigarettes per day at ages 30 and 40 and at enrollment,Not reported,peripheral blood
Initial,27K,66,0.35,null,null,66.6,7.6,whole blood,COPDGene,,Former smokers,European,whole blood
Initial,27K,68,0,null,null,53.2,9.6,whole blood,Sister Study,National Institute of Environmental Health Sciences (NIEHS) Sister Study,Current smoker,European,whole blood
Initial,27K,69,0,33,-82,60.2,12,leukocyte,,,case,European,leukocyte
Initial,27K,69,1,21,55,35,null,saliva,,,,Not reported,saliva
Initial,27K,69,1,44,73,61,null,prostate,,,,Not reported,prostate
Initial,27K,715,0.62,16,88,33,null,whole blood,,,,Not reported,whole blood
Initial,27K,8,0.25,16,68,43,null,buccal epithelium,,,,Not reported,buccal epithelium
Initial,27K,84,0.08,22,78,48,null,tumor tissue,,,Adenomas,Not reported,tumor tissue
Initial,27K,87,0,33,85,60.2,12.1,leukocyte,,,control,European,leukocyte
Initial,27K,9,0.44,null,null,33.6,7.26,whole blood,,,pre-symptomatic,Not reported,whole blood
Initial,27K,93,0,49,75,null,null,peripheral blood mononuclear cell,,,31 twin pairs and 31 singletons,Not reported,peripheral blood mononuclear cell
Initial,27K,972,0.29,null,null,66.3,7.6,leukocyte,GENOA,Genetic Epidemiology Network of Arteriopathy,,African American or Afro-Caribbean,leukocyte
Initial,450K,1,0,10.6,10.6,10.6,0,bone marrow,,,t(4;11),European,bone marrow
Initial,450K,1,0,11.8,11.8,11.8,0,bone marrow,,,t(12;21) and trisomy 21,European,bone marrow
Initial,450K,1,1,11.75,11.75,11.75,0,bone marrow,,,Hypodiploidy,European,bone marrow
Initial,450K,1,1,12.92,12.92,12.92,0,bone marrow,,,Trisomy 5,European,bone marrow
Initial,450K,1,1,2.6,2.6,2.6,0,bone marrow,,,t(9;12) and monosomy 7,European,bone marrow
Initial,450K,1,1,3.8,3.8,3.8,0,bone marrow,,,t(1;19),European,bone marrow
Initial,450K,1,1,52,52,52,0,neutrophil,,,,European,neutrophil
Initial,450K,1,null,null,null,null,null,cardiomyocyte,,,24h PM2.5 exposure,Not reported,cardiomyocyte
Initial,450K,1,null,null,null,null,null,cardiomyocyte,,,control group,Not reported,cardiomyocyte
Initial,450K,1,null,null,null,null,null,fibroblast,,,healthy control,Not reported,fibroblast
Initial,450K,1,null,null,null,null,null,lymphoblastoid cell line,,,ICF patients,Not reported,lymphoblastoid cell line
Initial,450K,1,null,null,null,null,null,MCF10A cell line,,,,Not reported,MCF10A cell line
Initial,450K,1,null,null,null,null,null,untrasformed fibroblast,,,ICF patients,Not reported,untrasformed fibroblast
Initial,450K,10,0,21,52,36.4,10.6,CD14+ monocyte,,,control,European,CD14+ monocyte
Initial,450K,10,0,null,null,48.2,9.2,visceral adipose tissue,,,No Type 2 Diabetes,Not reported,visceral adipose tissue
Initial,450K,10,0.2,null,null,47,11,whole blood,,,worst responders,East Asian,whole blood
Initial,450K,10,0.5,0,0,0,0,cord blood,,,Exposed,Not reported,cord blood
Initial,450K,10,0.5,0,0,0,0,cord blood,,,Non-exposed,Not reported,cord blood
Initial,450K,10,0.5,28,67,44,13,neutrophil,,,primary APS,European,neutrophil
Initial,450K,10,0.5,null,null,52.7,18.5,whole blood,,,best responders,East Asian,whole blood
Initial,450K,10,0.5,null,null,59.6,11.9,colon,,,colorectal laterally spreading tumor,East Asian,colon
Initial,450K,10,0.5,null,null,59.6,11.9,colon,,,matched normal samples,Not reported,colon
Initial,450K,10,0.5,null,null,null,null,whole blood,,,Bipolar disorder and major depressive disorder patientsaffected carriers of the linked haplotye(ALH) ,Not reported,whole blood
Initial,450K,10,0.7,0,0,0,0,whole blood,,,Down syndrome,Not reported,whole blood
Initial,450K,10,0.7,null,null,37,9.8,whole blood,,,Controls,South Asian,whole blood
Initial,450K,10,0.7,null,null,37.4,10.2,whole blood,,,case,South Asian,whole blood
Initial,450K,10,1,null,null,18,5.5,whole blood,,,Tolerant,European,whole blood
Initial,450K,10,1,null,null,31.9,15.1,skin,,,NN,Not reported,skin
Initial,450K,10,1,null,null,46.6,4.4,peripheral blood,SABRE,Southall And Brent REvisited,Former smokers,South Asian,peripheral blood
Initial,450K,10,null,0,0,0,0,placenta,,,3rd Trimester control,Not reported,placenta
Initial,450K,10,null,0,0,0,0,placenta,,,3rd Trimester CPM16,Not reported,placenta
Initial,450K,100,0,18,82,37.2,null,breast,,,cancer-free women,African American or Afro-Caribbean;European;Hispanic or Latin American,breast
Initial,450K,100,0.11,null,null,56.1,13.6,whole blood,,,Patients with pSS,European,whole blood
Initial,450K,100,0.52,53,69,62,null,whole blood,Lifelines,,Type 2 diabetic individuals,European,whole blood
Initial,450K,100,0.66,null,null,72.8,6.3,whole blood,,,,East Asian,whole blood
Initial,450K,100,0.7,null,null,37.8,6.2,whole blood,,,Controls,East Asian,whole blood
Initial,450K,100,0.84,null,null,34.5,8.3,whole blood,,,Patients with BD,East Asian,whole blood
Initial,450K,100,1,null,null,48.3,7.8,whole blood,,,Past,European;Other,whole blood
Initial,450K,100,1,null,null,49.2,6.74,leukocyte,,,Smokers,African American or Afro-Caribbean,leukocyte
Initial,450K,100,1,null,null,49.7,8.7,leukocyte,,,Non-smokers,African American or Afro-Caribbean,leukocyte
Initial,450K,1000,0.5,null,null,62.1,6.5,whole blood,ESTHER,"Epidemiologische Studie zu Chancen der Verh‚Ç¨utung, Fr√ºherkennung und optimierten Therapie chronischer Erkrankungen in der √§lteren Bev√∂lkerung",,European,whole blood
Initial,450K,101,0.55,0,0,0,0,umbilical cord blood,,,Exposed group,East Asian,umbilical cord blood
Initial,450K,101,0.61,46,93,67.8,null,tumor tissue,DACHS,,Metastatic CRC,Not reported,tumor tissue
Initial,450K,101,0.8,null,null,59,10.2,whole blood,ACS-1,,,East Asian,whole blood
Initial,450K,1011,null,null,null,69,null,whole blood,SATSA,Swedish Adoption/Twin Study of Aging,,European,whole blood
Initial,450K,1017,null,null,null,47.3,11,whole blood,LifeLines,,,European,whole blood
Initial,450K,1019,null,0,0,0,0,cord blood,MoBa1,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,102,0,null,null,65.02,8.25,saliva,,,Grandmothers - CDV-,Not reported,saliva
Initial,450K,103,0,null,null,52.9,7.1,whole blood,AMDTSS,Australian Mammographic Density Twins and Sisters Study,AT siblings,Not reported,whole blood
Initial,450K,103,0.46,null,null,69.5,0.7,whole blood,,,Current smokers,European,whole blood
Initial,450K,103,0.52,0,0,0,0,umbilical cord blood,,,Reference group,East Asian,umbilical cord blood
Initial,450K,1034,null,null,null,29.9,4.3,cord blood,MoBa1,,,European,cord blood
Initial,450K,1034,null,null,null,29.9,4.3,cord blood ,MoBa1,,,European,cord blood 
Initial,450K,104,0.41,null,null,16,3,nasal epithelial cell,EVA-PR,Epigenetic Variation and Childhood Asthma in Puerto Ricans,Non-atopic controls,Hispanic or Latin American,nasal epithelial cell
Initial,450K,104,0.52,null,null,47,1.7,adipose tissue,LEAP,New England Family Study,46 current smokers and 58 non-smokers,European;Not reported,adipose tissue
Initial,450K,104,0.55,40,87,68.63,11.01,whole blood,,,,European,whole blood
Initial,450K,1049,null,0,0,0,0,cord blood,MoBa1,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,1053,null,0,0,0,0,cord blood,MoBa1,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,106,0.63,null,null,4.2,2.7,whole blood,,Chicago Food Allergy Study,CMA cases,European,whole blood
Initial,450K,1062,0.53,0,0,0,0,cord blood,MoBa,Norwegian Mother and Child Cohort Study,,European,cord blood
Initial,450K,1063,null,0,0,0,0,cord blood,MoBa1,Norwegian Mother and Child Cohort Study,,European,cord blood
Initial,450K,1066,0.53,0,0,0,0,whole blood,MoBa1,,,European,whole blood
Initial,450K,107,0.43,null,null,56.5,10.4,whole blood,REGICOR,EWAS nested in the Girona Heart Registry,Current Smokers,European,whole blood
Initial,450K,1074,0.67,null,null,52.5,10.2,whole blood,LOLIPOP,The London Life Sciences Prospective Population Study,Incident T2D,Asian unspecified,whole blood
Initial,450K,108,null,10,10,10,0,whole blood,IoW,Isle of Wight,,European,whole blood
Initial,450K,108,null,null,null,null,null,kidney,,,,Not reported,kidney
Initial,450K,1085,0.54,45,65,57.3,8.1,whole blood,ICGN,International COPD Genetics Network,,European,whole blood
Initial,450K,1088,0.68,49,82,68,null,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,109,1,0,7,null,null,whole blood,ARIES,Accessible Resource for Integrated Epigenomics Studies,,Not reported,whole blood
Initial,450K,1091,null,null,null,null,null,whole blood,LBC1936,Lothian Birth Cohort 1936,,Not reported,whole blood
Initial,450K,11,0,23,64,45.5,12.9,CD4+ T cell,,,Controls,European,CD4+ T cell
Initial,450K,11,0,23,69,45.9,15.5,CD4+ T cell,,,pSS cases,European,CD4+ T cell
Initial,450K,11,0,null,null,52.6,4.9,B-lymphocyte,,,control,European,B-lymphocyte
Initial,450K,11,0,null,null,52.6,4.9,T-lymphocyte,,,control,European,T-lymphocyte
Initial,450K,11,0.64,2.7,14,7.5,3.7,bone marrow,,,No abnormal finding (NAF),European,bone marrow
Initial,450K,11,0.64,null,null,65.3,12.6,tumor tissue,,,Non-obese,Not reported,tumor tissue
Initial,450K,11,1,3,6,null,null,buccal epithelium,,,6 FASD patients and 5 matched controls,European,buccal epithelium
Initial,450K,11,1,null,null,22.45,4.74,sperm,,,3 months of exercise training,Not reported,sperm
Initial,450K,11,null,null,null,64.1,12.5,peripheral blood mononuclear cell,,,Responders,Not reported,peripheral blood mononuclear cell
Initial,450K,110,0.41,null,null,11.6,3.4,buccal epithelial cell,,NeuroDevNet FASD cohort,FASD cases,European;Other,buccal epithelial cell
Initial,450K,1103,0.51,null,null,54.5,8.87,leukocyte,KORA,,Baseline,European,leukocyte
Initial,450K,1103,0.51,null,null,61.5,8.9,leukocyte,KORA,,Follow-up,European,leukocyte
Initial,450K,111,0.38,65,90,71,5.9,whole blood,OATS,Older Australian Twins Study,,European,whole blood
Initial,450K,111,0.42,null,null,61.7,7.7,buffy coat,,,Former smokers,African American or Afro-Caribbean,buffy coat
Initial,450K,111,0.45,0,0,0,0,whole blood,NEST,,,European,whole blood
Initial,450K,111,0.6,7.5,7.5,7.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Current wheeze,Not reported,whole blood
Initial,450K,112,0,null,null,59.9,7.3,whole blood,AMDTSS,Australian Mammographic Density Twins and Sisters Study,BT siblings,Not reported,whole blood
Initial,450K,113,0.44,null,null,8.9,0.1,leukocyte,,,,South Asian,leukocyte
Initial,450K,114,0.55,null,null,65,8,CD14+ monocyte,,,Current smokers,African American or Afro-Caribbean;European;Hispanic or Latin American,CD14+ monocyte
Initial,450K,115,0.48,0,0,0,0,whole blood,Healthy Start,,,Hispanic or Latin American,whole blood
Initial,450K,116,0.49,0,0,0,0,neonatal blood,,,control,Not reported,neonatal blood
Initial,450K,116,0.81,null,null,null,null,lung,EAGLE,Environment And Genetics in Lung cancer Etiology study,Current nonsmokers,Not reported,lung
Initial,450K,116,1,null,null,50,8,whole blood,,,Current (Case),European;Other,whole blood
Initial,450K,117,0.5,26.4,40.6,32.3,null,leukocyte,,,Healthy volunteers,Not reported,leukocyte
Initial,450K,117,0.89,null,null,50.2,8.7,whole blood,VACS,Veteran Aging Cohort Study,HIV-uninfected,African American or Afro-Caribbean;European;Other,whole blood
Initial,450K,117,null,null,null,43.5,4.5,whole blood,BHS,Bogalusa Heart Study,MetS+,African American or Afro-Caribbean,whole blood
Initial,450K,118,0,null,null,50.3,4.8,whole blood,Sister Study,National Institute of Environmental Health Sciences (NIEHS) Sister Study,Never-smoker,European,whole blood
Initial,450K,118,0.5,0,0,0,0,whole blood,IOW F2,,,European,whole blood
Initial,450K,118,null,null,null,31,4.4,cord blood,NHBCS,,,European,cord blood
Initial,450K,118,null,null,null,31,4.4,cord blood ,NHBCS,,,European,cord blood 
Initial,450K,119,0.57,25.5,47.8,34.3,null,leukocyte,,,Ulcerative colitis,Not reported,leukocyte
Initial,450K,12,0,null,null,26.8,2.2,peripheral blood mononuclear cell,,,Fetal Intolerance,African American or Afro-Caribbean,peripheral blood mononuclear cell
Initial,450K,12,0,null,null,50.5,3.6,whole blood,Sister Study,National Institute of Environmental Health Sciences (NIEHS) Sister Study,Current smoker,European,whole blood
Initial,450K,12,0,null,null,52.6,4.9,B-lymphocyte,,,control,European,B-lymphocyte
Initial,450K,12,0,null,null,52.6,4.9,T-lymphocyte,,,control,European,T-lymphocyte
Initial,450K,12,0,null,null,64.6,7.5,B-lymphocyte,,,RA,European,B-lymphocyte
Initial,450K,12,0,null,null,64.6,7.5,T-lymphocyte,,,RA,European,T-lymphocyte
Initial,450K,12,0,null,null,64.8,4.6,peripheral blood mononuclear cell,,,six-month self-management intervention,Not reported,peripheral blood mononuclear cell
Initial,450K,12,0.25,23,57,40.6,11.4,CD4+ T cell,,,control,East Asian,CD4+ T cell
Initial,450K,12,0.25,23,57,40.8,11.5,CD4+ T cell,,,RA,East Asian,CD4+ T cell
Initial,450K,12,0.25,null,null,40.6,11.4,CD4+ T cell,,,RA Controls,East Asian,CD4+ T cell
Initial,450K,12,0.25,null,null,40.8,11.5,CD4+ T cell,,,RA Patients,East Asian,CD4+ T cell
Initial,450K,12,0.33,0,0,0,0,CD4+ T cell,,,Healthy,Not reported,CD4+ T cell
Initial,450K,12,0.33,1,1,1,0,CD4+ T cell,,,Healthy,Not reported,CD4+ T cell
Initial,450K,12,0.42,0,0,0,0,umbilical cord blood,,,Infected,Not reported,umbilical cord blood
Initial,450K,12,0.42,0,0,0,0,umbilical cord blood,,,Non-infected,Not reported,umbilical cord blood
Initial,450K,12,0.42,2,30,16.1,8.5,whole blood,,,control,Not reported,whole blood
Initial,450K,12,0.42,4,30,16.3,8.4,whole blood,,,type 1 diabetes,Not reported,whole blood
Initial,450K,12,0.42,null,null,31.4,6.7,leukocyte,,,10‚Äâh after the first metformin intake,Not reported,leukocyte
Initial,450K,12,0.42,null,null,31.4,6.7,leukocyte,,,before starting a metformin therapy,Not reported,leukocyte
Initial,450K,12,0.42,null,null,31.4,6.7,leukocyte,,,time point after 7‚Äâdays of metformin administration,Not reported,leukocyte
Initial,450K,12,0.42,null,null,69,9.1,peripheral blood mononuclear cell,,,MZ twins Control,Not reported,peripheral blood mononuclear cell
Initial,450K,12,0.42,null,null,69,9.1,peripheral blood mononuclear cell,,,MZ twins Parkinson's disease,Not reported,peripheral blood mononuclear cell
Initial,450K,12,0.5,8.8,9.2,9,null,whole blood,PMNS,Pune Maternal Nutrition Study,B12 Supplementation,Not reported,whole blood
Initial,450K,12,0.5,null,null,43,13,neutrophil,,,control,European,neutrophil
Initial,450K,12,0.5,null,null,68.3,7.7,skeletal muscle,,,Type 2 diabetic,European,skeletal muscle
Initial,450K,12,0.5,null,null,68.3,7.7,subcutaneous adipose tissue,,,Non-diabetic,European,subcutaneous adipose tissue
Initial,450K,12,0.58,10.7,10.9,10.7,null,whole blood,PMNS,Pune Maternal Nutrition Study,Placebo,Not reported,whole blood
Initial,450K,12,0.58,47,65,60,4.9,gastric mucosa,,,gastric cancer patients,Not reported,gastric mucosa
Initial,450K,12,0.58,52,68,62,4.7,gastric mucosa,,,individuals with gastric atrophy,Not reported,gastric mucosa
Initial,450K,12,0.58,8.9,9.2,9.1,null,whole blood,PMNS,Pune Maternal Nutrition Study,Placebo,Not reported,whole blood
Initial,450K,12,0.6,8.9,9.2,8.9,null,whole blood,PMNS,Pune Maternal Nutrition Study,B12 + folic acid Supplementation,Not reported,whole blood
Initial,450K,12,0.66,20,50,37,10.9,whole blood,,,,European,whole blood
Initial,450K,12,0.75,0,0,0,0,CD4+ T cell,,,Food Allergy,Not reported,CD4+ T cell
Initial,450K,12,0.75,0,0,0,0,neonatal blood,,,Behavioral Disorders,Not reported,neonatal blood
Initial,450K,12,0.75,1,1,1,0,CD4+ T cell,,,Food Allergy,Not reported,CD4+ T cell
Initial,450K,12,0.75,null,null,71,7.2,peripheral blood mononuclear cell,,,Poor responder,East Asian,peripheral blood mononuclear cell
Initial,450K,12,1,18,24,21.1,2.7,leukocyte,,,4 wk (thrice weekly) of sprint interval training,Not reported,leukocyte
Initial,450K,12,1,24,28,26.3,null,sperm,GUTS,Growing Up Today Study,childhood abuse (None),European,sperm
Initial,450K,12,1,null,null,21.58,2.71,whole blood,,,Congenital hypopituitarism,Not reported,whole blood
Initial,450K,12,1,null,null,24,3.67,whole blood,,,Controls,Not reported,whole blood
Initial,450K,12,1,null,null,43.8,17.6,skin,,,PP,Not reported,skin
Initial,450K,12,1,null,null,68,15.5,peripheral blood mononuclear cell,,,Good responder,East Asian,peripheral blood mononuclear cell
Initial,450K,12,null,null,null,28.4,8,peripheral blood mononuclear cell,,,Responders,Not reported,peripheral blood mononuclear cell
Initial,450K,12,null,null,null,63.2,7.4,peripheral blood mononuclear cell,,,Non-responders,Not reported,peripheral blood mononuclear cell
Initial,450K,12,null,null,null,null,null,cartilage,,,knee OA patients,Not reported,cartilage
Initial,450K,12,null,null,null,null,null,peripheral blood mononuclear cell,,,non-COPD age-matched subjects,Not reported,peripheral blood mononuclear cell
Initial,450K,120,0,null,null,null,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers,Not reported,whole blood
Initial,450K,120,0.48,34,75,46.7,5.8,whole blood,BSGS,Brisbane Systems Genetics Study,,European,whole blood
Initial,450K,1202,0.49,52,68,60,null,whole blood,MESA,,,African American or Afro-Caribbean;European;Hispanic or Latin American,whole blood
Initial,450K,1207,0.48,null,null,69.6,9.4,CD14+ monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,African American or Afro-Caribbean;European;Hispanic or Latin American,CD14+ monocyte
Initial,450K,121,0,17,76,38,null,breast,,,,African American or Afro-Caribbean;European,breast
Initial,450K,121,0,28,91,62.2,11.3,leukocyte,,,case,European,leukocyte
Initial,450K,121,0.52,24.9,50.7,32.4,null,leukocyte,,,Crohn‚Äôs disease,Not reported,leukocyte
Initial,450K,121,0.89,null,null,null,null,lung,EAGLE,Environment And Genetics in Lung cancer Etiology study,Current smokers,Not reported,lung
Initial,450K,1216,null,null,null,null,null,cancer tissues,TCGA,The Cancer Genome Atlas,,Not reported,cancer tissues
Initial,450K,122,0.8,null,null,65.2,2.7,whole blood,HBCS,,,European,whole blood
Initial,450K,123,0,null,null,null,null,peripheral blood mononuclear cell,,,unaffected controls,Not reported,peripheral blood mononuclear cell
Initial,450K,123,0.41,null,null,null,null,whole blood,,,,Greater Middle Eastern,whole blood
Initial,450K,124,0.42,0,0,0,0,cord blood,,,Never-smokers,East Asian,cord blood
Initial,450K,124,0.516,null,null,null,null,tumor tissue,,,,Not reported,tumor tissue
Initial,450K,1249,0.675,null,null,69.1,8.1,whole blood,MCCS,Melbourne Collaborative Cohort Study,,Not reported,whole blood
Initial,450K,1251,0.48,null,null,60,9,CD14+ monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,"EA (n = 588), AA (n = 263) and Hispanic ancestry (n = 400)",African American or Afro-Caribbean;European;Hispanic or Latin American,CD14+ monocyte
Initial,450K,126,0.45,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Controls,Not reported,cord blood
Initial,450K,126,0.52,0,0,0,0,cord blood,GECKO,,Unexposed,European,cord blood
Initial,450K,1262,0.21,null,null,56.5,5.8,buffy coat,,,Never smokers,African American or Afro-Caribbean,buffy coat
Initial,450K,127,0.49,0,0,0,0,cord blood,,,,South Asian,cord blood
Initial,450K,127,0.51,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,450K,127,0.57,null,null,55.3,16.1,whole blood,TCGA,The Cancer Genome Atlas,Training group,African unspecified;Asian unspecified;European;Not reported,whole blood
Initial,450K,127,0.58,0,0,0,0,whole blood,CBC,,,Hispanic or Latin American,whole blood
Initial,450K,1275,0.51,null,null,60,9,whole blood,EPIC-Norfolk,European Prospective Investigation into Cancer and Nutrition,,European,whole blood
Initial,450K,1275,null,0,0,0,0,cord blood,MoBa,Norwegian Mother and Child Cohort Study,,European,cord blood
Initial,450K,128,0.24,null,null,38.4,12.9,whole blood,,,Never smokers,African American or Afro-Caribbean,whole blood
Initial,450K,129,0,null,null,56.57,3.98,buffy coat,NOWAC,Norwegian Women and Cancer Study,Controls,Not reported,buffy coat
Initial,450K,129,0.54,0,0,0,0,cord blood,GECKO,,,European,cord blood
Initial,450K,13,0,21,66,49.8,14.3,CD14+ monocyte,,,Myasthenia gravis,European,CD14+ monocyte
Initial,450K,13,0,null,null,40,9,whole blood,,,control,European,whole blood
Initial,450K,13,0,null,null,53.5,7.9,myoblast,,,women,Not reported,myoblast
Initial,450K,13,0,null,null,53.5,7.9,myotube,,,women,Not reported,myotube
Initial,450K,13,0.15,2.3,7,4.28,1.39,bone marrow,,,t(12;21),European,bone marrow
Initial,450K,13,0.23,0,0,0,0,placenta,,,EOPE,Not reported,placenta
Initial,450K,13,0.23,0,0,0,0,umbilical cord leukocyte,,,EOPE,Not reported,umbilical cord leukocyte
Initial,450K,13,0.46,35,79,59.6,9.8,colorectal tumour,,,Active smokers,Not reported,colorectal tumour
Initial,450K,13,1,null,null,17.2,4.3,whole blood,,EuroPrevall study,Tolerant control boys,European,whole blood
Initial,450K,13,1,null,null,24.4,5.19,sperm,,,control,Not reported,sperm
Initial,450K,13,1,null,null,52.4,5.3,myoblast,,,men,Not reported,myoblast
Initial,450K,13,1,null,null,52.4,5.3,myotube,,,men,Not reported,myotube
Initial,450K,130,1,0,0,0,0,whole blood,,,,European;Not reported,whole blood
Initial,450K,131,0,null,null,56.55,4.01,buffy coat,NOWAC,Norwegian Women and Cancer Study,Cases,Not reported,buffy coat
Initial,450K,131,0.53,0,0,0,0,whole blood,EARLI,,,Other admixed ancestry,whole blood
Initial,450K,132,0,30,74,49,15.5,whole blood,DTR,,,European,whole blood
Initial,450K,132,0.49,null,null,32.2,9.8,whole blood,,,Obese,Not reported,whole blood
Initial,450K,132,0.72,0,0,0,0,whole blood,NCL,Norway Facial Cleft Study,cleft lip and palate,European,whole blood
Initial,450K,132,0.76,null,null,59.5,14.6,liver,,,pairs of HCC tumor and adjacent non-tumor tissues,African American or Afro-Caribbean;Asian unspecified;European;Hispanic or Latin American;Other,liver
Initial,450K,132,null,null,null,27.2,5.7,whole blood,CBC,,,Hispanic or Latin American,whole blood
Initial,450K,132,null,null,null,27.2,5.7,whole blood,CBC ,,,Hispanic or Latin American,whole blood
Initial,450K,132,null,null,null,null,null,liver,,,paired HCC and adjacent normal,Not reported,liver
Initial,450K,134,0.35,65,91,null,null,leukocyte,,,,Not reported,leukocyte
Initial,450K,134,0.5,0,0,0,0,cord blood,NHBCS,New Hampshire Birth Cohort Study,,Not reported,cord blood
Initial,450K,135,0,33,88,62.4,11.4,leukocyte,,,control,European,leukocyte
Initial,450K,135,0,null,null,55.8,4.2,whole blood,NOWAC,,Never smokers,European,whole blood
Initial,450K,135,1,30,70,47,15,whole blood,DTR,,,European,whole blood
Initial,450K,136,0.58,0,0,0,0,whole blood,CBC,,,European,whole blood
Initial,450K,136,null,0,0,0,0,cord blood,GECKO,Groningen Expert Center for Kids with Obesity,,Not reported,cord blood
Initial,450K,137,0.78,null,null,46.5,8.9,whole blood,COW-1,,,East Asian,whole blood
Initial,450K,138,0,0,0,0,0,cord blood,,,,European;Not reported,cord blood
Initial,450K,138,0.49,0,0,0,0,cord blood,NHBCS,New Hampshire Birth Cohort Study,,European;Not reported,cord blood
Initial,450K,138,0.55,0,0,0,0,whole blood,PRISM,,,Other admixed ancestry,whole blood
Initial,450K,139,1,null,null,55.7,3.3,whole blood,ETS,Emory Twin Study,,European,whole blood
Initial,450K,139,null,null,null,null,null,bladder,,,,Not reported,bladder
Initial,450K,14,0,null,null,26.2,1.4,CD4+ T cell,,,Normal BMI,European,CD4+ T cell
Initial,450K,14,0,null,null,26.2,1.4,CD8+ T cell,,,Normal BMI,European,CD8+ T cell
Initial,450K,14,0,null,null,29.7,5.85,skeletal muscle,,,Controls,Not reported,skeletal muscle
Initial,450K,14,0,null,null,43.4,13.5,skin,,,NN,Not reported,skin
Initial,450K,14,0,null,null,null,null,whole blood,,,medically-indicated PTB,African American or Afro-Caribbean,whole blood
Initial,450K,14,0.33,0,0,0,0,chorionic villi,,,Anencephaly,European,chorionic villi
Initial,450K,14,0.57,0,0,0,0,cord blood T lymphocyte,,,Past depression group,European;Other,cord blood T lymphocyte
Initial,450K,14,0.64,2.3,10.3,4.65,2.42,bone marrow,,,Hyperdiploidy (HHD),European,bone marrow
Initial,450K,14,0.64,45,92,73.3,12.6,bladder,,,recurred,Not reported,bladder
Initial,450K,14,0.64,null,null,21.9,3.6,whole blood,,,Converters,Not reported,whole blood
Initial,450K,14,0.64,null,null,27,4,adipose tissue,LIPOGAIN,,,Not reported,adipose tissue
Initial,450K,14,0.64,null,null,27,4,adipose tissue,LIPOGAIN,,PUFA group Baseline,Not reported,adipose tissue
Initial,450K,14,0.64,null,null,67.6,7.7,adipose tissue,,,Nondiabetic,Not reported,adipose tissue
Initial,450K,14,0.64,null,null,67.6,7.7,adipose tissue,,,Type 2 diabetes,Not reported,adipose tissue
Initial,450K,14,0.71,19,39,30.3,7.3,whole blood,,,,European,whole blood
Initial,450K,14,1,25,50,null,null,sperm,,,nonsmoker,Not reported,sperm
Initial,450K,14,1,25,50,null,null,sperm,,,smoker,Not reported,sperm
Initial,450K,14,1,null,null,47.9,4.2,peripheral blood,SABRE,Southall And Brent REvisited,Former smokers,European,peripheral blood
Initial,450K,14,null,null,null,12,7.5,whole blood,,,patients with mutations in ARID1B,Not reported,whole blood
Initial,450K,141,0.52,0,0,0,0,placenta,RICHS,Rhode Island Child Health Study,,European;Not reported,placenta
Initial,450K,142,1,null,null,null,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers,Not reported,whole blood
Initial,450K,143,0.54,0,0,0,0,whole blood,PROGRESS,,,Hispanic or Latin American,whole blood
Initial,450K,144,0,null,null,57.7,7.1,leukocyte,EPIC Netherlands,,,European,leukocyte
Initial,450K,144,0,null,null,null,null,whole blood,,,controls,African American or Afro-Caribbean,whole blood
Initial,450K,144,null,30,36,33,null,whole blood,,,26 PTB,Not reported,whole blood
Initial,450K,145,0.52,13,79,35,null,brain,,,,Not reported,brain
Initial,450K,1450,0.44,null,null,63.7,8.1,whole blood,RS,Rotterdam Study,,European,whole blood
Initial,450K,146,0,null,null,null,null,whole blood,,,Early sPTBs,African American or Afro-Caribbean,whole blood
Initial,450K,147,0,30,39,null,null,saliva,,,,African American or Afro-Caribbean,saliva
Initial,450K,147,0.59,null,null,5.6,0.1,whole blood,EDEN,Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l‚Äô Enfant,,European,whole blood
Initial,450K,148,0.57,null,null,64.77,9.44,whole blood,EGCUT,,,European,whole blood
Initial,450K,149,0.59,7.5,7.5,7.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Current asthma,Not reported,whole blood
Initial,450K,1496,0.52,null,null,58.8,10.9,whole blood,FHS,Framingham Heart Study,,European,whole blood
Initial,450K,15,0,49,86,62,null,tumor tissue,,,,Not reported,tumor tissue
Initial,450K,15,0,null,null,37,10,neutrophil,,,SLE,European,neutrophil
Initial,450K,15,0.47,0,0,0,0,cord blood T lymphocyte,,,Control group,European;Other,cord blood T lymphocyte
Initial,450K,15,0.47,0,0,0,0,cord blood T lymphocyte,,,Current,European;Other,cord blood T lymphocyte
Initial,450K,15,0.53,22,58,null,null,peripheral blood mononuclear cell,,,Allergic participants,Not reported,peripheral blood mononuclear cell
Initial,450K,15,0.67,null,null,59.5,10.7,pancreatic islet,,,Type 2 diabetes,Not reported,pancreatic islet
Initial,450K,15,1,null,null,null,null,sperm,,,Current smokers,Not reported,sperm
Initial,450K,15,1,null,null,null,null,sperm,,,Never smokers,Not reported,sperm
Initial,450K,15,null,null,null,null,null,whole blood,,,No PD,Not reported,whole blood
Initial,450K,15,null,null,null,null,null,whole blood,,,PD + anxiety,Not reported,whole blood
Initial,450K,15,null,null,null,null,null,whole blood,,,PD + no anxiety,Not reported,whole blood
Initial,450K,150,0.23,null,null,71.6,6,whole blood,GENOA,Genetic Epidemiology Network of Atherosclerosis,,African American or Afro-Caribbean,whole blood
Initial,450K,150,0.51,57,74,null,null,buffy coat,BWD,,,European,buffy coat
Initial,450K,150,0.58,0,0,0,0,cord blood,EDEN,,,European,cord blood
Initial,450K,151,0.6,null,null,72.6,4.5,whole blood,BASICMAR_1,,type 2 diabetes mellitus,European,whole blood
Initial,450K,152,null,null,null,43.1,4.5,whole blood,BHS,Bogalusa Heart Study,MetS-,African American or Afro-Caribbean,whole blood
Initial,450K,1522,0.48,32,72,58.6,7.5,whole blood,KORA F4,Cooperative Health Research in the Region of Augsburg,"classified according to mild, moderate, or severe levels of anxiety (29.4%/6.0%/1.5%, respectively)",European,whole blood
Initial,450K,153,0.62,61,73,70,null,lung,TCGA,,Heavy smoking,Not reported,lung
Initial,450K,1538,0.51,null,null,67.4,8.5,whole blood,,,Former smokers,European,whole blood
Initial,450K,154,0.15,null,null,52.3,12.4,leukocyte,EnviroGenoMarkers,,EPIC-Italy,European,leukocyte
Initial,450K,155,0,36,70,52.6,7,whole blood,EPIC,European Prospective Investigation into Cancer and Nutrition,,European,whole blood
Initial,450K,155,0.53,35,71,54.7,6.9,whole blood,EPIC,European Prospective Investigation into Cancer and Nutrition,,European,whole blood
Initial,450K,155,null,null,null,32,5.7,cord blood,CBC,,,European,cord blood
Initial,450K,155,null,null,null,32,5.7,cord blood ,CBC,,,European,cord blood 
Initial,450K,157,null,0,0,0,0,cord blood,MoBa2,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,158,0,null,null,58.2,11.4,ovarian,TCGA,The Cancer Genome Atlas,recurrence >12 months,Not reported,ovarian
Initial,450K,158,0.608,17.9,86,65.4,null,tumor tissue,TCGA,The Cancer Genome Atlas,,Not reported,tumor tissue
Initial,450K,159,0,null,null,58.8,5.6,leukocyte,EPIC-Netherlands,European Prospective Investigation into Cancer and Nutrition,,European,leukocyte
Initial,450K,159,0.75,41,70,61,7.1,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,16,0,null,null,33.9,15.7,skin,,,paird PP / PN,Not reported,skin
Initial,450K,16,0.313,26,82,57,null,lung,,,Never smokers,Not reported,lung
Initial,450K,16,0.37,0,0,0,0,chorionic villi,,,control,European,chorionic villi
Initial,450K,16,0.44,null,null,28.7,46.5,peripheral blood mononuclear cell,,,30 hours diesel exhaust exposure,Asian unspecified;European;Greater Middle Eastern;South Asian,peripheral blood mononuclear cell
Initial,450K,16,0.44,null,null,28.7,46.5,peripheral blood mononuclear cell,,,30 hours filtered air exposure,Asian unspecified;European;Greater Middle Eastern;South Asian,peripheral blood mononuclear cell
Initial,450K,16,0.44,null,null,28.7,46.5,peripheral blood mononuclear cell,,,6 hours diesel exhaust exposure,Asian unspecified;European;Greater Middle Eastern;South Asian,peripheral blood mononuclear cell
Initial,450K,16,0.44,null,null,28.7,46.5,peripheral blood mononuclear cell,,,6 hours filtered air exposure,Asian unspecified;European;Greater Middle Eastern;South Asian,peripheral blood mononuclear cell
Initial,450K,16,0.44,null,null,28.7,46.5,peripheral blood mononuclear cell,,,pre-exposure,Asian unspecified;European;Greater Middle Eastern;South Asian,peripheral blood mononuclear cell
Initial,450K,16,0.56,0,0,0,0,placenta,,,control,Not reported,placenta
Initial,450K,16,0.56,18,88,69.6,21.3,glia,,,,European,glia
Initial,450K,16,0.56,18,88,69.6,21.3,neuron,,,,European,neuron
Initial,450K,16,0.563,42,71,56,null,lung,,,Current smokers,Not reported,lung
Initial,450K,16,0.75,0,0,0,0,neonatal blood,,,Psychological Development,Not reported,neonatal blood
Initial,450K,16,1,null,null,46.9,3.9,peripheral blood,SABRE,Southall And Brent REvisited,Current smokers,European,peripheral blood
Initial,450K,16,1,null,null,55.7,7.3,prostate gland tissue,,,adjacent normal tissues,Not reported,prostate gland tissue
Initial,450K,16,1,null,null,62.25,18.18,whole blood,,,8 atherosclerotic patients and 8 healthy subjects,Not reported,whole blood
Initial,450K,16,1,null,null,null,null,CD14+ monocyte,,,BD patients,Not reported,CD14+ monocyte
Initial,450K,16,1,null,null,null,null,CD14+ monocyte,,,healthy controls,Not reported,CD14+ monocyte
Initial,450K,16,1,null,null,null,null,CD4+ T cell,,,BD patients,Not reported,CD4+ T cell
Initial,450K,16,1,null,null,null,null,CD4+ T cell,,,healthy controls,Not reported,CD4+ T cell
Initial,450K,16,1,null,null,null,null,sperm,,,nonobstructive azoospermia,Not reported,sperm
Initial,450K,16,null,0,0,0,0,placenta,,,,European,placenta
Initial,450K,16,null,null,null,55.6,2.1,peripheral blood mononuclear cell,,,Non-SLE patients,European,peripheral blood mononuclear cell
Initial,450K,16,null,null,null,null,null,nasal epithelial cell,,,healthy controls,Not reported,nasal epithelial cell
Initial,450K,160,0.45,null,null,59.2,2,whole blood,,Dutch Hunger Winter Families study,,European,whole blood
Initial,450K,160,0.66,38,90,63,null,kidney,,,,Not reported,kidney
Initial,450K,160,1,58,69,63.5,2.8,whole blood,HBCS,Helsinki Birth Cohort Study,,European,whole blood
Initial,450K,161,0.55,null,null,65.4,6.8,whole blood,CODAM,,,European,whole blood
Initial,450K,162,0,null,null,null,null,breast,EPIC,European Prospective Investigation into Cancer and Nutrition,Cases,European,breast
Initial,450K,162,0,null,null,null,null,breast,EPIC,European Prospective Investigation into Cancer and Nutrition,Control,European,breast
Initial,450K,162,0.46,0,0,0,0,whole blood,Gen3G,,,European,whole blood
Initial,450K,163,0.52,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,450K,1630,0.48,null,null,60.99,8.89,whole blood,KORA F4,,,European,whole blood
Initial,450K,164,0.29,null,null,15.4,0.6,whole blood,,,Low-risk group,Not reported,whole blood
Initial,450K,164,0.5,null,null,65.6,6.8,whole blood,BIOS,Biobank-based Integrative Omics Study,,Not reported,whole blood
Initial,450K,164,0.85,null,null,50.6,null,whole blood,RODAM,Research on Obesity and Diabetes among African Migrants,No abdominal obesity,Sub-Saharan African,whole blood
Initial,450K,165,0.28,null,null,63.8,10.7,whole blood,REGICOR,EWAS nested in the Girona Heart Registry,"Former Smokers, > 5 y",European,whole blood
Initial,450K,165,0.46,null,null,86.7,0.4,whole blood,LBC1921,Lothian Birth Cohort 1921,,European,whole blood
Initial,450K,1658,0.49,32,81,61,8.9,whole blood,KORA F4,Cooperative Health Research in the Region of Augsburg,,European,whole blood
Initial,450K,166,0,56,78,66,null,whole blood,MADT,Middle Aged Danish Twins Study,Female,European,whole blood
Initial,450K,166,0.49,0,0,0,0,whole blood,INMA,,,European,whole blood
Initial,450K,166,0.54,40,88,69,null,saliva,PEG2,Parkinson‚Äôs Environment and Genes study,82 PD,European,saliva
Initial,450K,1669,null,null,null,18.4,0.36,whole blood,E-Risk,Environmental Risk Longitudinal Twin Study,,Not reported,whole blood
Initial,450K,168,null,null,null,65.1,10.66,lung,,,lung cancer female subjects,Not reported,lung
Initial,450K,169,0.45,null,null,58,6.8,whole blood,,,Current smokers,European,whole blood
Initial,450K,169,0.61,null,null,15,3,nasal epithelial cell,EVA-PR,Epigenetic Variation and Childhood Asthma in Puerto Ricans,Atopic asthma,Hispanic or Latin American,nasal epithelial cell
Initial,450K,17,0,null,null,31.2,5.4,skeletal muscle,,,PCOS,Not reported,skeletal muscle
Initial,450K,17,0.47,0,0,0,0,placenta,,,diabetes during pregnancy,Hispanic or Latin American;Native American,placenta
Initial,450K,17,0.47,null,null,49,null,whole blood,,,t(1;11) Carriers,Not reported,whole blood
Initial,450K,17,0.47,null,null,65.2,7.5,buffy coat,,,Non-exposure group (Generation 1),East Asian,buffy coat
Initial,450K,17,0.47,null,null,null,null,placenta,,,Control,Hispanic or Latin American;Native American,placenta
Initial,450K,17,0.471,null,null,81.54,9.16,hippocampus,,,symptomatic AD,Not reported,hippocampus
Initial,450K,17,0.52,null,null,61.4,11.4,peripheral blood mononuclear cell,,,Parkinson's disease,Not reported,peripheral blood mononuclear cell
Initial,450K,17,0.71,null,null,26.9,4.7,adipose tissue,LIPOGAIN,,SFA group Baseline,Not reported,adipose tissue
Initial,450K,17,0.71,null,null,65.7,8.1,tumor tissue,,,Obese,Not reported,tumor tissue
Initial,450K,17,0.76,null,null,26.9,4.7,adipose tissue,LIPOGAIN,,SFA group Overfeeding,Not reported,adipose tissue
Initial,450K,17,1,23,29,25.2,null,sperm,GUTS,Growing Up Today Study,childhood abuse (High),European,sperm
Initial,450K,17,1,null,null,40.1,7.5,whole blood,DILGOM,"DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study",insufcient sleep,Not reported,whole blood
Initial,450K,17,1,null,null,41.8,8.8,whole blood,Airline,,insufcient sleep,Not reported,whole blood
Initial,450K,17,1,null,null,null,null,subcutaneous adipose tissue,LIPOGAIN,,,Not reported,subcutaneous adipose tissue
Initial,450K,17,null,null,null,55.6,2.1,peripheral blood mononuclear cell,,,Non-SLE patients,African American or Afro-Caribbean,peripheral blood mononuclear cell
Initial,450K,17,null,null,null,null,null,colon,,,normal healthy individuals,Not reported,colon
Initial,450K,17,null,null,null,null,null,kidney,,,,Not reported,kidney
Initial,450K,17,null,null,null,null,null,thyroid,,,benign thyroid lesions,Not reported,thyroid
Initial,450K,170,0.72,null,null,74.3,12.2,whole blood,,,Former smokers,European,whole blood
Initial,450K,170,null,null,null,28,4.1,cord blood,GEN3G,,,European,cord blood
Initial,450K,170,null,null,null,28,4.1,cord blood ,GEN3G,,,European,cord blood 
Initial,450K,1709,0.49,null,null,61,8.9,whole blood,KORA F4,Cooperative Health Research in the Region of Augsburg,,European,whole blood
Initial,450K,171,0.46,null,null,15,3,nasal epithelial cell,EVA-PR,Epigenetic Variation and Childhood Asthma in Puerto Ricans,No atopy,Hispanic or Latin American,nasal epithelial cell
Initial,450K,171,1,null,null,49.5,7.6,whole blood,,,Current (Case),European;Other,whole blood
Initial,450K,172,1,57,79,66,null,whole blood,MADT,Middle Aged Danish Twins Study,Male,European,whole blood
Initial,450K,1727,0.49,null,null,61,8.9,whole blood,KORA,,,European,whole blood
Initial,450K,173,0.53,58,74,66.4,null,lung,TCGA,,Light smoking,Not reported,lung
Initial,450K,1730,0.48,null,null,67,9,whole blood,FHS,Framingham Heart Study,,European,whole blood
Initial,450K,175,0.45,null,null,57.9,6.6,whole blood,RS,Rotterdam Study,Current smokers,European,whole blood
Initial,450K,176,null,18,18,18,0,whole blood,IoW,Isle of Wight,,European,whole blood
Initial,450K,176,null,null,null,30.4,4,cord blood,GECKO,,,European,cord blood
Initial,450K,178,0.44,48,94,67.6,9.5,whole blood,SATSA,The Swedish Adoption/Twin Study of Aging,,European,whole blood
Initial,450K,179,0.56,6,17,10.7,null,whole blood,CNTR,Chinese National Twin Registry,,East Asian,whole blood
Initial,450K,1797,0.49,null,null,60,9,whole blood,KORA F4,Cooperative Health Research in the Region of Augsburg,,European,whole blood
Initial,450K,1799,0.49,null,null,60.92,8.9,whole blood,KORA F4,Cooperative Health Research in the Region of Augsburg,,Not reported,whole blood
Initial,450K,1799,0.49,null,null,61,8.9,whole blood,KORA,,,European,whole blood
Initial,450K,18,0,22,43,null,null,whole blood,,,case,Not reported,whole blood
Initial,450K,18,0.167,null,null,37.7,12.5,leukocyte,,,Simple hepatic steatosis,East Asian,leukocyte
Initial,450K,18,0.28,16,69,29.5,null,CD4+ T cell,,,,Not reported,CD4+ T cell
Initial,450K,18,0.44,0,0,0,0,cord blood,,,Array cohort A Controls,European,cord blood
Initial,450K,18,0.44,null,null,10.8,3.5,buffy coat,,,Exposure group (Generation 3),East Asian,buffy coat
Initial,450K,18,0.44,null,null,29.8,9,muscle,,,Kwashiorkor,Not reported,muscle
Initial,450K,18,0.56,22,79,56.6,12.5,colorectal mucosa,,,Active smokers,Not reported,colorectal mucosa
Initial,450K,18,0.56,null,null,9.4,2.5,leukocyte,,,Siblings not exposed to GDM in utero,Not reported,leukocyte
Initial,450K,18,0.61,null,null,5.8,1.4,leukocyte,,,Siblings exposed to GDM in utero,Not reported,leukocyte
Initial,450K,18,0.71,11,14.3,12.7,null,leukocyte,BISCUIT,Scottish Children Undergoing Investigation before Treatment study,controls,Not reported,leukocyte
Initial,450K,18,0.71,12.2,14.1,11.9,null,leukocyte,BISCUIT,Scottish Children Undergoing Investigation before Treatment study,patients,Not reported,leukocyte
Initial,450K,18,0.72,null,null,54.9,4,left ventricle,,,case,Not reported,left ventricle
Initial,450K,18,0.89,null,null,33.6,5.2,buffy coat,,,Exposure group (Generation 2),East Asian,buffy coat
Initial,450K,18,null,null,null,49.4,2,peripheral blood mononuclear cell,,,SLE patients,European,peripheral blood mononuclear cell
Initial,450K,18,null,null,null,null,null,tumor tissue,,,Adrenocortical carcinomas,Not reported,tumor tissue
Initial,450K,180,0,null,null,null,null,leukocyte,EPIC-Turin,European Prospective Investigation into Cancer and Nutrition,,Not reported,leukocyte
Initial,450K,181,0.39,33,49,43.2,3.9,whole blood,YFS,Young Finns Study,,European,whole blood
Initial,450K,181,1,null,null,19.2,0.7,lymphocyte,,Strong African- American Healthy Adults project,,African American or Afro-Caribbean,lymphocyte
Initial,450K,1814,null,32,81,null,null,whole blood,KORA F4,,,Not reported,whole blood
Initial,450K,1823,0.47,null,null,63.5,7.3,whole blood,FHS Offspring,Framingham Offspring Study,,European,whole blood
Initial,450K,184,0.4,16.5,16.5,16.5,16.5,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Current asthma,Not reported,whole blood
Initial,450K,184,0.48,0,0,0,0,placenta,RICHS,The Rhode Island Child Health Study,Non-night shift,Not reported,placenta
Initial,450K,184,0.6,null,null,62.4,9.4,whole blood,BIOS,Biobank-based Integrative Omics Study,,Not reported,whole blood
Initial,450K,184,0.72,null,null,59,8.1,whole blood,RS,Rotterdam Study,Never smokers,European,whole blood
Initial,450K,184,null,null,null,null,null,whole blood,,,,European,whole blood
Initial,450K,185,0.45,null,null,76,5,whole blood,CHS,Cardiovascular Health Study,,European,whole blood
Initial,450K,186,0.45,null,null,65.3,7,leukocyte,CODAM,Cohort on Diabetes and Atherosclerosis Maastricht ,,European,leukocyte
Initial,450K,187,0,null,null,50.5,4.8,whole blood,,Sister Study,,Not reported,whole blood
Initial,450K,187,0.51,6,12,null,null,whole blood,ICAC,,,African American or Afro-Caribbean,whole blood
Initial,450K,187,1,null,null,73.8,7.3,whole blood,,,Never smokers,European,whole blood
Initial,450K,189,0,null,null,51.6,8.9,whole blood,EPIC,European Prospective Investigation into Cancer and Nutrition,Former smokers,European,whole blood
Initial,450K,189,null,null,null,76,5.1,blood,CHS,Cardiovascular Health Study,,European,blood
Initial,450K,19,0,null,null,38,0.2,peripheral blood mononuclear cell,,,smoking within 5 years,European,peripheral blood mononuclear cell
Initial,450K,19,0,null,null,58.26,10.61,CD19+ B cell,,,Female control,Not reported,CD19+ B cell
Initial,450K,19,0.47,null,null,25,5.7,muscle,,,Marasmus,Not reported,muscle
Initial,450K,19,0.63,53,81,66.3,8.5,white matter,,,control,Not reported,white matter
Initial,450K,19,0.63,null,null,73.6,6.6,retinal pigment epithelium,,,normal control,Not reported,retinal pigment epithelium
Initial,450K,19,0.68,58,76,67.9,5.4,carotid,,,Carotid atherosclerotic samples,Not reported,carotid
Initial,450K,19,0.74,0,0,0,0,cord blood,MoBa,Norwegian Mother and Child Cohort Study,prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder,European,cord blood
Initial,450K,19,1,19,36,26,4.8,sperm,,,control,Not reported,sperm
Initial,450K,19,1,null,null,51.1,null,peripheral blood mononuclear cell,,,HIV-infected,Not reported,peripheral blood mononuclear cell
Initial,450K,19,1,null,null,51.1,null,peripheral blood mononuclear cell,,,HIV-uninfected,Not reported,peripheral blood mononuclear cell
Initial,450K,19,1,null,null,61.21,8.55,CD19+ B cell,,,Male CLL,Not reported,CD19+ B cell
Initial,450K,19,1,null,null,null,null,sperm,,,heavy smokers,Not reported,sperm
Initial,450K,190,0,null,null,51.3,8.9,buffy coat,,,Former smokers,European,buffy coat
Initial,450K,190,0.35,null,null,73,5,whole blood,CHS,Cardiovascular Health Study,,African American or Afro-Caribbean,whole blood
Initial,450K,190,0.42,5,14,10.2,null,saliva,,,94 maltreated children and 96 healthy control children,African American or Afro-Caribbean;European;Hispanic or Latin American;Other admixed ancestry,saliva
Initial,450K,190,0.44,0,0,0,0,cord blood,,,,East Asian,cord blood
Initial,450K,191,0.5,null,null,8.1,0.3,whole blood,PIAMA,Prevention and Incidence of Asthma and Mite Allergy,,European,whole blood
Initial,450K,191,0.54,null,null,58.3,8.4,buffy coat,,,Current smokers,European,buffy coat
Initial,450K,191,0.62,null,null,50.1,14.4,prefrontal cortex,,,schizophrenia,European;Not reported,prefrontal cortex
Initial,450K,192,0.42,5,14,10.2,null,saliva,,,96 were maltreated children,African American or Afro-Caribbean;European;Hispanic or Latin American;Other admixed ancestry,saliva
Initial,450K,192,0.55,null,null,36.2,18.8,peripheral blood mononuclear cell,,,,European,peripheral blood mononuclear cell
Initial,450K,192,1,62,71,66,null,whole blood,KING,,,African American or Afro-Caribbean;European;Hispanic or Latin American,whole blood
Initial,450K,192,1,null,null,65.8,6,whole blood,,,Controls,East Asian,whole blood
Initial,450K,192,1,null,null,65.9,6.4,whole blood,,,Cases,East Asian,whole blood
Initial,450K,193,0,null,null,48.6,8.8,whole blood,EPIC,European Prospective Investigation into Cancer and Nutrition,Current smokers,European,whole blood
Initial,450K,193,0.52,0,0,0,0,cord blood,MoBa,Mother and Child Cohort Study,,European,cord blood
Initial,450K,193,0.55,null,null,65.3,11,tumor tissue and adjacent normal tissue,,,pancreatic adenocarcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,193,0.56,8,10,null,null,whole blood,GALA II,,,Not reported,whole blood
Initial,450K,1935,0.39,null,null,65,9,whole blood,FHS,,,European,whole blood
Initial,450K,194,0.53,16.5,16.5,16.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Ever asthma,Not reported,whole blood
Initial,450K,194,0.56,36,70,54.4,6.4,whole blood,EPIC,European Prospective Investigation into Cancer and Nutrition,,European,whole blood
Initial,450K,194,0.68,null,null,64.9,8.3,carotid plaque,AEMS450K1,Athero-Express Biobank Study,Current Smokers,Not reported,carotid plaque
Initial,450K,195,0,null,null,59.1,9.71,skin,TwinsUK,,37 current smokers and 158 non-smokers cancer-free female subjects,European,skin
Initial,450K,195,0.5,null,null,58.1,6.7,whole blood,,Rotterdam Study,Current smokers,European,whole blood
Initial,450K,196,0,null,null,48.9,8.8,buffy coat,,,Current smokers,European,buffy coat
Initial,450K,196,0.45,null,null,1.4,null,leukocyte,,,Controls,Not reported,leukocyte
Initial,450K,196,null,null,null,73,5.4,blood,CHS,Cardiovascular Health Study,,African American or Afro-Caribbean,blood
Initial,450K,196,null,null,null,null,null,whole blood,,,diabetic kidney disease,European,whole blood
Initial,450K,197,0.5,4,16,null,null,whole blood,PIAMA,,,European,whole blood
Initial,450K,197,0.51,0,0,0,0,cord blood,ENVIRONAGE,,,European,cord blood
Initial,450K,199,0.4,0,0,0,0,whole blood,CHS,,,Other admixed ancestry,whole blood
Initial,450K,199,0.47,null,null,39.6,16.9,whole blood,F5L,The French-Canadian Family study on Factor V Leiden,,Not reported,whole blood
Initial,450K,2,0.5,11.5,14.3,12.9,1.97,bone marrow,,,t(9;22),European,bone marrow
Initial,450K,2,0.5,null,null,null,null,metastatic tumor,,,metastatic tumors,East Asian,metastatic tumor
Initial,450K,2,0.5,null,null,null,null,primary tumor,,,primary tumor,East Asian,primary tumor
Initial,450K,2,1,43,55,49,8.5,gastric mucosa,,,unsuccessfully eradicated,East Asian,gastric mucosa
Initial,450K,2,1,43,55,49,8.5,leukocyte,,,unsuccessfully eradicated,East Asian,leukocyte
Initial,450K,2,null,null,null,null,null,BEAS-2B cell,,,,Not reported,BEAS-2B cell
Initial,450K,2,null,null,null,null,null,lymphoblastoid cell line,,,healthy control,Not reported,lymphoblastoid cell line
Initial,450K,20,0,null,null,47,null,saliva,,,Folic acid 200¬µg/day,Not reported,saliva
Initial,450K,20,0,null,null,63.1,4.8,peripheral blood mononuclear cell,,,control,Not reported,peripheral blood mononuclear cell
Initial,450K,20,0.3,null,null,26.5,6.7,whole blood,,,Controls,European,whole blood
Initial,450K,20,0.35,null,null,36.2,null,leukocyte,,,with depressive symptoms,Not reported,leukocyte
Initial,450K,20,0.4,null,null,36.6,6.6,whole blood,,,Case Group I,European,whole blood
Initial,450K,20,0.45,null,null,79.69,9.64,entorhinal Cortex,,,symptomatic AD,Not reported,entorhinal Cortex
Initial,450K,20,0.5,0,0,0,0,placenta,,,normotensive preterm birth,Not reported,placenta
Initial,450K,20,0.5,0,0,0,0,umbilical cord leukocyte,,,normotensive preterm birth,Not reported,umbilical cord leukocyte
Initial,450K,20,0.5,null,null,17.2,7.1,whole blood,,EuroPrevall study,Controls,European,whole blood
Initial,450K,20,0.55,0,0,0,0,cord blood,,,Array cohort A insulin-treated GDM,European,cord blood
Initial,450K,20,0.6,null,null,11.8,4.8,whole blood,,EuroPrevall study,cow‚Äôs milk allergy,European,whole blood
Initial,450K,20,0.6,null,null,null,null,whole blood,,,carriers of the linked haplotye (LH),Not reported,whole blood
Initial,450K,20,0.8,10,null,6,15,nasal epithelial cell,,,,African unspecified;European;Other admixed ancestry,nasal epithelial cell
Initial,450K,20,1,21,51,35.3,8.9,peripheral blood mononuclear cell,,,,African American or Afro-Caribbean;Asian unspecified;European;Other admixed ancestry,peripheral blood mononuclear cell
Initial,450K,20,1,null,null,28.9,1.3,sperm,,,Low motility,Not reported,sperm
Initial,450K,20,1,null,null,36.4,3.2,sperm,,,m proven fertile males,Not reported,sperm
Initial,450K,20,1,null,null,36.4,3.2,sperm,,,oligospermic males,Not reported,sperm
Initial,450K,20,1,null,null,47.8,4.3,peripheral blood,SABRE,Southall And Brent REvisited,Current smokers,South Asian,peripheral blood
Initial,450K,20,1,null,null,null,null,sperm,,,nonsmokers,Not reported,sperm
Initial,450K,20,null,19.7,42.9,33.5,null,chorionic villi,,,EOPET,Not reported,chorionic villi
Initial,450K,20,null,25,37.3,31.8,null,chorionic villi,,,control,Not reported,chorionic villi
Initial,450K,20,null,null,null,null,null,bone marrow,,,ETV6-RUNX1,Not reported,bone marrow
Initial,450K,20,null,null,null,null,null,bone marrow,,,high hyperdiploidy (51‚Äì65 chromosomes),Not reported,bone marrow
Initial,450K,20,null,null,null,null,null,whole blood,,,healthy individuals,East Asian,whole blood
Initial,450K,200,1,58,67,62,null,whole blood,ESTHER,,,European,whole blood
Initial,450K,2003,0.36,null,null,56,6,whole blood,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,whole blood
Initial,450K,201,0.33,null,null,79.1,0.6,whole blood,,,Never smokers,European,whole blood
Initial,450K,201,0.85,null,null,63,11.9,tumor tissue and adjacent normal tissue,,,esophageal carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,202,1,null,null,50,8.4,whole blood,,,Never (Control),European;Other,whole blood
Initial,450K,2029,0.31,null,null,36.4,12.4,whole blood,NTR,Netherlands Twin Register,,Not reported,whole blood
Initial,450K,203,0.5,null,null,61,6.95,leukocyte,,,Japanese Americans,East Asian,leukocyte
Initial,450K,204,0.5,null,null,10.3,1.3,whole blood,EPOCH,Exploring Perinatal Outcomes in Children study,gestational diabetes-unexposed,Not reported,whole blood
Initial,450K,204,0.53,16.5,16.5,16.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Ever wheeze,Not reported,whole blood
Initial,450K,204,0.57,null,null,75,11.4,whole blood,BASICMAR_1,,control,European,whole blood
Initial,450K,205,0.52,0,0,0,0,whole blood,MoBa3,,,European,whole blood
Initial,450K,207,0.54,0,0,0,0,placenta,,,,African unspecified;Hispanic or Latin American;Other admixed ancestry,placenta
Initial,450K,207,0.55,null,null,57.1,7,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers follow-up,Not reported,whole blood
Initial,450K,2097,0.36,47,70,56.2,5.7,leukocyte,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,leukocyte
Initial,450K,21,0.38,2,29,9,null,whole blood,,,Control,Not reported,whole blood
Initial,450K,21,0.38,2,31,9,null,whole blood,,,17q12 deletion,Not reported,whole blood
Initial,450K,21,0.43,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Active ED,Not reported,cord blood
Initial,450K,21,0.48,null,null,null,null,peripheral blood mononuclear cell,,,Non-responders,Not reported,peripheral blood mononuclear cell
Initial,450K,21,0.524,null,null,79.95,9.46,dorsolateral prefrontal cortex,,,Symptomatic AD,Not reported,dorsolateral prefrontal cortex
Initial,450K,21,1,null,null,null,null,ascending aortic tissue,,,,Not reported,ascending aortic tissue
Initial,450K,21,null,null,null,0.72,0.06,leukocyte,,,Controls,African American or Afro-Caribbean;European;Hispanic or Latin American,leukocyte
Initial,450K,210,0.37,null,null,59.2,8.4,whole blood,,,Never smokers,European,whole blood
Initial,450K,210,0.37,null,null,59.2,8.4,whole blood,,Rotterdam Study,Never smokers,European,whole blood
Initial,450K,210,0.48,null,null,39.8,16.8,leukocyte,,FrenchCanadian family study on F5L thrombophilia,,European,leukocyte
Initial,450K,2106,0.37,null,null,56,6,whole blood,ARIC,,,African American or Afro-Caribbean,whole blood
Initial,450K,211,0.48,null,null,39.7,16.8,whole blood,F5L,,,European,whole blood
Initial,450K,211,0.5,null,null,28.17,14.83,whole blood,SFS,STANISLAS Family Study,,European,whole blood
Initial,450K,211,null,null,null,34,4.7,cord blood,EARLI,,,European;Other admixed ancestry,cord blood
Initial,450K,211,null,null,null,34,4.7,cord blood ,EARLI,,,European;Other admixed ancestry,cord blood 
Initial,450K,212,0.52,null,null,4.4,0.2,whole blood,INMA-SAB,Infancia y Medio Ambiente,,European,whole blood
Initial,450K,213,0.46,null,null,79.1,0.6,whole blood,,,Former smokers,European,whole blood
Initial,450K,213,0.51,0,0,0,0,cord blood,NEST,,,Not reported,cord blood
Initial,450K,213,1,null,null,37.6,10.1,whole blood,NTR,Netherlands Twin Register,31 cases and 182 controls,Not reported,whole blood
Initial,450K,214,0.54,null,null,4.1,0.2,whole blood,PIAMA,Prevention and Incidence of Asthma and Mite Allergy,,European,whole blood
Initial,450K,214,0.56,8,8,8,0,whole blood,BAMSE MeDALL,,,European,whole blood
Initial,450K,2148,0.46,40,92,65,null,peripheral blood mononuclear cell,FHS offspring,Framingham Heart Study Offspring Cohort,,European,peripheral blood mononuclear cell
Initial,450K,215,0.59,40,70,58.1,7.5,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,216,0,null,null,54.2,6.4,whole blood,EPIC-Italy,,,Not reported,whole blood
Initial,450K,216,0.39,null,null,8.2,9.1,peripheral blood,,,controls,Not reported,peripheral blood
Initial,450K,216,0.58,null,null,56,14,CD4+ T cell,,,Former smokers,European,CD4+ T cell
Initial,450K,217,null,null,null,null,null,kidney,,,,Not reported,kidney
Initial,450K,218,0,null,null,19.3,0.7,lymphocyte,,Strong African- American Healthy Adults project,,African American or Afro-Caribbean,lymphocyte
Initial,450K,219,0.26,null,null,65.9,6.4,whole blood,GENOA,Genetic Epidemiology Network of Arteriopathy,,African American or Afro-Caribbean,whole blood
Initial,450K,2199,0.31,null,null,38.2,12.6,leukocyte,NTR,,,Not reported,leukocyte
Initial,450K,22,0,51,89,null,null,peripheral blood mononuclear cell,CaMos,Canadian Multicenter Osteoporosis Study,osteoporosis subjects,Not reported,peripheral blood mononuclear cell
Initial,450K,22,0,52,85,null,null,peripheral blood mononuclear cell,CaMos,Canadian Multicenter Osteoporosis Study,normal subjects,Not reported,peripheral blood mononuclear cell
Initial,450K,22,0,9,12,10.9,1.26,saliva,,,,European;Not reported,saliva
Initial,450K,22,0,null,null,38,0.2,peripheral blood mononuclear cell,,,never-smokers,European,peripheral blood mononuclear cell
Initial,450K,22,0,null,null,38.2,11.1,CD4+ T cell,,,control,Not reported,CD4+ T cell
Initial,450K,22,0,null,null,58,19.13,CD19+ B cell,,,Healthy controls,European,CD19+ B cell
Initial,450K,22,0.27,16,69,34,null,CD14+ monocyte,,,,Not reported,CD14+ monocyte
Initial,450K,22,0.46,null,null,21.4,3.2,whole blood,BFS,Scottish Bipolar Family Study,well high-risk individuals who developed a mood disorder,Not reported,whole blood
Initial,450K,22,0.5,0,0,0,0,cord blood,PELS,Prenatal Early Life Stress cohort,Low pregnancy anxiety,European,cord blood
Initial,450K,22,0.5,null,null,38.1,5.6,whole blood,,,Controls,African American or Afro-Caribbean;European;Other,whole blood
Initial,450K,22,0.5,null,null,41.6,2.8,leukocyte,CARDIA,Coronary Artery Risk Development in Young Adults,,European,leukocyte
Initial,450K,22,0.55,null,null,36.3,9.3,whole blood,,,Intermittent explosive disorder,African American or Afro-Caribbean;European;Other,whole blood
Initial,450K,22,0.64,0,0,0,0,placenta,,,early-onset preeclampsia,Asian unspecified;European;Other,placenta
Initial,450K,220,0.57,null,null,55.2,6.8,whole blood,,Cardiogenics Consortium,Healthy blood donors,European,whole blood
Initial,450K,224,0.35,null,null,50.1,10.1,leukocyte,EnviroGenoMarkers,,NSHDS,European,leukocyte
Initial,450K,2249,0.46,null,null,66,8.8,whole blood,FHS,Framingham Heart Study,,European,whole blood
Initial,450K,226,0.41,0,0,0,0,cord blood,CHS,Children‚Äôs Health Study,,European,cord blood
Initial,450K,2264,0.37,null,null,56.2,5.8,whole blood,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,whole blood
Initial,450K,227,0.36,null,null,52.4,8.1,whole blood,GS,,,European,whole blood
Initial,450K,227,0.43,15,17,null,null,whole blood,ALSPAC,,,European,whole blood
Initial,450K,228,0.43,18.9,35.6,27.8,3.3,leukocyte,BP stress,Blood Pressure (BP) stress,,African American or Afro-Caribbean,leukocyte
Initial,450K,229,0,0,0,0,0,cord blood,,,Girls,African unspecified;European;Hispanic or Latin American;Other,cord blood
Initial,450K,229,0.4,0,0,0,0,cord blood,CHS,,,Not reported,cord blood
Initial,450K,23,0,null,null,47,null,saliva,,,Folic acid 5 mg/day,Not reported,saliva
Initial,450K,23,0.3,null,null,41,6.2,liver,,,Non-diabetic individuals with obesity,Not reported,liver
Initial,450K,23,0.3,null,null,41,6.2,subcutaneous adipose tissue,,,Non-diabetic individuals with obesity,Not reported,subcutaneous adipose tissue
Initial,450K,23,0.3,null,null,41,6.2,visceral adipose tissue,,,Non-diabetic individuals with obesity,Not reported,visceral adipose tissue
Initial,450K,23,0.3,null,null,41.8,9.9,liver,,,Diabetic individuals with obesity,Not reported,liver
Initial,450K,23,0.3,null,null,41.8,9.9,subcutaneous adipose tissue,,,Diabetic individuals with obesity,Not reported,subcutaneous adipose tissue
Initial,450K,23,0.3,null,null,41.8,9.9,visceral adipose tissue,,,Diabetic individuals with obesity,Not reported,visceral adipose tissue
Initial,450K,23,0.35,null,null,58.9,15.8,B-lymphocyte,,,Early RA,European,B-lymphocyte
Initial,450K,23,0.35,null,null,58.9,15.8,T-lymphocyte,,,Early RA,European,T-lymphocyte
Initial,450K,23,0.35,null,null,74.1,4.2,whole blood,,,Current smokers,European,whole blood
Initial,450K,23,0.43,null,null,47.1,10.7,leukocyte,,,Low folate (<300 Œºg/d),European,leukocyte
Initial,450K,23,0.43,null,null,null,null,peripheral blood mononuclear cell,,,Responders,Not reported,peripheral blood mononuclear cell
Initial,450K,23,0.52,0,0,0,0,neonatal blood,,,Intellectual Disability,Not reported,neonatal blood
Initial,450K,23,0.52,2,35,12,null,lymphocyte,,,,Not reported,lymphocyte
Initial,450K,23,0.52,null,null,27,0.8,skeletal muscle,,,,Not reported,skeletal muscle
Initial,450K,23,0.52,null,null,41.2,2.6,leukocyte,CARDIA,Coronary Artery Risk Development in Young Adults,high exposed,European,leukocyte
Initial,450K,23,0.57,0,0,0,0,cord blood,PELS,Prenatal Early Life Stress cohort,High pregnancy anxiety,European,cord blood
Initial,450K,23,0.57,null,null,21.7,2.8,whole blood,BFS,Scottish Bipolar Family Study,well high-risk individuals who remained well,Not reported,whole blood
Initial,450K,23,1,null,null,29.1,1.2,sperm,,,Low viability,Not reported,sperm
Initial,450K,23,1,null,null,37.3,4.4,adipose tissue,,,After exercise,Not reported,adipose tissue
Initial,450K,23,1,null,null,37.3,4.4,adipose tissue,,,Baseline,Not reported,adipose tissue
Initial,450K,23,1,null,null,46.9,10.3,CD3+ T cell,,,Controls,Not reported,CD3+ T cell
Initial,450K,23,1,null,null,62.2,12.6,peripheral blood mononuclear cell,,,control,Not reported,peripheral blood mononuclear cell
Initial,450K,23,null,null,null,0.72,0.05,leukocyte,,,CP Cases,African American or Afro-Caribbean;European;Hispanic or Latin American,leukocyte
Initial,450K,230,0.33,null,null,42,12,whole blood,GTP,Grady Trauma Project,,African American or Afro-Caribbean,whole blood
Initial,450K,2307,0.35,null,null,56.2,5.7,whole blood,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,whole blood
Initial,450K,231,null,null,null,29.6,4.4,cord blood,MoBa3,,,European,cord blood
Initial,450K,231,null,null,null,29.6,4.4,cord blood ,MoBa3,,,European,cord blood 
Initial,450K,232,0.15,null,null,61,7.4,buffy coat,,,Never smokers,African American or Afro-Caribbean,buffy coat
Initial,450K,232,0.53,null,null,8.3,0.4,whole blood,BAMSE,Children‚Äôs Allergy Environment Stockholm Epidemiology study,,European,whole blood
Initial,450K,235,0.57,null,null,79.1,0.55,whole blood,LBC1921,Lothian Birth Cohort 1921,,Not reported,whole blood
Initial,450K,237,0,null,null,53.1,7.2,whole blood,EPIC-Italy,,,Not reported,whole blood
Initial,450K,2377,0.45,null,null,67,9,whole blood,FHS,Framingham Heart Study,,Not reported,whole blood
Initial,450K,238,0.24,73,90,null,null,buffy coat,LSADT,Longitudinal Study of Aging Danish Twins,,European,buffy coat
Initial,450K,239,0.85,null,null,55.2,6.8,whole blood,,Cardiogenics Consortium,myocardial infarction,European,whole blood
Initial,450K,239,null,null,null,60.1,8.4,leukocyte,GENOA,Genetic Epidemiology Network of Atherosclerosis,,African American or Afro-Caribbean,leukocyte
Initial,450K,24,0,19,35,26.83,5.34,whole blood,,,,African American or Afro-Caribbean;European;Hispanic or Latin American;Other,whole blood
Initial,450K,24,0,24,47,36,null,whole blood,NIHS,Norfolk Island Health Study,Norfolk Island,European,whole blood
Initial,450K,24,0,null,null,56.6,13.8,CD19+ B cell,,,Patients with pSS,European,CD19+ B cell
Initial,450K,24,0,null,null,63.24,7.8,saliva,,,Grandmothers - CDV+,Not reported,saliva
Initial,450K,24,0.13,null,null,55,15,whole blood,,,pSS high fatigue,European,whole blood
Initial,450K,24,0.17,null,null,57,13,whole blood,,,pSS low fatigue,European,whole blood
Initial,450K,24,0.21,null,null,46.8,10,CD4+ T cell,,,SSc Controls,East Asian,CD4+ T cell
Initial,450K,24,0.21,null,null,46.8,10,CD8+ T cell,,,SSc Controls,East Asian,CD8+ T cell
Initial,450K,24,0.29,null,null,47.4,14.1,CD4+ T cell,,,SSc Patients,East Asian,CD4+ T cell
Initial,450K,24,0.29,null,null,47.4,14.1,CD8+ T cell,,,SSc Patients,East Asian,CD8+ T cell
Initial,450K,24,0.34,null,null,13,2.6,saliva,,,IPV+,Not reported,saliva
Initial,450K,24,0.39,null,null,7.9,7.3,peripheral blood,,,patients,Not reported,peripheral blood
Initial,450K,24,0.42,null,null,42.4,7.7,whole blood,,,Controls,European,whole blood
Initial,450K,24,0.42,null,null,42.5,6.9,whole blood,,,Cases,European,whole blood
Initial,450K,24,0.458,null,null,79.47,10.02,cerebellum,,,symptomatic AD,Not reported,cerebellum
Initial,450K,24,0.46,3.5,19,14,null,colon,,,,Not reported,colon
Initial,450K,24,0.46,5,17,11.6,null,buccal epithelial cell,NeuroDevNet,Kids Brain Health Network,Controls,Asian unspecified;European;Not reported,buccal epithelial cell
Initial,450K,24,0.5,0,0,0,0,cord blood,,,Array cohort B dietetically treated GDM,European,cord blood
Initial,450K,24,0.5,0,0,0,0,cord blood,,,Array cohort B insulin-treated GDM,European,cord blood
Initial,450K,24,0.5,0,6,2.24,1.07,peripheral blood mononuclear cell,,,Control,Not reported,peripheral blood mononuclear cell
Initial,450K,24,0.5,null,null,10.7,0.4,leukocyte,GENOI,Grupo Navarro de Obesidad Infantil,,European,leukocyte
Initial,450K,24,0.5,null,null,37,null,whole blood,,,t(1;11) Non-carriers,Not reported,whole blood
Initial,450K,24,0.54,0,7,1.91,1.52,peripheral blood mononuclear cell,,,KD,Not reported,peripheral blood mononuclear cell
Initial,450K,24,0.63,3.5,18,9.1,null,buccal epithelial cell,NeuroDevNet,Kids Brain Health Network,FASD cases,Asian unspecified;European;Not reported,buccal epithelial cell
Initial,450K,24,0.63,null,null,49.6,8.9,leukocyte,,,High folate (‚â•300 Œºg/d),European,leukocyte
Initial,450K,24,0.67,0,0,0,0,placenta,,,Pre-term Control,Asian unspecified;European;Other,placenta
Initial,450K,24,0.79,0,0,0,0,peripheral blood lymphocyte,,,Control,Not reported,peripheral blood lymphocyte
Initial,450K,24,0.83,0,0,0,0,peripheral blood lymphocyte,,,Case,Not reported,peripheral blood lymphocyte
Initial,450K,24,0.875,null,null,null,null,peripheral blood mononuclear cell,,,COPD patients,Not reported,peripheral blood mononuclear cell
Initial,450K,24,1,null,null,47.5,10.1,CD3+ T cell,,,post-treatment alcohol dependent patients,Not reported,CD3+ T cell
Initial,450K,24,1,null,null,47.5,10.1,CD3+ T cell,,,pre-treatment alcohol dependent patients,Not reported,CD3+ T cell
Initial,450K,24,null,0,0,0,0,cord blood,,,,African American or Afro-Caribbean;European;Hispanic or Latin American;Other,cord blood
Initial,450K,24,null,null,null,40.7,8.5,CD19+ B cell,,,MS participant,Not reported,CD19+ B cell
Initial,450K,24,null,null,null,43.3,16.4,CD19+ B cell,,,Control,Not reported,CD19+ B cell
Initial,450K,24,null,null,null,null,null,peripheral blood mononuclear cell,,,cognitively impaired participants (MoCA <26),Not reported,peripheral blood mononuclear cell
Initial,450K,24,null,null,null,null,null,peripheral blood mononuclear cell,,,Controls,Not reported,peripheral blood mononuclear cell
Initial,450K,240,0.52,0,0,0,0,whole blood,Healthy Start,,,European,whole blood
Initial,450K,240,0.69,null,null,42.3,16,prefrontal cortex,,,adult control,European;Not reported,prefrontal cortex
Initial,450K,2408,0.46,null,null,66.4,8.9,whole blood,FHS,,,European,whole blood
Initial,450K,241,1,null,null,42.5,14,whole blood,NTR,Netherlands Twin Register,30 cases and 211 controls,Not reported,whole blood
Initial,450K,242,0.52,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,450K,242,null,0,0,0,0,cord blood,MoBa2,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,2427,0.45,null,null,66,9,whole blood,FHS,Framingham Heart Study,,European,whole blood
Initial,450K,243,0.35,null,null,43,5,whole blood,BHS,Bogalusa Heart Study,,African unspecified,whole blood
Initial,450K,243,null,null,null,null,null,liver,,,"224 HCC, nine cirrhotic, and ten normal",Not reported,liver
Initial,450K,244,0.46,0,7,null,null,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,whole blood
Initial,450K,244,0.54,null,null,4.26,0.19,whole blood,BAMSE,Children‚Äôs Allergy Environment Stockholm Epidemiology study,,European,whole blood
Initial,450K,246,null,null,null,null,null,whole blood,,,control,European,whole blood
Initial,450K,2468,0.48,null,null,67,9,whole blood,FHS,Framingham Heart Study,,Not reported,whole blood
Initial,450K,249,1,0,0,0,0,cord blood,,,Boys,African unspecified;European;Hispanic or Latin American;Other,cord blood
Initial,450K,2496,0.67,54.1,65.5,60.8,null,peripheral blood mononuclear cell,MCCS,Melbourne Collaborative Cohort Study,,European,peripheral blood mononuclear cell
Initial,450K,25,0,21,43,null,null,whole blood,,,control,Not reported,whole blood
Initial,450K,25,0.2,18,76,40,null,thyroid,,,,Not reported,thyroid
Initial,450K,25,0.52,0,0,0,0,cord blood,POSEIDON,,Smoking subgroup,Not reported,cord blood
Initial,450K,25,0.52,null,null,23.8,4.1,whole blood,,,Non-converters,Not reported,whole blood
Initial,450K,25,0.56,0,0,0,0,placenta,ELGAN,Extremely Low for Gestational Age Newborns,Indicated EPTB,African American or Afro-Caribbean;European;Other,placenta
Initial,450K,25,0.6,null,null,73.6,8.9,retinal pigment epithelium,,,AMD,Not reported,retinal pigment epithelium
Initial,450K,25,1,14,14,14,0,peripheral blood mononuclear cell,COAST,,post-puberty,African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Initial,450K,25,1,8,8,8,0,peripheral blood mononuclear cell,COAST,,pre-puberty,African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Initial,450K,25,1,null,null,40,15.1,skin,,,paird PP / PN,Not reported,skin
Initial,450K,25,1,null,null,41.6,13.2,skin,,,NN,Not reported,skin
Initial,450K,25,null,null,null,null,null,bladder,,,,Not reported,bladder
Initial,450K,251,0,null,null,null,null,whole blood,MCCS,Melbourne Collaborative Cohort Study,,Not reported,whole blood
Initial,450K,251,0.247,null,null,53.3,8.1,leukocyte,EPIC-Italy,European Prospective Investigation into Cancer and Nutrition study,,European,leukocyte
Initial,450K,2519,0.31,null,null,36.79,13.01,whole blood,,,,Not reported,whole blood
Initial,450K,252,null,0,0,0,0,cord blood,MoBa3,Norwegian Mother and Child Cohort Study,,European,cord blood
Initial,450K,2542,0.46,null,null,66.3,8.9,whole blood,FHS,Framingham Offspring Study,,European,whole blood
Initial,450K,255,0.53,0,0,0,0,whole blood,GECKO,,,European,whole blood
Initial,450K,255,null,0,0,0,0,cord blood,GECKO,,GECKO,European,cord blood
Initial,450K,256,0.465,50.6,53.2,51.9,null,whole blood,,,T2D cases,Sub-Saharan African,whole blood
Initial,450K,257,0.5,null,null,50.4,null,whole blood,RODAM,Research on Obesity and Diabetes among African Migrants,No obesity,Sub-Saharan African,whole blood
Initial,450K,257,0.51,0,0,0,0,cord blood,Project Viva,,,African unspecified;European;Hispanic or Latin American;Other,cord blood
Initial,450K,257,0.54,0,0,0,0,cord blood,POSEIDON,,Non-smoking subgroup,Not reported,cord blood
Initial,450K,2586,0.67,40,76,61,null,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,259,1,null,null,null,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers,Not reported,whole blood
Initial,450K,2595,0.46,null,null,66.3,8.9,whole blood,FHS,Framingham Heart Study,,European,whole blood
Initial,450K,26,0,null,null,58,14,CD19+ B cell,,,pSS patients,European,CD19+ B cell
Initial,450K,26,0.54,null,null,13.6,0.1,whole blood,,,Non-obese sample,Not reported,whole blood
Initial,450K,26,1,null,null,68.2,6.1,whole blood,,,Current smokers,European,whole blood
Initial,450K,26,null,null,null,49.4,2,peripheral blood mononuclear cell,,,SLE patients (disease activity index<=6),African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Initial,450K,261,0,52,78,64,null,leukocyte,,,,Not reported,leukocyte
Initial,450K,261,0.79,null,null,53.8,13.1,whole blood,WHZH,,,East Asian,whole blood
Initial,450K,261,0.97,null,null,48.8,8,whole blood,VACS,Veteran Aging Cohort Study,HIV-infected,African American or Afro-Caribbean;European;Other,whole blood
Initial,450K,262,0.54,46,76,57,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers,Not reported,whole blood
Initial,450K,262,0.54,null,null,57,7,whole blood,,,Current smokers,European,whole blood
Initial,450K,2645,null,null,null,66.4,8.9,whole blood,FHS Offspring,Framingham Heart Study Offspring cohort,family,European,whole blood
Initial,450K,265,0.506,null,null,7.7,0.7,whole blood,Project Viva,,,African unspecified;Asian unspecified;European;Hispanic or Latin American;Other,whole blood
Initial,450K,267,null,16,16,16,0,whole blood,BAMSE,,,European,whole blood
Initial,450K,268,0.49,0,0,0,0,cord blood,Project Viva,Project Viva,,European;Not reported,cord blood
Initial,450K,2680,0.68,null,null,51,10.1,whole blood,LOLIPOP,The London Life Sciences Prospective Population Study,,South Asian,whole blood
Initial,450K,2690,0.69,53.8,65.4,60.7,null,peripheral blood mononuclear cell,MCCS,Melbourne Collaborative Cohort Study,normal samples,European,peripheral blood mononuclear cell
Initial,450K,27,0.33,null,null,40,null,leukocyte,,,without depressive symptoms,Not reported,leukocyte
Initial,450K,27,0.44,0,0,0,0,frontal cortex,,,,Not reported,frontal cortex
Initial,450K,27,0.56,0,0,0,0,placenta,,,normotensive fetal growth restricted,Not reported,placenta
Initial,450K,27,0.56,0,0,0,0,umbilical cord leukocyte,,,normotensive fetal growth restricted,Not reported,umbilical cord leukocyte
Initial,450K,27,0.62,1,12,null,null,whole blood,,,Kabuki syndrome samples,Not reported,whole blood
Initial,450K,27,0.74,null,null,14,3,saliva,,,CDV+,Not reported,saliva
Initial,450K,270,0,null,null,54.2,7.1,whole blood,EPIC-Italy,European Prospective Investigation into Cancer and Nutrition,Never smokers,European,whole blood
Initial,450K,271,0.47,null,null,60.9,8.5,whole blood,RS,Rotterdam Study,Former smokers,European,whole blood
Initial,450K,272,0.4,null,null,70,9,CD14+ monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,African American or Afro-Caribbean,CD14+ monocyte
Initial,450K,2722,0.47,null,null,58.5,11.6,whole blood,FHS,,,European,whole blood
Initial,450K,274,0.52,null,null,62.5,7.8,whole blood,,,Current smokers,European,whole blood
Initial,450K,274,0.54,0.12,1,null,null,saliva,,,,Not reported,saliva
Initial,450K,2743,null,null,null,56.6,5.9,leukocyte,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,leukocyte
Initial,450K,2775,0,null,null,57.8,8.8,whole blood,,National Institute of Environmental Health Sciences (NIEHS) Sister Study,,Not reported,whole blood
Initial,450K,2775,0.68,39,70,60,null,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,28,0,null,null,38.6,12.7,CD4+ T cell,,,multiple sclerosis,Not reported,CD4+ T cell
Initial,450K,28,0,null,null,46,8,lymphoblast,IAS,Iowa Adoptions Studies,heavy users (alcohol use in every week in the past 6 months),European;Not reported,lymphoblast
Initial,450K,28,0.39,35,78,55.3,10,white matter,,,multiple sclerosis,Not reported,white matter
Initial,450K,28,0.46,18,55,null,null,CD4+ T cell,,,control,Not reported,CD4+ T cell
Initial,450K,28,0.46,18,55,null,null,CD8+ T cell,,,control,Not reported,CD8+ T cell
Initial,450K,28,0.64,null,null,52,8.1,whole blood,,,Cases,European,whole blood
Initial,450K,28,null,43,85,64.1,10.2,CD3+ T cell,,,breast cancer,Not reported,CD3+ T cell
Initial,450K,280,0.55,null,null,null,null,cord blood,MeDALL,Mechanisms of the Development of ALLergy,,European,cord blood
Initial,450K,280,0.57,null,null,50.8,7.8,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers baseline,Not reported,whole blood
Initial,450K,280,null,null,null,null,null,bladder,,,,Not reported,bladder
Initial,450K,282,1,null,null,49.2,8,whole blood,,,Never (Control),European;Other,whole blood
Initial,450K,283,0.49,40,70,57.5,8.2,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,283,0.5,0,0,0,0,whole blood,CHAMACOS,,,Hispanic or Latin American,whole blood
Initial,450K,283,0.72,null,null,70,9,carotid plaque,AEMS450K1,Athero-Express Biobank Study,Former or Never Smokers,Not reported,carotid plaque
Initial,450K,284,0.33,null,null,52,10,buffy coat,HyperGen,Hypertension Genetic Epidemiology Network,MetS+,African American or Afro-Caribbean,buffy coat
Initial,450K,284,0.5,13.8,19,16.2,1.3,leukocyte,LACHY,"Lifestyle, Adiposity, and Cardiovascular Health in Youth",,African American or Afro-Caribbean,leukocyte
Initial,450K,284,0.5,null,null,16.2,1.27,leukocyte,,,,African American or Afro-Caribbean,leukocyte
Initial,450K,287,0.47,58,68,63,null,whole blood,Fukuoka,,,African American or Afro-Caribbean;European;Hispanic or Latin American,whole blood
Initial,450K,288,0.28,null,null,72.6,16.6,whole blood,,,Never smokers,European,whole blood
Initial,450K,29,0,null,null,63.28,14.83,CD19+ B cell,,,female CLL,Not reported,CD19+ B cell
Initial,450K,29,null,null,null,null,null,oral tongue sub-site,,,adjacent normal tissue,Not reported,oral tongue sub-site
Initial,450K,29,null,null,null,null,null,prefrontal cortex,,,Controls,European,prefrontal cortex
Initial,450K,29,null,null,null,null,null,prefrontal cortex,,,Major Depressive Disorder,European,prefrontal cortex
Initial,450K,290,0.5,null,null,50.7,null,whole blood,RODAM,Research on Obesity and Diabetes among African Migrants,Obesity,Sub-Saharan African,whole blood
Initial,450K,291,0,null,null,59.18,9.58,adipose tissue,TwinsUK,,non-smokers,European,adipose tissue
Initial,450K,293,0.2,null,null,43.5,14.3,leukocyte,MARTHA,MARseille Thrombosis Association Study ,,European,leukocyte
Initial,450K,294,1,47.5,84.5,59.2,7.9,whole blood,RS,,,European,whole blood
Initial,450K,298,0,null,null,12.5,1.4,whole blood,NIEHS,National Institute of Environmenal Health Sciences,Case subjects,European,whole blood
Initial,450K,3,0,54,70,null,null,synovial fibroblast,BEACON,Birmingham early arthritis cohort,"established, long-standing rheumatoid arthritis",Not reported,synovial fibroblast
Initial,450K,3,1,60,75,null,null,whole blood,,,LA Type I,East Asian,whole blood
Initial,450K,3,1,60,85,null,null,whole blood,,,LA Type II,East Asian,whole blood
Initial,450K,3,1,70,75,null,null,whole blood,,,Normal,East Asian,whole blood
Initial,450K,3,1,70,75,null,null,whole blood,,,Normal,European,whole blood
Initial,450K,3,null,4,6,null,null,leukocyte,,,obese subjects,East Asian,leukocyte
Initial,450K,3,null,null,null,null,null,Molt-3 cell,,,HHV-6B-infected,Not reported,Molt-3 cell
Initial,450K,3,null,null,null,null,null,Molt-3 cell,,,HHV-6B-uninfected,Not reported,Molt-3 cell
Initial,450K,30,0,14,14,14,0,peripheral blood mononuclear cell,COAST,,post-puberty,African American or Afro-Caribbean;European;Hispanic or Latin American,peripheral blood mononuclear cell
Initial,450K,30,0,8,8,8,0,peripheral blood mononuclear cell,COAST,,pre-puberty,African American or Afro-Caribbean;European;Hispanic or Latin American,peripheral blood mononuclear cell
Initial,450K,30,0.13,18,55,null,null,CD4+ T cell,,,multiple sclerosis,Not reported,CD4+ T cell
Initial,450K,30,0.13,18,55,null,null,CD8+ T cell,,,multiple sclerosis,Not reported,CD8+ T cell
Initial,450K,30,0.47,null,null,70.4,4.9,whole blood,,,Current smokers,African American or Afro-Caribbean,whole blood
Initial,450K,30,0.5,0,0,0,0,cord blood,,,Control,Not reported,cord blood
Initial,450K,30,0.5,0,0,0,0,cord blood,ROLO,,Intervention,Not reported,cord blood
Initial,450K,30,0.57,0,0,0,0,cord blood,,,Gestational diabetes,East Asian,cord blood
Initial,450K,30,0.6,null,null,46.6,7.2,leukocyte,,,Control,East Asian,leukocyte
Initial,450K,30,0.63,0,0,0,0,cord blood,,,15 monozygotic twin pairs who later became discordant for CP,Aboriginal Australian,cord blood
Initial,450K,30,0.67,45,88,65.5,11.7,carotid,,,donor-paired aortic samples,Not reported,carotid
Initial,450K,30,0.67,null,null,60.4,8.8,buccal mucosa,COPDGene,,Current Smokers,African American or Afro-Caribbean;European,buccal mucosa
Initial,450K,30,1,null,null,21.9,0.4,peripheral blood mononuclear cell,,,perinatal exposed to high PCBs and PCDFs,East Asian,peripheral blood mononuclear cell
Initial,450K,30,1,null,null,22.3,0.4,peripheral blood mononuclear cell,,,Non-exposed referents,East Asian,peripheral blood mononuclear cell
Initial,450K,30,1,null,null,74.1,7.4,whole blood,COPD,Chronic Obstructive Pulmonary Disease cohort ,Former smokers,East Asian,whole blood
Initial,450K,30,null,null,null,3,3.3,whole blood,,,matched controls,Not reported,whole blood
Initial,450K,300,0.57,0,0,0,0,cord blood,,,Unexposed group,African American or Afro-Caribbean,cord blood
Initial,450K,301,0,null,null,54.1,10.4,leukocyte,EPIC-Italy,,Post-Menopausal Breast Cancer,European,leukocyte
Initial,450K,303,0.42,null,null,2,6.4,whole blood,,Dutch Hunger Winter Families study,,European,whole blood
Initial,450K,303,0.53,null,null,56.3,9.4,leukocyte,EPIC-Italy,,Colorectal Cancer,European,leukocyte
Initial,450K,305,0.5,25,81,51,16.5,whole blood,EGCUT3,,,European,whole blood
Initial,450K,306,0.57,6,15,9,null,leukocyte,PR-GOAL,,,African American or Afro-Caribbean;European,leukocyte
Initial,450K,307,0.47,null,null,61.6,8.6,whole blood,,,Former smokers,European,whole blood
Initial,450K,307,0.52,8,8,8,0,whole blood,BAMSE EpiGene,,,European,whole blood
Initial,450K,308,0.47,null,null,5.5,0.07,buffy coat,CHOP,,not exposed,European,buffy coat
Initial,450K,308,0.52,null,null,8.3,0.5,whole blood,BAMSE-epi,Children‚Äôs Allergy Environment Stockholm Epidemiology study,,European,whole blood
Initial,450K,31,0,null,null,47.9,1.63,peripheral blood mononuclear cell,,,Healthy Controls,Not reported,peripheral blood mononuclear cell
Initial,450K,31,0.1,null,null,53.7,11.9,CD4+ T cell,,,GD Controls,European,CD4+ T cell
Initial,450K,31,0.1,null,null,53.7,11.9,CD8+ T cell,,,GD Controls,European,CD8+ T cell
Initial,450K,31,0.26,null,null,62,10.7,whole blood,REGICOR,EWAS nested in the Girona Heart Registry,"Former Smokers, 1 to 5 y",European,whole blood
Initial,450K,31,0.36,null,null,79.2,0.5,whole blood,,,Current smokers,European,whole blood
Initial,450K,31,0.45,18,94,74.8,16.8,glia,,,,European,glia
Initial,450K,31,0.45,18,94,74.8,16.8,neuron,,,,European,neuron
Initial,450K,31,0.52,null,null,58.8,8,buffy coat,,,Exposure group (Generation 1),East Asian,buffy coat
Initial,450K,31,0.55,null,null,76.4,6.3,buccal epithelial cell,,,,European,buccal epithelial cell
Initial,450K,31,0.61,null,null,65.7,0.1,whole blood,,,Clinical Controls,Not reported,whole blood
Initial,450K,31,0.77,null,null,54.1,11.7,cardiac tissue,,,symptom-free patients after heart transplantation,Not reported,cardiac tissue
Initial,450K,31,0.97,null,null,71.5,5.3,whole blood,COPD,Chronic Obstructive Pulmonary Disease cohort ,Current smokers,East Asian,whole blood
Initial,450K,31,1,null,null,55.2,9.9,tumor tissue,,,prostate adenocarcinoma,Not reported,tumor tissue
Initial,450K,31,null,0,0,0,0,cord blood,,Colorado Healthy Start cohort,gestational diabetes-exposed,Not reported,cord blood
Initial,450K,31,null,null,null,49.4,2,peripheral blood mononuclear cell,,,SLE patients (disease activity index>6),African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Initial,450K,310,0.48,21,69,29.5,14.2,whole blood,FTC,Finnish Twin Cohort,,Not reported,whole blood
Initial,450K,311,null,0,0,0,0,cord blood,VIVA,Project Viva,,Not reported,cord blood
Initial,450K,312,0.55,null,null,15,3,nasal epithelial cell,EVA-PR,Epigenetic Variation and Childhood Asthma in Puerto Ricans,Atopy,Hispanic or Latin American,nasal epithelial cell
Initial,450K,313,0.66,19,90,61,null,tumor tissue,,,,Not reported,tumor tissue
Initial,450K,315,0,38,70,55.5,7.9,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,319,0.37,null,null,52.3,7.7,whole blood,,,Controls,European,whole blood
Initial,450K,319,0.41,0,0,0,0,cord blood,ALSPAC,,,European,cord blood
Initial,450K,319,0.41,7,7,7,0,whole blood,ALSPAC,,,European,whole blood
Initial,450K,319,0.49,null,null,61.5,8.6,whole blood,,Rotterdam Study,Former smokers,European,whole blood
Initial,450K,32,0,null,null,36.4,15.8,skin,,,PP,Not reported,skin
Initial,450K,32,null,null,null,null,null,nasal epithelial cell,,,CF patients,Not reported,nasal epithelial cell
Initial,450K,320,0.74,null,null,62.2,12.1,tumor tissue and adjacent normal tissue,,,renal papillary cell carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,321,0.368,null,null,84.1,5.8,prefrontal cortex,MAP,Memory and Aging Project,,Not reported,prefrontal cortex
Initial,450K,321,0.54,null,null,65.4,13.2,tumor tissue and adjacent normal tissue,,,colon adenocarcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,323,0.4,null,null,75.6,5.2,whole blood,CHS,,,European,whole blood
Initial,450K,324,0.52,0,0,0,0,whole blood,EXPOsOMICS,,,European,whole blood
Initial,450K,329,0.51,0,0,0,0,whole blood,Project Viva,,,European,whole blood
Initial,450K,33,0,null,null,45,10.3,leukocyte,,,female controls,Not reported,leukocyte
Initial,450K,33,0,null,null,49.9,1.56,peripheral blood mononuclear cell,,,ME/CFS Cases,Not reported,peripheral blood mononuclear cell
Initial,450K,33,0.52,0,0,0,0,cord blood,,,Normal pregnancy,East Asian,cord blood
Initial,450K,33,0.76,null,null,45.5,7.8,whole blood,,,Case,African American or Afro-Caribbean;European,whole blood
Initial,450K,33,0.76,null,null,46.7,7.8,whole blood,,,Control,African American or Afro-Caribbean;European,whole blood
Initial,450K,33,null,null,null,55.6,2.1,peripheral blood mononuclear cell,,,Non-SLE patients,African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Initial,450K,330,0,null,null,55.6,6.4,leukocyte,NOWAC,,,European,leukocyte
Initial,450K,330,0.33,null,null,46,11,buffy coat,HyperGen,Hypertension Genetic Epidemiology Network,MetS‚àí,African American or Afro-Caribbean,buffy coat
Initial,450K,330,null,null,null,30.6,4.5,cord blood,MEDALL,,,European,cord blood
Initial,450K,330,null,null,null,30.6,4.5,cord blood ,MEDALL ,,,European,cord blood 
Initial,450K,332,1,null,null,58.9,8.6,whole blood,TwinsUK,,,European,whole blood
Initial,450K,336,0.52,0,0,0,0,cord blood,CHAMACOS,Center of Health Assessment of Mothers and Children of Salinas,,Hispanic or Latin American,cord blood
Initial,450K,338,0.518,null,null,5.32,0.32,buccal epithelium,PAWS,Peers and Wellness Study,,African American or Afro-Caribbean;Asian unspecified;European;Hispanic or Latin American;Other,buccal epithelium
Initial,450K,34,0.53,null,null,14.55,2.65,saliva,,,Adolescents - CDV+,Not reported,saliva
Initial,450K,34,0.65,null,null,56,9,pancreatic islet,,,Non-diabetics,Not reported,pancreatic islet
Initial,450K,34,1,49.2,65.5,57.3,null,leukocyte,,,,European,leukocyte
Initial,450K,342,0.53,8,8,8,0,whole blood,,BAMSE EpiGene,,European,whole blood
Initial,450K,342,0.67,null,null,65.1,11.9,whole blood,REGICOR,EWAS nested in the Girona Heart Registry,Never Smokers,European,whole blood
Initial,450K,343,0.54,0,0,0,0,placenta,,New Hampshire Birth Cohort Study,,Not reported,placenta
Initial,450K,343,0.54,0,0,0,0,placenta,NHBCS,New Hampshire Birth Cohort Study,,European;Not reported,placenta
Initial,450K,343,0.98,4,18,null,null,whole blood,SSC,Simons Simplex Collection,ASD cases,African unspecified;Asian unspecified;European;Other,whole blood
Initial,450K,343,1,4,18,null,null,whole blood,SSC,Simons Simplex Collection,unaffected siblings,African unspecified;Asian unspecified;European;Other,whole blood
Initial,450K,343,null,null,null,33.1,4.5,cord blood,Project Viva,,,European,cord blood
Initial,450K,343,null,null,null,33.1,4.5,cord blood ,Project Viva,,,European,cord blood 
Initial,450K,344,1,null,null,70.9,6.6,leukocyte,NAS,,Baseline,European,leukocyte
Initial,450K,344,1,null,null,74.5,6.6,leukocyte,NAS,,Follow-up,European,leukocyte
Initial,450K,347,0.15,null,null,47,17.2,whole blood,,,Patients,Not reported,whole blood
Initial,450K,347,null,4,8,null,null,whole blood,BAMSE,Children‚Äôs Allergy Environment Stockholm Epidemiology study,,European,whole blood
Initial,450K,348,0.46,null,null,58.9,0.5,whole blood,,Dutch Hunger Winter Families study,,European,whole blood
Initial,450K,349,0.22,null,null,43.8,14.1,whole blood,MARTHA,,,European,whole blood
Initial,450K,35,0.46,0,0,0,0,prefrontal cortex,,,fetal control,European;Not reported,prefrontal cortex
Initial,450K,35,0.49,null,null,50.5,7.3,liver,,,Type 2 Diabetics,Not reported,liver
Initial,450K,35,0.771,null,null,37.7,12.4,leukocyte,,,NAFLD,East Asian,leukocyte
Initial,450K,35,1,null,null,27.6,0.9,sperm,,,Normal viability,Not reported,sperm
Initial,450K,350,0.55,56,80,66,null,whole blood,,,40 PTB,Not reported,whole blood
Initial,450K,356,0,47.7,90.1,60.8,8.2,whole blood,RS,,,European,whole blood
Initial,450K,36,0,34,81,61,null,tumor tissue,,,18 responder and 18 non-responder,Not reported,tumor tissue
Initial,450K,36,0.11,null,null,56.2,15.5,CD4+ T cell,,,GD Patients,European,CD4+ T cell
Initial,450K,36,0.58,0,0,0,0,placenta,,,uncomplicated pregnancies,Not reported,placenta
Initial,450K,36,0.58,0,0,0,0,umbilical cord leukocyte,,,uncomplicated pregnancies,Not reported,umbilical cord leukocyte
Initial,450K,36,0.58,41,82,63.9,11.5,colorectal tumour,,,Never smokers,Not reported,colorectal tumour
Initial,450K,361,null,null,null,null,null,tumor tissue,,,tumor tissue,Not reported,tumor tissue
Initial,450K,362,null,0,0,0,0,cord blood,MeDALL,Mechanisms of the Development of ALLergy,,European,cord blood
Initial,450K,364,0.4,15,17,null,null,whole blood,ALSPAC,,,European,whole blood
Initial,450K,365,0.485,null,null,57.7,12.6,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,MetS+,European,CD4+ T cell
Initial,450K,365,0.5,null,null,69.4,0.88,whole blood,LBC1936,,Not frail,Not reported,whole blood
Initial,450K,367,0.33,18,18,18,0,whole blood,IoW,Isle of Wight birth cohort,,Not reported,whole blood
Initial,450K,368,null,null,null,25.3,5,cord blood,CHAMACOS,,,Hispanic or Latin American,cord blood
Initial,450K,368,null,null,null,25.3,5,cord blood ,CHAMACOS,,,Hispanic or Latin American,cord blood 
Initial,450K,369,0.336,18,18,18,0,whole blood,IoW,Isle of Wight birth cohort,,Not reported,whole blood
Initial,450K,37,0,null,null,40.3,15.3,skin,,,NN,Not reported,skin
Initial,450K,37,0.11,null,null,55,16.3,CD8+ T cell,,,GD Patients,European,CD8+ T cell
Initial,450K,37,0.64,0,0,0,0,placenta,,,,Not reported,placenta
Initial,450K,37,1,null,null,69.4,0.6,whole blood,GTP,Grady Trauma Project,Non-PTSD,Aboriginal Australian,whole blood
Initial,450K,37,null,null,null,null,null,liver,,,paired HCC and adjacent normal,Not reported,liver
Initial,450K,374,0.18,null,null,null,null,leukocyte,EPIC-Turin,European Prospective Investigation into Cancer and Nutrition,,Not reported,leukocyte
Initial,450K,374,0.48,5.5,5.5,5.5,0,whole blood,,,,European,whole blood
Initial,450K,375,null,null,null,null,null,liver,,,HCC,Not reported,liver
Initial,450K,378,0.42,null,null,27.9,8.3,whole blood,,,Control (BMI < 30),Not reported,whole blood
Initial,450K,378,null,0,0,0,0,cord blood,CHAMACOS,Center for Health Assessment of Mothers and Children of Salinas,,Hispanic or Latin American,cord blood
Initial,450K,379,0.613,null,null,null,null,primary tumor,TCGA,The Cancer Genome Atlas,,Not reported,primary tumor
Initial,450K,38,0,null,null,37.32,6.39,saliva,,,Mothers - CDV+,Not reported,saliva
Initial,450K,38,1,null,null,27.9,0.9,sperm,,,Normal motility,Not reported,sperm
Initial,450K,38,null,0,0,0,0,cord blood,BEAR,Biomarkers of Exposure to ARsenic,,Not reported,cord blood
Initial,450K,380,0,14,94,50,null,whole blood,NSPHS,Northern Sweden Population Health Study,,European,whole blood
Initial,450K,380,0.29,null,null,65.6,7.3,leukocyte,GENOA,Genetic Epidemiology Network of Arteriopathy,,African American or Afro-Caribbean,leukocyte
Initial,450K,382,0.48,5.5,5.5,5.5,0,whole blood,CHOP,,,European,whole blood
Initial,450K,383,null,null,null,null,null,whole blood,,,cases,Not reported,whole blood
Initial,450K,384,null,null,null,28.8,6.4,cord blood,NEST,,,Other,cord blood
Initial,450K,384,null,null,null,28.8,6.4,cord blood ,NEST,,,Other,cord blood 
Initial,450K,385,0.58,null,null,69.6,0.8,whole blood,,,Former smokers,European,whole blood
Initial,450K,385,null,48,99,null,null,whole blood,SATSA,Swedish Adoption/Twin Study of Aging,twins,Not reported,whole blood
Initial,450K,387,0.367,null,null,79,7,prefrontal cortex,ROS,Religious Orders Study,,Not reported,prefrontal cortex
Initial,450K,39,0.15,null,null,72.9,6.1,whole blood,COPD,Chronic Obstructive Pulmonary Disease cohort ,Never smokers,East Asian,whole blood
Initial,450K,39,0.56,0,0,0,0,cord blood,,,Exposed group,African American or Afro-Caribbean,cord blood
Initial,450K,39,0.56,0,0,0,0,placenta,,,Nicotine Exposed,Not reported,placenta
Initial,450K,39,null,55,66,61,null,prostate,,,Adjacent,African American or Afro-Caribbean;European;Not reported,prostate
Initial,450K,39,null,null,null,49.4,2,peripheral blood mononuclear cell,,,SLE patients,African American or Afro-Caribbean,peripheral blood mononuclear cell
Initial,450K,391,0.49,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,450K,398,0,29.6,74.9,52.1,null,whole blood,EGM,EnivroGenoMarkers project,,European,whole blood
Initial,450K,399,0,69.8,70.7,70.1,null,whole blood,PIVUS,The prospective investigation of the Vasculature in Uppsala Seniors,,European,whole blood
Initial,450K,4,0.25,null,null,35.3,2.7,peripheral blood mononuclear cell,,,Balanced Constitution,Not reported,peripheral blood mononuclear cell
Initial,450K,4,0.5,46.2,75,70.56,9.96,corneal endothelial,,,Control,Not reported,corneal endothelial
Initial,450K,4,null,0,0,0,0,neonatal blood,,,schizophrenia,Not reported,neonatal blood
Initial,450K,4,null,4,6,null,null,leukocyte,,,matched controls,East Asian,leukocyte
Initial,450K,40,0,null,null,47,8,lymphoblast,IAS,Iowa Adoptions Studies,abstinent (no use in the past 6 months),European;Not reported,lymphoblast
Initial,450K,40,0,null,null,null,null,lymphocyte,,,Pre-guadecitabine,Not reported,lymphocyte
Initial,450K,40,0.53,null,null,null,null,bone marrow,,,,East Asian,bone marrow
Initial,450K,40,0.6,null,null,71.8,6.9,whole blood,COPD,,Controls,East Asian,whole blood
Initial,450K,40,0.68,40,85,73,null,lung,,,,Not reported,lung
Initial,450K,40,0.68,null,null,65.2,7.1,whole blood,AEMS450K1,Athero-Express Biobank Study,Current smokers,Not reported,whole blood
Initial,450K,40,1,null,null,null,null,subcutaneous adipose tissue,,Danish National Birth Registry,,Not reported,subcutaneous adipose tissue
Initial,450K,400,0,53,53,53,0,buccal cell,NSHD,National Survey of Health and Development,,Not reported,buccal cell
Initial,450K,400,0.12,null,null,47.1,13.2,whole blood,,,Controls,European,whole blood
Initial,450K,400,0.12,null,null,47.1,13.2,whole blood,,,Controls,Not reported,whole blood
Initial,450K,400,0.47,50,75,62,null,whole blood,ESTHER,,,Not reported,whole blood
Initial,450K,400,0.53,25,65,null,null,whole blood,,,,South Asian,whole blood
Initial,450K,401,0.5,null,null,68.4,9.4,CD14+ monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,Hispanic or Latin American,CD14+ monocyte
Initial,450K,404,0,null,null,38.5,11,whole blood,NTR,Netherlands Twin Register,38 cases and 366 controls,Not reported,whole blood
Initial,450K,408,0.419,null,null,51.5,7.5,leukocyte,NSHDS,,,European,leukocyte
Initial,450K,408,0.52,0,0,0,0,cord blood,LINA,,,Not reported,cord blood
Initial,450K,41,0.268,20,77,39,null,thyroid,,,non-neoplastic adjacent tissues (NT),Not reported,thyroid
Initial,450K,41,0.268,20,77,39,null,tumor tissue,,,papillary thyroid carcinoma,Not reported,tumor tissue
Initial,450K,41,0.33,null,null,37.56,11.4,airway epithelial cell,,,Control,Not reported,airway epithelial cell
Initial,450K,41,0.58,0,0,0,0,placenta,,,Controls,Not reported,placenta
Initial,450K,41,0.76,null,null,54.1,12.3,cardiac tissue,,,Cases,Not reported,cardiac tissue
Initial,450K,41,0.76,null,null,54.1,12.3,whole blood,,,Cases,Not reported,whole blood
Initial,450K,41,1,null,null,37.6,12.4,skin,,,PP,Not reported,skin
Initial,450K,41,1,null,null,56.4,0.6,leukocyte,LLSLFH,"Leuven Longitudinal Study on Lifestyle, Fitness and Health",,European,leukocyte
Initial,450K,41,null,null,null,null,null,liver,,,adjacent normal tissues,Not reported,liver
Initial,450K,412,0.74,null,null,68.1,8.7,tumor tissue and adjacent normal tissue,,,lung squamous cell carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,413,0.46,null,null,null,null,whole blood,NFBC 1986,,,European,whole blood
Initial,450K,413,null,0,0,0,0,cord blood,NEST,Newborn Epigenetics Study,,African American or Afro-Caribbean;European;Other,cord blood
Initial,450K,42,0.86,null,null,52,11.1,gastric mucosa,,,Gastric Cancer patients (normal gastric mucosa ),East Asian,gastric mucosa
Initial,450K,42,0.86,null,null,52.2,9.5,gastric mucosa,,,Controls,East Asian,gastric mucosa
Initial,450K,42,1,30,50,38.4,5.3,sperm,,,infertile,Not reported,sperm
Initial,450K,42,1,null,null,51.8,6.7,leukocyte,,,schizophrenia,East Asian,leukocyte
Initial,450K,42,1,null,null,67.9,0.6,whole blood,GTP,Grady Trauma Project,PTSD,Aboriginal Australian,whole blood
Initial,450K,42,null,null,null,11.9,11,whole blood,,,matched controls,Not reported,whole blood
Initial,450K,42,null,null,null,null,null,colon,,,adenomas,Not reported,colon
Initial,450K,42,null,null,null,null,null,whole blood,,,,Not reported,whole blood
Initial,450K,421,0.47,14,94,null,null,whole blood,NSPHS,Northern Sweden population Health Study ,,Not reported,whole blood
Initial,450K,422,0.15,null,null,50.4,null,whole blood,RODAM,Research on Obesity and Diabetes among African Migrants,Abdominal obesity,Sub-Saharan African,whole blood
Initial,450K,422,null,null,null,null,null,tumor tissue,,,endometrial cancer,Not reported,tumor tissue
Initial,450K,423,null,56,66,61,null,prostate,TCGA,,Prostate cancer,African American or Afro-Caribbean;Asian unspecified;European;Not reported,prostate
Initial,450K,424,0.68,null,null,59.8,13.3,tumor tissue and adjacent normal tissue,,,hepatocellular carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,426,0.52,0,0,0,0,placenta,ELGAN,,,European;Other,placenta
Initial,450K,427,0.47,16.5,16.5,16.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Controls,Not reported,whole blood
Initial,450K,43,0,null,null,47,null,saliva,,,Placebo,Not reported,saliva
Initial,450K,43,0.395,null,null,60.63,7.04,cerebellum,,,control,Not reported,cerebellum
Initial,450K,43,0.49,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Past ED,Not reported,cord blood
Initial,450K,43,0.49,null,null,71.1,3,leukocyte,B-PROOF,,Placebo,Not reported,leukocyte
Initial,450K,43,0.7,31,83,66,null,kidney,,,,Not reported,kidney
Initial,450K,431,1,null,null,72.3,6.6,whole blood,,,Former smokers,European,whole blood
Initial,450K,432,0.4,null,null,79.1,0.6,whole blood,LBC1921,,,European,whole blood
Initial,450K,432,0.45,null,null,69.5,0.8,whole blood,,,Never smokers,European,whole blood
Initial,450K,432,0.74,null,null,68.6,10.6,tumor tissue and adjacent normal tissue,,,bladder carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,435,0.39,null,null,79.1,0.6,whole blood,LBC1921,Lothian Birth Cohort 1921,,European,whole blood
Initial,450K,436,0,40,70,null,null,whole blood,AMDTSS,Australian Mammographic Density Twins and Sisters Study,,European,whole blood
Initial,450K,436,0.4,null,null,79.1,0.6,whole blood,LBC1921,,,European,whole blood
Initial,450K,436,0.55,0,0,0,0,whole blood,NCL,Norway Facial Cleft Study,Control,European,whole blood
Initial,450K,437,0.48,null,null,61,16.1,whole blood,InCHIANTI,,,European,whole blood
Initial,450K,438,0.51,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,450K,44,0.16,null,null,31,8.4,CD4+ T cell,,,SLE Patients,African unspecified;European,CD4+ T cell
Initial,450K,44,0.43,null,null,70.8,2.9,leukocyte,B-PROOF,,Folic acid and vitamin B12 intervention,Not reported,leukocyte
Initial,450K,44,0.61,0,0,0,0,cord blood,,,Stopped smokers before pregnancy,East Asian,cord blood
Initial,450K,44,1,44,72,63,null,prostate,,,,Not reported,prostate
Initial,450K,44,null,null,null,null,null,cord blood,,,,Not reported,cord blood
Initial,450K,440,0,null,null,65.1,7,whole blood,,,bladder cancer,African American or Afro-Caribbean;Asian unspecified;European;Hispanic or Latin American;Not reported;Other,whole blood
Initial,450K,440,0,null,null,65.1,7,whole blood,,,Controls,African American or Afro-Caribbean;Asian unspecified;European;Hispanic or Latin American;Other,whole blood
Initial,450K,442,0.7,null,null,71,8,whole blood,FHS,,,European,whole blood
Initial,450K,443,0.47,null,null,61.7,16.2,leukocyte,InCHIANTI,,Baseline,European,leukocyte
Initial,450K,443,0.47,null,null,70.8,16.2,leukocyte,InCHIANTI,,Follow-up,European,leukocyte
Initial,450K,444,0.39,78,81,79.1,0.6,whole blood,LBC1921,Lothian Birth Cohort 1921,,European,whole blood
Initial,450K,444,0.52,8,8,8,0,whole blood,MeDALL,Mechanisms of the Development of ALLergy,,European,whole blood
Initial,450K,446,0.39,null,null,79,1,whole blood,LBC1921,Lothian Birth Cohort,,Not reported,whole blood
Initial,450K,449,0.64,null,null,54.7,8.8,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Former smokers baseline,Not reported,whole blood
Initial,450K,45,0,null,null,27.3,2.3,peripheral blood mononuclear cell,,,Control,African American or Afro-Caribbean,peripheral blood mononuclear cell
Initial,450K,45,0.64,0,0,0,0,artery,,,,Not reported,artery
Initial,450K,45,0.76,null,null,59,12,rectal cancer tissue,,,,Not reported,rectal cancer tissue
Initial,450K,450,0,26,73,52,9,leukocyte,EPIC,EuropeanProspective Investigation into Cancer and Nutrition (EPIC) study,,European,leukocyte
Initial,450K,453,0.81,2,5,null,null,whole blood,SEED,Study to Explore Early Development,ASD cases,African unspecified;Asian unspecified;European;Other,whole blood
Initial,450K,454,0.29,null,null,54.2,7.1,leukocyte,EPIC-Italy,European Prospective Investigation into Cancer and Nutrition,,European,leukocyte
Initial,450K,457,0.404,49.8,51.5,50.7,null,whole blood,,,T2D controls,Sub-Saharan African,whole blood
Initial,450K,458,0.4,0,0,0,0,cord blood,MoBa2,,,European,cord blood
Initial,450K,46,0.35,0,0,0,0,cord blood,,,Sustained smokers during pregnancy,East Asian,cord blood
Initial,450K,46,0.35,null,null,57.7,13.9,T-lymphocyte,,,treatment-naive patients with early rheumatoid arthritis,European,T-lymphocyte
Initial,450K,46,0.48,0,0,0,0,cord blood,,,Array cohort B Controls,European,cord blood
Initial,450K,46,0.52,0,0,0,0,cord blood,,,Controls,European;Not reported,cord blood
Initial,450K,46,null,null,null,null,null,uterine,,,normal,Not reported,uterine
Initial,450K,460,0.53,9,14,null,null,whole blood,STOPPA,,,European,whole blood
Initial,450K,463,0,null,null,64.6,11.2,tumor tissue and adjacent normal tissue,,,endometrial carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,463,0.65,null,null,61.4,8.7,buffy coat,,,Former smokers,European,buffy coat
Initial,450K,464,0.39,null,null,78,5.5,whole blood,MOBILZE,,,European,whole blood
Initial,450K,464,0.7,38,67,55.4,6.7,peripheral blood,CARDIOGENICS,,,European,peripheral blood
Initial,450K,464,null,null,null,null,null,tumor tissue,,,endometrial cancer,Not reported,tumor tissue
Initial,450K,47,0,null,null,46,8,lymphoblast,IAS,Iowa Adoptions Studies,mild (use of alcohol in between 1 and 8 weeks the past 6 months),European;Not reported,lymphoblast
Initial,450K,47,0.26,null,null,48.8,17.7,CD19+ B cell,,,Controls,European,CD19+ B cell
Initial,450K,47,0.45,null,null,85,16,whole blood,CRELES,Costa Rican Study on Longevity and Healthy Aging,Non-Nicoya,Hispanic or Latin American,whole blood
Initial,450K,47,0.49,38,89,65.1,10.3,colorectal tumour,,,Former smokers,Not reported,colorectal tumour
Initial,450K,47,0.596,null,null,61.54,7.71,dorsolateral prefrontal cortex,,,control,Not reported,dorsolateral prefrontal cortex
Initial,450K,47,0.64,null,null,45.9,14.2,whole blood,,,Control,African American or Afro-Caribbean;European,whole blood
Initial,450K,47,0.89,null,null,45.7,14.5,whole blood,,,Case,African American or Afro-Caribbean;European,whole blood
Initial,450K,472,0.53,25,74,51.9,13.8,whole blood,FINRISK,The National FINRISK Study,,European,whole blood
Initial,450K,474,0.36,null,null,47,14.3,leukocyte,MENA,Methyl Epigenome Network Association project,,European,leukocyte
Initial,450K,476,0.4,78,95,79,null,whole blood,LBC1921,Lothian Birth Cohort 1921,,Not reported,whole blood
Initial,450K,476,0.66,null,null,44.8,13.2,whole blood,,,,East Asian,whole blood
Initial,450K,479,0,null,null,56.4,7.9,blood spot,,,,Aboriginal Australian,blood spot
Initial,450K,479,0,null,null,56.4,7.9,whole blood,,,,Aboriginal Australian,whole blood
Initial,450K,479,0.64,null,null,61.9,11.8,tumor tissue and adjacent normal tissue,,,renal clear cell carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,48,0.25,null,null,null,null,peripheral blood mononuclear cell,,,healthy control,Not reported,peripheral blood mononuclear cell
Initial,450K,48,0.33,25,40,31.8,4.6,whole blood,EGCUT1,,,European,whole blood
Initial,450K,48,0.35,null,null,38.1,null,leukocyte,,,PD,Not reported,leukocyte
Initial,450K,48,0.35,null,null,38.2,null,leukocyte,,,control,Not reported,leukocyte
Initial,450K,48,0.43,null,null,83,14,whole blood,CRELES,Costa Rican Study on Longevity and Healthy Aging,Nicoya,Hispanic or Latin American,whole blood
Initial,450K,48,0.46,45.1,11.2,null,null,whole blood,,,,African American or Afro-Caribbean;European,whole blood
Initial,450K,48,0.48,3.5,76,15,null,peripheral blood mononuclear cell,,,,Not reported,peripheral blood mononuclear cell
Initial,450K,48,0.5,0,0,0,0,cord blood,,,ICSI,European;Not reported,cord blood
Initial,450K,48,0.56,0,0,0,0,neonatal blood,,,Psychiatric,Not reported,neonatal blood
Initial,450K,48,0.6,6,15,null,null,whole blood,,,,East Asian,whole blood
Initial,450K,48,0.604,null,null,61.71,7.66,hippocampus,,,control,Not reported,hippocampus
Initial,450K,48,0.75,12,74,37.94,14.24,skin,,,24 paired,South Asian,skin
Initial,450K,480,null,null,null,null,null,urological tumor tissue,,,,Not reported,urological tumor tissue
Initial,450K,481,0.485,null,null,49.9,12.8,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,MetS-,European,CD4+ T cell
Initial,450K,482,0.52,0,0,0,0,leukocyte,,Project viva,,African unspecified;European;Other,leukocyte
Initial,450K,482,0.52,7.4,11.3,8.7,null,leukocyte,,482,,African unspecified;European;Other,leukocyte
Initial,450K,482,0.54,55,79,null,null,buffy coat,MADT,Middle Aged Danish Twins Study,,European,buffy coat
Initial,450K,484,0.52,null,null,53.2,9.6,whole blood,KORA F3,Cooperative Health Research in the Region of Augsburg,,European,whole blood
Initial,450K,485,0.15,null,null,52.3,12.4,leukocyte,EPIC-Italy,,EPICOR,European,leukocyte
Initial,450K,485,null,0,0,0,0,cord blood,,Project Viva,,African American or Afro-Caribbean;Asian unspecified;European;Hispanic or Latin American;Other,cord blood
Initial,450K,486,0.54,55,79,65.9,6.1,whole blood,MADT,Middle Aged Danish Twins Study,,European,whole blood
Initial,450K,489,0.47,null,null,65.5,10.2,tumor tissue and adjacent normal tissue,,,lung adenocarcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,49,0.1,null,null,55.6,14.4,CD19+ B cell,,,Cases,Not reported,CD19+ B cell
Initial,450K,49,0.49,34,82,63.7,11.8,colorectal mucosa,,,Never smokers,Not reported,colorectal mucosa
Initial,450K,49,0.53,0.9,1,0.9,null,whole blood,,,CPO,European;Not reported,whole blood
Initial,450K,49,0.592,null,null,61.62,7.61,entorhinal Cortex,,,control,Not reported,entorhinal Cortex
Initial,450K,49,0.61,0.3,0.4,0.3,null,whole blood,,,CLO,European;Not reported,whole blood
Initial,450K,49,0.84,0.4,0.5,0.5,null,whole blood,,, CLP,European;Not reported,whole blood
Initial,450K,490,0,null,null,null,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers,Not reported,whole blood
Initial,450K,491,0.47,null,null,47.4,20.9,whole blood,NSPHS,northern Sweden population health study,control,European,whole blood
Initial,450K,492,0,18.6,80.9,58,null,whole blood,TwinsUK,,,Not reported,whole blood
Initial,450K,498,0.45,null,null,62.8,15.8,whole blood,InCHIANTI,Invecchiare in Chianti Study,,European,whole blood
Initial,450K,499,0.45,null,null,63,16,whole blood,InCHIANTI,Invecchiare in Chianti,,European,whole blood
Initial,450K,5,0,42,70,null,null,synovial fibroblast,BEACON,Birmingham early arthritis cohort,Early RA,Not reported,synovial fibroblast
Initial,450K,5,0,null,null,null,null,endometrium,,,control,Not reported,endometrium
Initial,450K,5,0,null,null,null,null,endometrium,,,Endometriosis,Not reported,endometrium
Initial,450K,5,0.4,null,null,37.6,7.6,peripheral blood mononuclear cell,,,control,Not reported,peripheral blood mononuclear cell
Initial,450K,5,0.4,null,null,37.6,7.6,saliva,,,control,Not reported,saliva
Initial,450K,5,0.6,0,0,0,0,granulocyte,,,preterm (GA range 26‚Äì 30 weeks),Not reported,granulocyte
Initial,450K,5,0.6,0,0,0,0,monocyte,,,preterm (GA range 26‚Äì 30 weeks),Not reported,monocyte
Initial,450K,5,0.6,0,0,0,0,nucleated red blood cell,,,preterm (GA range 26‚Äì 30 weeks),Not reported,nucleated red blood cell
Initial,450K,5,0.6,0,0,0,0,T cell,,,preterm (GA range 26‚Äì 30 weeks),Not reported,T cell
Initial,450K,5,0.6,47,62,51,7.3,articular cartilage,,,Normal,East Asian,articular cartilage
Initial,450K,5,0.6,51,69,57.4,7.1,articular cartilage,,,KBD,East Asian,articular cartilage
Initial,450K,5,0.6,58,72,64.6,5.2,articular cartilage,,,OA,East Asian,articular cartilage
Initial,450K,5,0.6,null,null,37.6,7.6,peripheral blood mononuclear cell,,,RA,Not reported,peripheral blood mononuclear cell
Initial,450K,5,0.6,null,null,37.6,7.6,saliva,,,RA,Not reported,saliva
Initial,450K,5,0.8,0,0,0,0,granulocyte,,,term (GA 38 weeks),Not reported,granulocyte
Initial,450K,5,0.8,0,0,0,0,monocyte,,,term (GA 38 weeks),Not reported,monocyte
Initial,450K,5,0.8,0,0,0,0,nucleated red blood cell,,,term (GA 38 weeks),Not reported,nucleated red blood cell
Initial,450K,5,0.8,0,0,0,0,T cell,,,term (GA 38 weeks),Not reported,T cell
Initial,450K,5,0.8,null,null,13.6,0.1,whole blood,,,Obese sample,Not reported,whole blood
Initial,450K,5,1,22,31,null,null,whole blood,,,Ankylosing spondylitis,East Asian,whole blood
Initial,450K,5,1,23,27,25.4,null,sperm,GUTS,Growing Up Today Study,childhood abuse (Medium),European,sperm
Initial,450K,5,1,23,34,null,null,whole blood,,,Healthy controls,East Asian,whole blood
Initial,450K,5,1,35,49,40,5.6,sperm,,,control,Not reported,sperm
Initial,450K,5,1,null,null,63.2,2.5,periprostatic adipose tissue,,,obese/overweight,Not reported,periprostatic adipose tissue
Initial,450K,5,1,null,null,65.2,3.8,periprostatic adipose tissue,,,normal weight,Not reported,periprostatic adipose tissue
Initial,450K,5,1,null,null,null,null,sperm,,,control,Not reported,sperm
Initial,450K,5,null,0,0,0,0,placenta,,,1st Trimester control,Not reported,placenta
Initial,450K,5,null,0,0,0,0,placenta,,,1st Trimester T16,Not reported,placenta
Initial,450K,5,null,null,45,null,null,NR,,,early onset,Not reported,NR
Initial,450K,5,null,null,null,3,3.9,whole blood,,,patients with mutations in SMARCB1,Not reported,whole blood
Initial,450K,5,null,null,null,null,null,whole blood,,,Controls,Not reported,whole blood
Initial,450K,50,0,null,null,44,8,lymphoblast,IAS,Iowa Adoptions Studies,moderate users (use of alcohol in between 9 and 25 weeks in the past 6 months),European;Not reported,lymphoblast
Initial,450K,50,0,null,null,48.1,7,peripheral blood mononuclear cell,FACHS,Family and Community Health Study,Smoker,African American or Afro-Caribbean,peripheral blood mononuclear cell
Initial,450K,50,0.22,null,null,29.2,6.3,CD4+ T cell,,,SLE Controls,African unspecified;European,CD4+ T cell
Initial,450K,50,0.26,null,null,45.42,null,whole blood,,,Healthy Controls,European,whole blood
Initial,450K,50,0.26,null,null,45.48,null,whole blood,,,Dep-Inflam,European,whole blood
Initial,450K,50,0.26,null,null,45.58,null,whole blood,,,Inflammation,European,whole blood
Initial,450K,50,0.26,null,null,45.66,null,whole blood,,,Depression,European,whole blood
Initial,450K,50,0.52,null,null,58.9,58.9,whole blood,,,Current smokers,European,whole blood
Initial,450K,50,0.76,26,87,62,null,head and neck,,,,Not reported,head and neck
Initial,450K,50,1,null,null,8.9,0.1,leukocyte,,,,South Asian,leukocyte
Initial,450K,50,null,null,null,null,null,thyroid,,,nonneoplastic thyroid tissues,Not reported,thyroid
Initial,450K,500,0.49,50,75,null,null,whole blood,ESTHER,,,Not reported,whole blood
Initial,450K,500,0.52,null,null,53.1,9.6,whole blood,KORA F3,Cooperative Health Research in the Region of Augsburg,,Not reported,whole blood
Initial,450K,501,0.41,21,72,26.6,11,whole blood,FTC,Finnish Twin Cohort,,European,whole blood
Initial,450K,502,0.38,null,null,70,10,CD14+ monocyte,,,Never smokers,African American or Afro-Caribbean;European;Hispanic or Latin American,CD14+ monocyte
Initial,450K,502,0.48,null,null,58,7,whole blood,RS,Rotterdam Study,,European,whole blood
Initial,450K,507,0.49,0,0,0,0,cord blood,GOYA,,,European,cord blood
Initial,450K,508,0.55,35,92,70,null,whole blood,PEG1,Parkinson‚Äôs Environment and Genes study,289 PD,European,whole blood
Initial,450K,509,0.49,17,17,17,0,whole blood,Raine Study,,,European,whole blood
Initial,450K,51,0,null,null,59.8,11.3,ovarian,TCGA,The Cancer Genome Atlas,recurrence ‚â§12 months,Not reported,ovarian
Initial,450K,51,1,null,null,36.3,17.2,whole blood,,,,Greater Middle Eastern,whole blood
Initial,450K,512,0,null,null,54,8.6,buffy coat,,,Never smokers,European,buffy coat
Initial,450K,514,0.66,null,null,51.9,7.5,whole blood,EPICOR,European Prospective Investigation into Cancer and Nutrition,,European,whole blood
Initial,450K,515,0.53,2,5,null,null,whole blood,SEED,Study to Explore Early Development,healthy controls,African unspecified;Asian unspecified;European;Other,whole blood
Initial,450K,52,0.44,null,null,45.8,16.4,whole blood,NKI-RS,Nathan Kline Institute-Rockland Sample,alcohol use disorder,Not reported,whole blood
Initial,450K,52,0.48,null,null,66.8,8.4,buccal mucosa,COPDGene,,Former Smokers,African American or Afro-Caribbean;European,buccal mucosa
Initial,450K,52,0.64,0,0,0,0,umbilical vein endothelial cell,,,,Not reported,umbilical vein endothelial cell
Initial,450K,520,0,36.5,76.8,58.4,null,whole blood,HWFS,Dutch Hunger Winter Families Study,,European,whole blood
Initial,450K,523,0.64,null,null,61.5,8.9,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Former smokers follow-up,Not reported,whole blood
Initial,450K,524,0.49,15,17,null,null,whole blood,ALSPAC,,,European,whole blood
Initial,450K,528,0,18.6,80.9,57.9,null,whole blood,TwinsUK,,,Not reported,whole blood
Initial,450K,528,0,null,null,54,8.5,whole blood,EPIC,European Prospective Investigation into Cancer and Nutrition,Never-smokers,European,whole blood
Initial,450K,528,0.46,40,70,58.3,7.9,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,529,0.35,null,null,59.9,8.9,buffy coat,,,Never smokers,European,buffy coat
Initial,450K,53,0.53,0,0,0,0,placenta,RICHS,The Rhode Island Child Health Study,Night shift,Not reported,placenta
Initial,450K,53,0.55,0,1.5,0,null,buccal epithelium,,,,Not reported,buccal epithelium
Initial,450K,53,0.55,null,null,55,12,tissue from bronchial washings,,,Controls,Not reported,tissue from bronchial washings
Initial,450K,53,0.64,null,null,64.7,8.2,whole blood,,,Control,Not reported,whole blood
Initial,450K,53,0.66,null,null,69.1,8.9,whole blood,AEMS450K1,Athero-Express Biobank Study,Former smokers,Not reported,whole blood
Initial,450K,53,1,2,15,6.8,3.4,whole blood,,,ASD,Not reported,whole blood
Initial,450K,53,null,null,null,21.5,1.4,cord blood,IOW F2,,,European,cord blood
Initial,450K,53,null,null,null,21.5,1.4,cord blood ,IOW F2,,,European,cord blood 
Initial,450K,538,0,null,null,72.6,6.4,whole blood,NAS,Normative Aging Study,,European,whole blood
Initial,450K,54,0,null,null,54.17,8.31,adipose tissue,TwinsUK,,current smokers,European,adipose tissue
Initial,450K,54,0.43,null,null,11.3,3.7,nasal epithelial cell,ESS,Exposure Sibling Study,Nonasthmatics,African unspecified;Other admixed ancestry,nasal epithelial cell
Initial,450K,54,0.63,null,null,12,2.9,nasal epithelial cell,ESS,Exposure Sibling Study,Asthmatics,African unspecified;Other admixed ancestry,nasal epithelial cell
Initial,450K,54,0.7,null,null,44.7,12.3,leukocyte,,,schizophrenia suicide attempters,European,leukocyte
Initial,450K,54,null,null,null,null,null,tumor tissue,,,OSCC,Not reported,tumor tissue
Initial,450K,540,0.49,0,0,0,0,whole blood,PREDO,,,European,whole blood
Initial,450K,544,0.48,null,null,4848,15.8,CD4+ T cell,GOLDN,,,European,CD4+ T cell
Initial,450K,545,0.54,null,null,46.6,null,whole blood,,,,African unspecified;European;Other,whole blood
Initial,450K,545,null,null,null,29.5,4.1,cord blood,GOYA,,,European,cord blood
Initial,450K,545,null,null,null,29.5,4.1,cord blood ,GOYA,,,European,cord blood 
Initial,450K,547,0.42,49.7,51.3,50.5,null,whole blood,RODAM,Research on Obesity and Diabetes among African Migrants,,Sub-Saharan African,whole blood
Initial,450K,547,1,null,null,61.6,6.8,tumor tissue and adjacent normal tissue,,,prostate adenocarcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,55,0.13,null,null,15.7,0.7,whole blood,,,High-risk group,Not reported,whole blood
Initial,450K,55,0.35,18,18,18,0,buccal epithelium,,,,European,buccal epithelium
Initial,450K,550,0.48,null,null,58.7,6.6,leukocyte,LLS,Leiden Longevity Study ,,European,leukocyte
Initial,450K,550,null,null,null,null,null,whole blood,LBC1921,Lothian Birth Cohort 1921,,Not reported,whole blood
Initial,450K,554,0.48,16.5,16.5,16.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Controls,Not reported,whole blood
Initial,450K,56,0.2,null,null,6.1,4,CD4+ T cell,,,Case,Not reported,CD4+ T cell
Initial,450K,56,1,null,null,19.3,12.2,peripheral blood,,,healthy control,Not reported,peripheral blood
Initial,450K,560,0.27,null,null,47.8,15.8,tumor tissue and adjacent normal tissue,,,thyroid carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,565,null,null,null,null,null,whole blood,,,control,Not reported,whole blood
Initial,450K,569,null,8,21,null,null,whole blood,GALA II,Genes-environments and Admixture in Latino Americans,,Hispanic or Latin American,whole blood
Initial,450K,57,0.25,null,null,6.4,4.2,CD4+ T cell,,,control,Not reported,CD4+ T cell
Initial,450K,57,null,null,null,49.4,2,peripheral blood mononuclear cell,,,SLE patients,African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Initial,450K,573,0.5,8,22,13,null,leukocyte,GALA II,,,African American or Afro-Caribbean;European,leukocyte
Initial,450K,574,0.49,null,null,60.9,10.2,whole blood,REGICOR,REgistre GIron√≠ del COR,,European,whole blood
Initial,450K,575,0.48,0,0,0,0,cord blood,ALSPAC,,,European,cord blood
Initial,450K,575,0.48,15,17,null,null,whole blood,ALSPAC,,,European,whole blood
Initial,450K,575,0.48,7,7,7,0,whole blood,ALSPAC,,,European,whole blood
Initial,450K,577,0.73,null,null,61.4,11.9,tumor tissue and adjacent normal tissue,,,head and neck squamous cell carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,579,null,0,0,0,0,cord blood,,Generation R Study,,Not reported,cord blood
Initial,450K,58,0.43,null,null,45.8,16.7,whole blood,NKI-RS,Nathan Kline Institute-Rockland Sample,healthy controls,Not reported,whole blood
Initial,450K,58,0.57,null,null,5.6,0.07,buffy coat,CHOP,,exposed,European,buffy coat
Initial,450K,58,0.59,null,null,45,13,airway epithelial cell,,,IL-13 treated,Not reported,airway epithelial cell
Initial,450K,58,0.59,null,null,45,13,airway epithelial cell,,,untreated,Not reported,airway epithelial cell
Initial,450K,580,0.56,null,null,69.1,11.4,whole blood,PEG,Parkinson's Environment and Genes Study,,European;Not reported,whole blood
Initial,450K,583,0.52,null,null,70.2,9.5,whole blood,RS,Rotterdam Study,,European,whole blood
Initial,450K,584,null,null,null,null,null,whole blood,SEED,Study to Explore Early Development,,African American or Afro-Caribbean;European;Other,whole blood
Initial,450K,587,0.54,33,94,69.3,null,tumor tissue,DACHS,,Non-metastatic CRC,Not reported,tumor tissue
Initial,450K,587,0.56,0,0,0,0,whole blood,MoBa2,,,European,whole blood
Initial,450K,59,0.75,0,0,0,0,placenta,ELGAN,Extremely Low for Gestational Age Newborns,Spontaneous EPTB,African American or Afro-Caribbean;European;Other,placenta
Initial,450K,591,0,27,76,null,null,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,595,0.5,26,80,49,null,whole blood,,,Subjects with airway obstruction,Not reported,whole blood
Initial,450K,597,0,null,null,56,9,whole blood,TwinsUK,,,European,whole blood
Initial,450K,6,0,null,null,34.8,2.9,endometrium,,,endometriosis‚Äêfree control,Not reported,endometrium
Initial,450K,6,0,null,null,36.2,7.1,endometrium,,,adjacent normal tissues,Not reported,endometrium
Initial,450K,6,0,null,null,36.2,7.1,endometrium,,,endometriotic lesions,Not reported,endometrium
Initial,450K,6,0.33,0,0,0,0,umbilical cord blood,,,healthy control,Not reported,umbilical cord blood
Initial,450K,6,0.5,42,55,48.7,4.7,gastric mucosa,,,successfully eradicated,East Asian,gastric mucosa
Initial,450K,6,0.5,42,55,48.7,4.7,leukocyte,,,successfully eradicated,East Asian,leukocyte
Initial,450K,6,0.66,0,0,0,0,umbilical cord blood,,,polycystic ovary syndrome,Not reported,umbilical cord blood
Initial,450K,6,0.67,45,58,null,null,adjacent normal tissue,,,adjacent normal tissue,East Asian,adjacent normal tissue
Initial,450K,6,0.67,45,58,null,null,tumor tissue,,,tumor tissue,East Asian,tumor tissue
Initial,450K,6,1,24,38,30,null,sperm,,,control,Not reported,sperm
Initial,450K,6,1,24,38,30,null,sperm,,,Control,Not reported,sperm
Initial,450K,6,1,28,32,30.16,null,sperm,,,oligozoospermic infertile patients,Not reported,sperm
Initial,450K,6,1,28,32,30.16,null,sperm,,,Patient,Not reported,sperm
Initial,450K,6,1,60,85,null,null,whole blood,,,LA,East Asian,whole blood
Initial,450K,6,1,null,null,30.5,1.7,whole blood,,,oligo/azoospermic infertile patients,Not reported,whole blood
Initial,450K,6,1,null,null,31,1.9,whole blood,,,normozoospermic fertile controls,Not reported,whole blood
Initial,450K,6,1,null,null,49.17,3.25,whole blood,,,Cases,Not reported,whole blood
Initial,450K,6,1,null,null,51.17,3.61,whole blood,,,Controls,Not reported,whole blood
Initial,450K,6,66.7,72,78,null,null,peripheral blood mononuclear cell,CLSA,Canadian Longitudinal Study on Aging,,Not reported,peripheral blood mononuclear cell
Initial,450K,6,null,null,null,null,null,adrenal gland,,,normal,Not reported,adrenal gland
Initial,450K,6,null,null,null,null,null,B lymphoblastoid cell,,,,Not reported,B lymphoblastoid cell
Initial,450K,6,null,null,null,null,null,bone marrow,,,dic(9;20)(p11‚Äì13; q11),Not reported,bone marrow
Initial,450K,6,null,null,null,null,null,bone marrow,,,TCF3-PBX1,Not reported,bone marrow
Initial,450K,60,0,23,31,27.17,null,whole blood,HUNT Study,,Lean,Not reported,whole blood
Initial,450K,60,0,23,31,27.17,null,whole blood,HUNT Study,,Obese,Not reported,whole blood
Initial,450K,60,0.28,null,null,48.9,7.9,liver,,,Nondiabetics,Not reported,liver
Initial,450K,60,0.7,null,null,6.6,6.3,prefrontal cortex,,,child control,European;Not reported,prefrontal cortex
Initial,450K,60,0.7,null,null,73.5,5.8,whole blood,COPD,,COPD cases,East Asian,whole blood
Initial,450K,60,1,null,null,49.2,8.2,whole blood,,,Past,European;Other,whole blood
Initial,450K,60,null,null,null,null,null,bronchi,,,Controls,Not reported,bronchi
Initial,450K,60,null,null,null,null,null,thyroid,,,papillary thyroid carcinoma,Not reported,thyroid
Initial,450K,600,1,40,70,58.2,7.7,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,608,0.42,null,null,68.6,5.6,leukocyte,RS,,,Not reported,leukocyte
Initial,450K,609,0,null,null,58.28,9.96,whole blood,TwinsUK,,,European,whole blood
Initial,450K,61,0,null,null,48.7,11,peripheral blood mononuclear cell,FACHS,Family and Community Health Study,non-smoker,African American or Afro-Caribbean,peripheral blood mononuclear cell
Initial,450K,61,0.25,null,null,null,null,peripheral blood mononuclear cell,,,ME/CFS diagnosed patients,Not reported,peripheral blood mononuclear cell
Initial,450K,611,0.45,null,null,31,0.3,whole blood,NFBC1966,,time point 1,European,whole blood
Initial,450K,612,0,null,null,12.7,1.5,whole blood,NIEHS,National Institute of Environmenal Health Sciences,Noncase subjects,European,whole blood
Initial,450K,614,0.35,null,null,62.2,9,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers follow-up,Not reported,whole blood
Initial,450K,615,0.35,null,null,55.1,9,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers baseline,Not reported,whole blood
Initial,450K,619,0.48,null,null,59.22,6.5,whole blood,LLS,,,European,whole blood
Initial,450K,62,0.47,null,null,69.5,0.7,whole blood,LBC1936,,Frail,Not reported,whole blood
Initial,450K,62,1,1,1,1,1,cord blood,,,,South Asian,cord blood
Initial,450K,62,1,null,null,39,7.3,whole blood,DILGOM,"DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study",sufcient sleep,Not reported,whole blood
Initial,450K,62,1,null,null,null,null,cord blood,,,,Not reported,cord blood
Initial,450K,623,1,null,null,72,7,whole blood,NAS,Normative Aging Study,,European,whole blood
Initial,450K,624,null,0,0,0,0,cord blood,MoBa2,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,629,0.52,0,0,0,0,blood spot,MINERvA,,ASD,European,blood spot
Initial,450K,63,0,null,null,8.9,0.2,leukocyte,,,,South Asian,leukocyte
Initial,450K,63,1,null,null,42.8,14.1,whole blood,NTR,Netherlands Twin Register,8 cases and 55 controls,Not reported,whole blood
Initial,450K,631,1,null,null,74.6,6.8,whole blood,NAS,Normative Aging Study,,European,whole blood
Initial,450K,632,0.49,7.5,7.5,7.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Controls,Not reported,whole blood
Initial,450K,633,0.48,0,0,0,0,whole blood,ALSPAC,,,European,whole blood
Initial,450K,633,1,null,null,72,null,whole blood,NAS,Normative Aging Study,,Not reported,whole blood
Initial,450K,634,0.5,0,0,0,0,blood spot,MINERvA,,Controls,European,blood spot
Initial,450K,635,0,null,null,58.8,9.3,adipose tissue,MuTHER,Multiple Tissue Human Expression Resource,Adipose tissue samples,European,adipose tissue
Initial,450K,637,null,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,639,null,0,0,0,0,cord blood,MoBa2,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,64,0,null,null,28.9,4.8,cord blood,TMICS,Taiwan Maternal and Infant Cohort Study,,East Asian,cord blood
Initial,450K,64,0.27,null,null,44.6,13.1,whole blood,,,Former smokers,African American or Afro-Caribbean,whole blood
Initial,450K,64,0.64,35,86,65,null,whole blood,PEG1,Parkinson‚Äôs Environment and Genes study,46 PD,Hispanic or Latin American,whole blood
Initial,450K,64,0.73,41,95,75.8,12.9,intima tissue,,,atheromatous plaque lesions,East Asian,intima tissue
Initial,450K,64,0.73,41,95,75.8,12.9,intima tissue,,,plaque‚Äëfree intima,East Asian,intima tissue
Initial,450K,64,0.75,38,89,65.5,10.9,colorectal mucosa,,,Former smokers,Not reported,colorectal mucosa
Initial,450K,64,1,null,null,48.3,4.3,peripheral blood,SABRE,Southall And Brent REvisited,Never smokers,South Asian,peripheral blood
Initial,450K,64,null,0,0,0,0,cord blood,,Colorado Healthy Start cohort,gestational diabetes-unexposed,Not reported,cord blood
Initial,450K,64,null,9,83,null,null,whole blood,,,mother‚Äì offspring,Not reported,whole blood
Initial,450K,640,0.56,null,null,70,9,CD14+ monocyte,,,Former smokers,African American or Afro-Caribbean;European;Hispanic or Latin American,CD14+ monocyte
Initial,450K,641,0.49,null,null,63.2,11.7,whole blood,REGICOR,,,Not reported,whole blood
Initial,450K,645,0.42,null,null,39.5,null,whole blood,,,Controls,African American or Afro-Caribbean;European,whole blood
Initial,450K,645,0.49,null,null,63.2,11.7,whole blood,REGICOR,,,European,whole blood
Initial,450K,646,1,null,null,73.7,6.8,whole blood,NAS,Normative Aging Study,97% Caucasians,European;Not reported,whole blood
Initial,450K,647,null,null,null,30,4.5,cord blood,MoBa2,,,European,cord blood
Initial,450K,647,null,null,null,30,4.5,cord blood ,MoBa2,,,European,cord blood 
Initial,450K,65,0,0,0,0,0,cord blood,,,,South Asian,cord blood
Initial,450K,65,0,null,null,51.8,8.4,whole blood,,The Generations Study,,Not reported,whole blood
Initial,450K,65,0,null,null,null,null,cord blood,,,,Not reported,cord blood
Initial,450K,65,0.49,null,null,65,8.4,lung,TCGA, The Cancer Genome Atlas,normal,Not reported,lung
Initial,450K,65,1,null,null,48.5,4.6,peripheral blood,SABRE,Southall And Brent REvisited,Never smokers,European,peripheral blood
Initial,450K,653,0.48,null,null,48,16.2,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Initial,450K,656,0.48,19,100,65,null,whole blood,,,,Not reported,whole blood
Initial,450K,656,0.48,19,101,null,null,whole blood,,,426 Caucasian and 230 Hispanic individuals,European;Hispanic or Latin American,whole blood
Initial,450K,656,1,19,101,null,null,whole blood,,,control,European,whole blood
Initial,450K,657,1,null,null,72.44,6.9,whole blood,NAS baseline,Normative Aging Study,NAS baseline,Not reported,whole blood
Initial,450K,658,0.57,22,79,46,null,whole blood,,,,Not reported,whole blood
Initial,450K,658,0.57,22,79,46,null,whole blood,,,Current- smokers,Not reported,whole blood
Initial,450K,66,0,29,75,54.1,9.1,whole blood,,,monozygotic female twin pairs,European,whole blood
Initial,450K,66,0.394,null,null,85.5,8,prefrontal cortex,,,Braak V-VI,Not reported,prefrontal cortex
Initial,450K,66,0.47,null,null,66,9.2,lung,TCGA, The Cancer Genome Atlas,tumor,Not reported,lung
Initial,450K,66,0.5,null,null,15.5,1.4,buffy coat,SYS,Saguenay Youth Study,Exposed,European,buffy coat
Initial,450K,66,0.5,null,null,15.6,1.5,buffy coat,SYS,Saguenay Youth Study,Nonexposed,European,buffy coat
Initial,450K,66,0.53,null,null,72.7,5.2,whole blood,,,Former smokers,African American or Afro-Caribbean,whole blood
Initial,450K,661,0.52,0,0,0,0,cord blood,Generation R,,,European,cord blood
Initial,450K,663,0.47,null,null,48.6,16.4,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Initial,450K,666,0.52,0,0,0,0,cord blood,MoBa1,,,European,cord blood
Initial,450K,666,null,0,0,0,0,cord blood,MoBa2,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,668,0.48,null,null,59.1,6.6,leukocyte,LLS,,,Not reported,leukocyte
Initial,450K,668,0.52,0,0,0,0,placenta,EDEN,,,European,placenta
Initial,450K,669,null,null,null,null,null,breast,TCGA,The Cancer Genome Atlas,,Not reported,breast
Initial,450K,67,1,null,null,36.3,9.71,leukocyte,,,male controls,Not reported,leukocyte
Initial,450K,67,null,null,null,36.4,10,leukocyte,,,KS patients,Not reported,leukocyte
Initial,450K,671,0.43,52,80,67.2,6.1,whole blood,RS-BIOS,Rotterdam study-Biobank-based Integrative Omics Studies,,European,whole blood
Initial,450K,671,0.49,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,European,cord blood
Initial,450K,671,null,0,0,0,0,cord blood,MoBa2,Norwegian Mother and Child Cohort Study,,European,cord blood
Initial,450K,674,null,null,null,72.5,6.8,buffy coat,NAS,The Normative Aging Study,,European,buffy coat
Initial,450K,678,0,18,80,46,null,whole blood,,,,Not reported,whole blood
Initial,450K,68,0.5,null,null,70.5,5.9,whole blood,MCC-Sp,,THM <= 85 Œºg/L,Not reported,whole blood
Initial,450K,680,0,null,null,40.6,12.1,whole blood,NTR,Netherlands Twin Register,74 cases and 606 controls,Not reported,whole blood
Initial,450K,681,1,null,null,null,null,peripheral blood mononuclear cell,VACS,Veterans Aging Cohort Study,,Not reported,peripheral blood mononuclear cell
Initial,450K,688,0.49,0,0,0,0,cord blood,ALSPAC,,,European,cord blood
Initial,450K,689,0.45,null,null,59.5,8,whole blood,RS-III,Rotterdam Study,,European,whole blood
Initial,450K,689,0.62,null,null,37.7,null,whole blood,,,Cases,African American or Afro-Caribbean;European,whole blood
Initial,450K,69,0.449,null,null,31.1,4.43,adipose tissue,,Finnish Twin Cohort,,Not reported,adipose tissue
Initial,450K,69,0.59,null,null,64,null,whole blood,ESTHER,,"Diabetic, poorly controlled",Not reported,whole blood
Initial,450K,69,0.7,null,null,44.7,12.3,leukocyte,,,non-suicide attempters,European,leukocyte
Initial,450K,69,null,0,0,0,0,cord blood,GECKO,Groningen Expert Center for Kids with Obesity,,Not reported,cord blood
Initial,450K,690,null,null,null,58.4,9.3,whole blood,TwinsUK,,twins,European,whole blood
Initial,450K,691,0.31,null,null,34,12.1,whole blood,NTR,,,European,whole blood
Initial,450K,691,null,7,7,7,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Initial,450K,692,0.32,null,null,34,12.1,whole blood,BIOS,Biobank-based Integrative Omics Study,,Not reported,whole blood
Initial,450K,698,0.47,14,94,50.4,null,whole blood,NSPHS,Northern Sweden population Health Study,,Not reported,whole blood
Initial,450K,7,0.71,32,72,null,null,synovial fibroblast,BEACON,Birmingham early arthritis cohort,patients with resolving arthritis,Not reported,synovial fibroblast
Initial,450K,7,1,36,54,40.6,6.3,sperm,,,Patient,Not reported,sperm
Initial,450K,7,1,36.2,59.1,42.7,7.8,liver,,,Non-Obese Controls,European,liver
Initial,450K,7,1,36.4,59.8,45.8,7.6,liver,,,Obese Non-Diabetic,European,liver
Initial,450K,7,1,59,84,71.4,9.3,bladder,,,not recurred,Not reported,bladder
Initial,450K,7,1,null,null,21.2,14.3,peripheral blood,,,Claes-Jensen syndrome,Not reported,peripheral blood
Initial,450K,7,null,null,null,11.5,11.3,whole blood,,,NCBRS subjects,Not reported,whole blood
Initial,450K,7,null,null,null,null,null,NR,,,elderly onset,Not reported,NR
Initial,450K,70,0,null,null,50,1.5,peripheral blood mononuclear cell,,,myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS),European,peripheral blood mononuclear cell
Initial,450K,70,0,null,null,51.2,5,whole blood,Sister Study,National Institute of Environmental Health Sciences (NIEHS) Sister Study,Former smoker,European,whole blood
Initial,450K,70,0.59,null,null,70.1,5.6,whole blood,MCC-Sp,,THM > 85 Œºg/L,Not reported,whole blood
Initial,450K,70,0.74,null,null,64,9,tissue from bronchial washings,,,Cases,Not reported,tissue from bronchial washings
Initial,450K,70,1,1,16,3.1,null,peripheral blood mononuclear cell,,,,Not reported,peripheral blood mononuclear cell
Initial,450K,700,0.45,null,null,59.8,8,leukocyte,RS,Rotterdam Study,,European,leukocyte
Initial,450K,702,null,7,7,7,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Initial,450K,703,0.45,null,null,47,17,CD4+ T cell,,,Never smokers,European,CD4+ T cell
Initial,450K,703,null,7,7,7,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Initial,450K,704,0.42,null,null,47.3,12.5,leukocyte,LLD,,,Not reported,leukocyte
Initial,450K,706,0.37,null,null,88,6.7,dorsolateral prefrontal cortex,,,,Not reported,dorsolateral prefrontal cortex
Initial,450K,710,null,7,7,7,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Initial,450K,713,null,0,0,0,0,cord blood,Generation R,,,European,cord blood
Initial,450K,715,0,34,60,47.5,4.3,whole blood,ALSPAC,,,European,whole blood
Initial,450K,717,0.52,0,0,0,0,whole blood,Generation R,,,European,whole blood
Initial,450K,719,null,7,7,7,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Initial,450K,72,0,null,null,36.3,17.2,whole blood,,,,Greater Middle Eastern,whole blood
Initial,450K,720,0.5,null,null,56.2,5.8,buffy coat,,,Current smokers,African American or Afro-Caribbean,buffy coat
Initial,450K,722,0.42,null,null,67.6,6,whole blood,RS-II-3/ RS-III-2,,,European,whole blood
Initial,450K,722,0.46,null,null,59.8,8.1,whole blood,RS-III,,,European,whole blood
Initial,450K,723,0.42,null,null,67.6,6,whole blood,BIOS,Biobank-based Integrative Omics Study,,Not reported,whole blood
Initial,450K,723,null,0,0,0,0,cord blood,,Generation R Study,,Not reported,cord blood
Initial,450K,725,0.46,null,null,59.9,8.2,leukocyte,,,,Not reported,leukocyte
Initial,450K,727,null,null,null,59.7,8.2,whole blood,RS-III,Rotterdam Study,,European,whole blood
Initial,450K,728,0.42,null,null,67.5,5.9,whole blood,RS-Bios,Rotterdam Bios,,European,whole blood
Initial,450K,728,0.46,46,89,59.9,8.2,whole blood,RS3,Rotterdam Study,,European,whole blood
Initial,450K,728,0.47,14,94,50.4,null,leukocyte,NSPHS,,,Not reported,leukocyte
Initial,450K,729,0.46,null,null,59.9,8.2,whole blood,RS-III-I,,,European,whole blood
Initial,450K,73,0.25,null,null,51.7,13.9,CD19+ B cell,,,Controls,Not reported,CD19+ B cell
Initial,450K,73,0.49,null,null,44,13,CD4+ T cell,,,Current smokers,European,CD4+ T cell
Initial,450K,731,0.46,46.4,89.3,59.6,null,whole blood,RS,,,European,whole blood
Initial,450K,733,0,35,60,47.4,4.5,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,European,whole blood
Initial,450K,733,0.54,4,5,null,null,whole blood,MeDALL,Mechanisms of the Development of ALLergy,,European;Hispanic or Latin American,whole blood
Initial,450K,739,0.48,null,null,59,6.7,whole blood,LLS,,,European,whole blood
Initial,450K,74,0.3,null,null,39.1,12.9,airway epithelial cell,,,Asthma,Not reported,airway epithelial cell
Initial,450K,74,0.47,26.4,45.5,32.8,null,leukocyte,,,Symptomatic controls,Not reported,leukocyte
Initial,450K,74,0.54,9.8,14.3,12.6,null,whole blood,RISK,Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn‚Äôs Disease cohort,Controls without IBD,Not reported,whole blood
Initial,450K,74,0.64,null,null,69,13.6,whole blood,,,stable coronary artery disease,Not reported,whole blood
Initial,450K,742,0.49,7.5,7.5,7.5,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,Controls,Not reported,whole blood
Initial,450K,744,0.42,null,null,45.6,13.3,whole blood,LLD,,,European,whole blood
Initial,450K,748,0.42,null,null,45.6,13.3,whole blood,BIOS,Biobank-based Integrative Omics Study,,Not reported,whole blood
Initial,450K,749,0.35,31,81,62.1,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers,Not reported,whole blood
Initial,450K,749,0.68,null,null,49.9,9.8,whole blood,LOLIPOP,The London Life Sciences Prospective Population Study,Controls,Asian unspecified,whole blood
Initial,450K,75,0.52,0,0,0,0,cord blood,Rhea,,,European,cord blood
Initial,450K,75,1,21.6,71.2,41.6,12.8,whole blood,,,,European,whole blood
Initial,450K,750,0.5,null,null,48.9,16,buffy coat,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network Study,After 3 weeks,European,buffy coat
Initial,450K,750,0.5,null,null,48.9,16,buffy coat,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network Study,Baseline,European,buffy coat
Initial,450K,751,0.42,18,81,45.5,13.3,whole blood,LLD,LifeLines-DEEP,,European,whole blood
Initial,450K,753,0.35,null,null,62.1,8.9,whole blood,,,Never smokers,European,whole blood
Initial,450K,754,0,0,0,0,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,whole blood
Initial,450K,757,0.58,null,null,67.6,5.9,whole blood,RS-BIOS,,,European,whole blood
Initial,450K,76,0.37,null,null,37,7.5,whole blood,,,Controls,European,whole blood
Initial,450K,76,0.41,null,null,5.5,4,whole blood,,Chicago Food Allergy Study,Normal controls,European,whole blood
Initial,450K,76,0.58,null,null,75.6,5.1,whole blood,,,Former smokers,European,whole blood
Initial,450K,76,0.61,42,84,62.16,10.17,whole blood,,,,African American or Afro-Caribbean,whole blood
Initial,450K,76,0.78,null,null,59,10,bronchi,,,Bronchial washing Lung cancer,Not reported,bronchi
Initial,450K,765,0,null,null,null,null,tumor tissue,,,breast cancer,Not reported,tumor tissue
Initial,450K,767,null,null,null,null,null,breast,,,,African unspecified;European,breast
Initial,450K,77,0,null,null,42,12.5,whole blood,NTR,Netherlands Twin Register,7 cases and 70 controls,Not reported,whole blood
Initial,450K,77,0,null,null,56,4.6,whole blood,NOWAC,,Former smokers,European,whole blood
Initial,450K,77,0.47,0,0,0,0,cord blood,,,Stopped smokers afer confrming pregnancy,East Asian,cord blood
Initial,450K,77,0.47,null,null,47.4,20.9,whole blood,NSPHS,Northern Sweden population Health Study,Myocardial infarction,European,whole blood
Initial,450K,77,0.51,null,null,58.7,79,buffy coat,,,Current smokers,African American or Afro-Caribbean,buffy coat
Initial,450K,77,0.55,0,0,0,0,whole blood,Healthy Start,,,African American or Afro-Caribbean,whole blood
Initial,450K,77,0.74,0,0,0,0,cord blood,MoBa,Norwegian Mother and Child Cohort Study,sporadically exposed with attention-deficit/hyperactivity disorder,European,cord blood
Initial,450K,774,null,7,7,7,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Initial,450K,775,0,18.7,83.1,58,10.3,whole blood,TUK,,,European,whole blood
Initial,450K,775,null,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,78,1,null,null,31.2,0.6,sperm,,,non-smokers,Not reported,sperm
Initial,450K,78,1,null,null,32.4,0.9,sperm,,,smokers,Not reported,sperm
Initial,450K,780,0,null,null,47.14,4.61,buccal cell,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,buccal cell
Initial,450K,780,45,0,0,0,0,cord blood,ALSPAC,,,European,cord blood
Initial,450K,782,0.6,35,81,61,null,whole blood,KORA F4,Kooperative Gesundheitsforschung in der Region Augsburg,Former smokers,Not reported,whole blood
Initial,450K,782,0.61,null,null,61.1,9,whole blood,,,Former smokers,European,whole blood
Initial,450K,785,0.48,null,null,58.4,7.5,whole blood,BIOS,Biobank-based Integrative Omics Study,,Not reported,whole blood
Initial,450K,788,null,null,null,29.7,4.4,cord blood,ALSPAC,,,European,cord blood
Initial,450K,788,null,null,null,29.7,4.4,cord blood ,ALSPAC,,,European,cord blood 
Initial,450K,79,0.14,null,null,54.2,12.2,whole blood,TwinsUK,,Non-RA,European,whole blood
Initial,450K,79,0.14,null,null,54.2,12.2,whole blood,TwinsUK,,RA,European,whole blood
Initial,450K,792,0.57,0,0,0,0,whole blood,NCL,,,European,whole blood
Initial,450K,792,null,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,8,0,22,54,42.5,13,whole blood,,,,European,whole blood
Initial,450K,8,0,25,37,34.4,3.9,cord blood,,,GDM,East Asian,cord blood
Initial,450K,8,0,25,37,34.4,3.9,whole blood,,,GDM,East Asian,whole blood
Initial,450K,8,0,27,38,33.3,3.2,cord blood,,,Non-GDM,East Asian,cord blood
Initial,450K,8,0,27,38,33.3,3.2,whole blood,,,Non-GDM,East Asian,whole blood
Initial,450K,8,0,34,61,40,null,urine,,,Controls,European;Not reported,urine
Initial,450K,8,0,null,null,30.9,1.7,CD4+ T cell,,,Obese BMI,European,CD4+ T cell
Initial,450K,8,0,null,null,30.9,1.7,CD8+ T cell,,,Obese BMI,European,CD8+ T cell
Initial,450K,8,0,null,null,50.3,7.7,visceral adipose tissue,,,Type 2 diabetes,Not reported,visceral adipose tissue
Initial,450K,8,0.25,null,null,44.6,3.6,peripheral blood mononuclear cell,,,Phlegm-dampness Constitution,Not reported,peripheral blood mononuclear cell
Initial,450K,8,0.5,0,0,0,0,placenta,,,preeclampsia,Not reported,placenta
Initial,450K,8,0.5,21,61,null,null,peripheral blood mononuclear cell,,,Controls,Not reported,peripheral blood mononuclear cell
Initial,450K,8,0.5,48,55,null,null,peripheral blood mononuclear cell,CLSA,Canadian Longitudinal Study on Aging,,Not reported,peripheral blood mononuclear cell
Initial,450K,8,0.63,45,63,56.1,2.6,lung,,,COPD,Not reported,lung
Initial,450K,8,0.75,55,69,62.6,1.87,lung,,,Non-smokers,Not reported,lung
Initial,450K,8,0.75,55,69,62.62,1.87,lung,,,Non-smokers,Not reported,lung
Initial,450K,8,0.875,null,null,56.8,8.3,lung,,,Beryllium sensitized,European,lung
Initial,450K,8,0.875,null,null,58.6,6.8,lung,,,Chronic beryllium disease,European,lung
Initial,450K,8,0.88,52,71,61,2.3,lung,,,Smokers,Not reported,lung
Initial,450K,8,0.88,52,71,61,2.33,lung,,,Smokers,Not reported,lung
Initial,450K,8,1,0,0,0,0,placenta,,,Control,Hispanic or Latin American;Native American,placenta
Initial,450K,8,1,0,0,0,0,placenta,,,diabetes during pregnancy,Hispanic or Latin American;Native American,placenta
Initial,450K,8,1,21.4,62.1,41.2,11.3,liver,,,Obese Type 2 Diabetic,European,liver
Initial,450K,8,1,null,null,21.1,2.2,leukocyte,,,8 weeks of resistance exercise training,Not reported,leukocyte
Initial,450K,8,1,null,null,21.1,2.2,leukocyte,,,control,Not reported,leukocyte
Initial,450K,8,1,null,null,27.6,2.4,skeletal muscle,,,7 weeks loading,Not reported,skeletal muscle
Initial,450K,8,1,null,null,27.6,2.4,skeletal muscle,,,7 weeks reloading,Not reported,skeletal muscle
Initial,450K,8,1,null,null,27.6,2.4,skeletal muscle,,,7 weeks unloading,Not reported,skeletal muscle
Initial,450K,8,1,null,null,27.6,2.4,skeletal muscle,,,baseline,Not reported,skeletal muscle
Initial,450K,8,null,null,null,49.7,6.6,whole blood,LVAD,Impact of Left Ventricular Assist Devices Implantation on Micro- and Macrovascular Function,Healthy,Not reported,whole blood
Initial,450K,8,null,null,null,78,8.4,whole blood,LVAD,Impact of Left Ventricular Assist Devices Implantation on Micro- and Macrovascular Function,,Not reported,whole blood
Initial,450K,8,null,null,null,null,null,thyroid,,,follicular thyroid carcinoma,Not reported,thyroid
Initial,450K,80,0,29,86,60,null,tumor tissue,,,,Not reported,tumor tissue
Initial,450K,80,0,50,84,null,null,bone,,,postmenopausal women,Not reported,bone
Initial,450K,800,0.51,null,null,69,4.3,whole blood,KORA,Kooperative Gesundheitsforschung in der Region Augsburg,,European,whole blood
Initial,450K,809,0.53,0,0,0,0,cord blood,,Generation R Study,,European,cord blood
Initial,450K,81,0.49,null,null,9.6,1.7,whole blood,EPOCH,Exploring Perinatal Outcomes in Children study,gestational diabetes-exposed,Not reported,whole blood
Initial,450K,81,0.52,null,null,72.7,12.9,whole blood,,,acute coronary syndrome,Not reported,whole blood
Initial,450K,81,null,null,null,null,null,urological tumor tissue,,,,Not reported,urological tumor tissue
Initial,450K,813,null,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,817,0.49,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,European,cord blood
Initial,450K,818,0.5,null,null,70,0.2,whole blood,PIVUS,Prospective Investigation of the Vasculature in Uppsala Seniors Study,,European,whole blood
Initial,450K,82,0,null,null,54.2,4.2,whole blood,NOWAC,,Current smokers,European,whole blood
Initial,450K,822,null,null,null,48.8,15.9,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,family,European,CD4+ T cell
Initial,450K,828,0.51,0,0,0,0,cord blood,ALSPAC,,,European,cord blood
Initial,450K,835,0.49,null,null,62,null,whole blood,ESTHER,,Nondiabetic,Not reported,whole blood
Initial,450K,836,0.34,null,null,65.8,9.6,whole blood,,,Never smokers,European,whole blood
Initial,450K,838,null,0,0,0,0,cord blood,,Generation R Study,,Not reported,cord blood
Initial,450K,84,0.44,0,0,0,0,whole blood,NCL,Norway Facial Cleft Study,cleft palate,European,whole blood
Initial,450K,84,0.45,null,null,1.4,null,leukocyte,,,Cases,European,leukocyte
Initial,450K,84,0.48,0,0,0,0,cord blood,INMA,,,European,cord blood
Initial,450K,84,0.56,null,null,64,null,whole blood,ESTHER,,"Diabetic, controlled",Not reported,whole blood
Initial,450K,84,0.68,0,0,0,0,placenta,ELGANs,,,European;Not reported,placenta
Initial,450K,84,null,null,null,13,9.7,whole blood,,,matched controls,Not reported,whole blood
Initial,450K,840,null,7,7,7,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,European,whole blood
Initial,450K,8413,null,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,85,0.34,null,null,76.8,5.2,whole blood,,,Never smokers,European,whole blood
Initial,450K,85,null,0,0,0,0,blood spot,CHS,Children‚Äôs Health Study,CHS,European,blood spot
Initial,450K,850,0.37,null,null,46.8,14.5,whole blood,,,,Hispanic or Latin American,whole blood
Initial,450K,850,0.37,null,null,null,null,whole blood,,,,Hispanic or Latin American,whole blood
Initial,450K,851,null,0,0,0,0,cord blood,,Generation R Study,,Not reported,cord blood
Initial,450K,851,null,null,null,null,null,whole blood,MeDALL,,,European,whole blood
Initial,450K,86,0,null,null,52.9,7.2,whole blood,EPIC-Italy,European Prospective Investigation into Cancer and Nutrition,Former smokers,European,whole blood
Initial,450K,860,null,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,ALSPAC,European,cord blood
Initial,450K,866,0.43,null,null,65.4,7.3,whole blood,RS,Rotterdam Study,,European,whole blood
Initial,450K,866,0.48,null,null,57.2,5.9,buffy coat,,,Former smokers,African American or Afro-Caribbean,buffy coat
Initial,450K,866,null,0,0,0,0,cord blood,,Generation R Study,,Not reported,cord blood
Initial,450K,867,null,null,null,29.1,4.9,cord blood,NFCS,,,European,cord blood
Initial,450K,867,null,null,null,29.1,4.9,cord blood ,NFCS,,,European,cord blood 
Initial,450K,868,0.47,41,63,null,null,whole blood,KORA,Cooperative Health Research in the Region of Augsburg,,Not reported,whole blood
Initial,450K,87,0,null,null,39.19,6.15,saliva,,,Mothers - CDV-,Not reported,saliva
Initial,450K,87,0,null,null,null,null,peripheral blood mononuclear cell,,,breast cancer cases,Not reported,peripheral blood mononuclear cell
Initial,450K,87,0.61,26,74,56.7,10.5,pancreatic islet,,Nordic Network for Islet Transplantation,,Not reported,pancreatic islet
Initial,450K,871,0,null,null,55.2,9.1,whole blood,,Sister Study,,Not reported,whole blood
Initial,450K,873,null,0,0,0,0,cord blood,MoBa1,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,875,null,null,null,31.5,4.2,cord blood,Generation R,,,European,cord blood
Initial,450K,875,null,null,null,31.5,4.2,cord blood ,Generation R,,,,cord blood 
Initial,450K,876,0.12,null,null,58.6,13.1,tumor tissue and adjacent normal tissue,,,breast carcinoma,Not reported,tumor tissue and adjacent normal tissue
Initial,450K,88,0,49,74,63,null,leukocyte,,,,Not reported,leukocyte
Initial,450K,88,0.47,21,85,54.7,14.8,brain,TCGA, The Cancer Genome Atlas,,Not reported,brain
Initial,450K,88,null,null,null,null,null,colon,,,colorectal cancer,Not reported,colon
Initial,450K,883,0,null,null,66.3,9,leukocyte,FHS Offspring,,,European,leukocyte
Initial,450K,883,null,0,0,0,0,cord blood,,Generation R Study,,European,cord blood
Initial,450K,889,null,0,0,0,0,heel stick blood,NFCS,Norway Facial Clefts Study,,European,heel stick blood
Initial,450K,89,0,null,null,62.7,11,leukocyte,,,,European,leukocyte
Initial,450K,89,0.39,0,0,0,0,whole blood,RICHS,,,European,whole blood
Initial,450K,89,0.45,null,null,36,10.4,whole blood,,,Cases,European,whole blood
Initial,450K,9,0,0,0,0,0,placenta,,,Control,Hispanic or Latin American;Native American,placenta
Initial,450K,9,0,0,0,0,0,placenta,,,diabetes during pregnancy,Hispanic or Latin American;Native American,placenta
Initial,450K,9,0,null,null,38,0.2,peripheral blood mononuclear cell,,,smoking beyond 5 years,European,peripheral blood mononuclear cell
Initial,450K,9,0,null,null,42.3,18.9,skin,,,PP,Not reported,skin
Initial,450K,9,0,null,null,null,null,leukocyte,,,post-treatment,Not reported,leukocyte
Initial,450K,9,0.33,null,null,null,null,whole blood,,,m,Not reported,whole blood
Initial,450K,9,0.33,null,null,null,null,whole blood,,,married-in controls,Not reported,whole blood
Initial,450K,9,0.44,null,null,13.1,6.3,buffy coat,,,Non-exposure group (Generation 3),East Asian,buffy coat
Initial,450K,9,0.44,null,null,40,7,buffy coat,,,Non-exposure group (Generation 2),East Asian,buffy coat
Initial,450K,9,0.56,47.7,83.9,64,10.98,corneal endothelial,,,FECD,Not reported,corneal endothelial
Initial,450K,9,0.67,null,null,57.2,6.5,right ventricle,,,control,Not reported,right ventricle
Initial,450K,9,1,null,null,46.7,6.7,whole blood,Airline,,sufcient sleep,Not reported,whole blood
Initial,450K,9,1,null,null,47.22,18.43,CD19+ B cell,,,Male control,Not reported,CD19+ B cell
Initial,450K,9,null,50,83,61.4,10.2,CD3+ T cell,,,Controls,Not reported,CD3+ T cell
Initial,450K,9,null,null,null,33.4,6.6,peripheral blood mononuclear cell,,,Non-responders,Not reported,peripheral blood mononuclear cell
Initial,450K,9,null,null,null,null,null,cartilage,,,hip OA patients,Not reported,cartilage
Initial,450K,9,null,null,null,null,null,whole blood,,,non-Kabuki syndrome controls,Not reported,whole blood
Initial,450K,90,0,null,null,null,null,breast,NBS,Normal Breast Study,,Not reported,breast
Initial,450K,90,0.45,null,null,13.38,2.38,saliva,,,Adolescents - CDV-,Not reported,saliva
Initial,450K,90,null,0,0,0,0,cord blood,IOW,Isle of Wight birth cohort,,European,cord blood
Initial,450K,901,0.49,0,0,0,0,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,903,0.56,18,80,46,null,whole blood,,,,Not reported,whole blood
Initial,450K,903,0.56,18,80,46,null,whole blood,,,Never- smokers,Not reported,whole blood
Initial,450K,903,null,null,null,69.5,0.8,whole blood,LBC1936,Lothian Birth Cohort 1936,,European,whole blood
Initial,450K,905,0.51,null,null,69.6,0.8,whole blood,LBC1936,,,European,whole blood
Initial,450K,91,0.35,14,83,47.2,null,tumor tissue,,,,Not reported,tumor tissue
Initial,450K,91,0.59,41,69,56.2,8.7,whole blood,MCCS,Melbourne Collaborative Cohort Study,,European,whole blood
Initial,450K,912,0.52,0,0,0,0,cord blood,Generation R,,,European,cord blood
Initial,450K,914,0.49,0,0,0,0,cord blood,ARIES,,,Not reported,cord blood
Initial,450K,916,0.51,null,null,69.6,0.8,whole blood,LBC1936,,,European,whole blood
Initial,450K,918,0.51,68,71,69.5,0.8,whole blood,LBC1936,Lothian Birth Cohort 1936,,European,whole blood
Initial,450K,92,0.5,14,20.9,17.7,1.7,leukocyte,EpiGO,Epigenetic Basis of Obesity-Induced Cardiovascular Disease and Type 2 Diabetes,lean,African American or Afro-Caribbean,leukocyte
Initial,450K,92,0.51,null,null,11.7,1.55,whole blood,DNBC,Danish National Birth Registry,GDM,Not reported,whole blood
Initial,450K,92,0.55,0,0,0,0,whole blood,NCL,Norway Facial Cleft Study,cleft lip,European,whole blood
Initial,450K,92,0.77,22,87,65,null,whole blood,,,,Not reported,whole blood
Initial,450K,920,0.51,null,null,69.6,0.8,whole blood,LBC1936,Lothian Birth Cohort 1936,,European,whole blood
Initial,450K,920,0.51,null,null,70,1,whole blood,LBC1936,Lothian Birth Cohort 1936,,European,whole blood
Initial,450K,920,0.6,null,null,70,1,whole blood,LBC1936,Lothian Birth Cohort,,Not reported,whole blood
Initial,450K,93,0,12,62,32,null,whole blood,,,,Hispanic or Latin American,whole blood
Initial,450K,93,0.51,25,84,53.4,23.5,whole blood,EGCUT2,,,European,whole blood
Initial,450K,93,0.6,36,88,68,null,saliva,PEG2,Parkinson‚Äôs Environment and Genes study,46 PD,Hispanic or Latin American,saliva
Initial,450K,934,0.47,null,null,69,9,CD14+ monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,African unspecified;European;Hispanic or Latin American,CD14+ monocyte
Initial,450K,94,0.37,null,null,43.4,11.7,whole blood,,,Current smokers,African American or Afro-Caribbean,whole blood
Initial,450K,94,0.39,null,null,13.5,2.3,saliva,,,CDV ‚àí,Not reported,saliva
Initial,450K,94,0.5,null,null,11.7,1.51,whole blood,DNBC,Danish National Birth Registry,Control offspring,Not reported,whole blood
Initial,450K,94,0.72,18,65,29,null,whole blood,,,,Not reported,whole blood
Initial,450K,947,0.51,0,0,0,0,whole blood,GOYA,,,European,whole blood
Initial,450K,949,0.5,67,77,70,null,whole blood,LBC1936,Lothian Birth Cohort 1936,,Not reported,whole blood
Initial,450K,95,0,null,null,50.4,7.5,whole blood,EPIC-Italy,European Prospective Investigation into Cancer and Nutrition,Current smokers,European,whole blood
Initial,450K,96,0.19,null,null,74.1,5.6,whole blood,,,Never smokers,African American or Afro-Caribbean,whole blood
Initial,450K,96,0.47,null,null,11.3,3.4,buccal epithelial cell,,NeuroDevNet FASD cohort,Controls,European;Other,buccal epithelial cell
Initial,450K,96,0.49,14.1,21,17.7,1.8,leukocyte,EpiGO,Epigenetic Basis of Obesity-Induced Cardiovascular Disease and Type 2 Diabetes,obese,African American or Afro-Caribbean,leukocyte
Initial,450K,96,0.5,null,null,52.4,23.7,leukocyte,EGCUT,Estonian Biobank ,,European,leukocyte
Initial,450K,96,0.51,null,null,49.8,7.4,whole blood,,,,African American or Afro-Caribbean;European,whole blood
Initial,450K,96,0.54,0,0,0,0,cord blood,MoBa,Norwegian Mother and Child Cohort Study,unexposed without attention-deficit/hyperactivity disorder,European,cord blood
Initial,450K,96,0.55,0,0,0,0,whole blood,NHBCS,,,European,whole blood
Initial,450K,96,0.69,0,0,0,0,cord blood,MoBa,Norwegian Mother and Child Cohort Study,unexposed with attention-deficit/hyperactivity disorder,European,cord blood
Initial,450K,96,null,null,null,28.3,5.5,cord blood,RICHS,,,European,cord blood
Initial,450K,96,null,null,null,28.3,5.5,cord blood ,RICHS,,,European,cord blood 
Initial,450K,962,0.47,null,null,50.5,11.3,whole blood,SAPALDIA,,time point 1,European,whole blood
Initial,450K,962,0.47,null,null,58.8,11.3,whole blood,SAPALDIA,,time point 2,European,whole blood
Initial,450K,962,null,0,0,0,0,cord blood,MoBa1,Norwegian Mother and Child Cohort Study,,Not reported,cord blood
Initial,450K,966,0.49,15,17,null,null,cord blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,cord blood
Initial,450K,966,0.49,15,17,null,null,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,whole blood
Initial,450K,966,0.49,7,7,7,0,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,whole blood
Initial,450K,968,0.48,null,null,17.1,1.1,whole blood,ARIES,,,Not reported,whole blood
Initial,450K,97,0.49,null,null,13.8,2.5,saliva,,,IPV ‚àí,Not reported,saliva
Initial,450K,97,0.8,null,null,59.4,11.5,whole blood,ACS-2,,,East Asian,whole blood
Initial,450K,970,0.48,null,null,47.8,16.3,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Initial,450K,974,0.49,null,null,15.5,null,whole blood,ARIES,,,Not reported,whole blood
Initial,450K,977,null,null,null,null,null,urological tumor tissue,,,,Not reported,urological tumor tissue
Initial,450K,98,0.449,46,63,50,null,whole blood,Lifelines,,Control individuals,European,whole blood
Initial,450K,99,0.48,0,0,0,0,whole blood,NEST,,,African American or Afro-Caribbean,whole blood
Initial,450K,99,0.5,null,null,65.4,7.1,whole blood,ESTHER,"Epidemiologische Studie zu Chancen der Verh‚Ç¨utung, Fr√ºherkennung und optimierten Therapie chronischer Erkrankungen in der √§lteren Bev√∂lkerung",,European,whole blood
Initial,450K,99,0.55,0,0,0,0,cord blood,Piccolipi√π,,,European,cord blood
Initial,450K,991,0.48,null,null,48.8,16,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Initial,450K,991,0.48,null,null,49,16,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Initial,450K,991,0.48,null,null,49,16,whole blood,GOLDN,,,European,whole blood
Initial,850K,11,0.55,0,0,0,0,cord blood,,,,Not reported,cord blood
Initial,850K,11,0.55,10,10,10,0,whole blood,,,,Not reported,whole blood
Initial,850K,11,0.55,5,5,5,0,whole blood,,,,Not reported,whole blood
Initial,850K,13,0,12,57,19,null,CD16+  neutrophil,,,healthy control,Not reported,CD16+  neutrophil
Initial,850K,13,0,12,57,19,null,CD19+ B cell,,,healthy control,Not reported,CD19+ B cell
Initial,850K,13,0,12,57,19,null,CD4+ T cell,,,healthy control,Not reported,CD4+ T cell
Initial,850K,13,0,12,57,19,null,CD8+ T cell,,,healthy control,Not reported,CD8+ T cell
Initial,850K,13,0,12,57,19,null,whole blood,,,healthy control,Not reported,whole blood
Initial,850K,157,0.38,50,70,null,null,buffy coat,,,,Not reported,buffy coat
Initial,850K,16,0.125,6,17,11.5,null,CD16+  neutrophil,,,paediatric-onset systemic lupus erythematosus patients,Not reported,CD16+  neutrophil
Initial,850K,16,0.125,6,17,11.5,null,CD19+ B cell,,,paediatric-onset systemic lupus erythematosus patients,Not reported,CD19+ B cell
Initial,850K,16,0.125,6,17,11.5,null,CD4+ T cell,,,paediatric-onset systemic lupus erythematosus patients,Not reported,CD4+ T cell
Initial,850K,16,0.125,6,17,11.5,null,CD8+ T cell,,,paediatric-onset systemic lupus erythematosus patients,Not reported,CD8+ T cell
Initial,850K,16,0.125,6,17,11.5,null,whole blood,,,paediatric-onset systemic lupus erythematosus patients,Not reported,whole blood
Initial,850K,16,0.56,0,0,0,0,cord blood,,,term brth,East Asian,cord blood
Initial,850K,16,0.56,0,0,0,0,placenta,,,term birth,East Asian,placenta
Initial,850K,164,0.59,10.6,15,12.6,null,whole blood,RISK,Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn‚Äôs Disease cohort,crohn disease at diagnosis,Not reported,whole blood
Initial,850K,18,null,4,12,null,null,whole blood,,,case,Not reported,whole blood
Initial,850K,18,null,4,12,null,null,whole blood,,,control,Not reported,whole blood
Initial,850K,22,0.5,0,0,0,0,chorionic villi,,,aCA case,Not reported,chorionic villi
Initial,850K,22,0.59,0,0,0,0,chorionic villi,,,Non-aCA case,Not reported,chorionic villi
Initial,850K,3,null,60,74,69,null,blood,COPD,Chronic Obstructive Pulmonary Disease cohort,1 years after lung cancer detection,Not reported,blood
Initial,850K,3,null,60,74,69,null,blood,COPD,Chronic Obstructive Pulmonary Disease cohort,1 years before lung cancer detection,Not reported,blood
Initial,850K,3,null,60,74,69,null,blood,COPD,Chronic Obstructive Pulmonary Disease cohort,2 years before lung cancer detection,Not reported,blood
Initial,850K,3,null,null,null,null,null,whole blood,,,control,Not reported,whole blood
Initial,850K,3,null,null,null,null,null,whole blood,,,Werner syndrome,Not reported,whole blood
Initial,850K,30,0.33,18,58,25.6,7.7,buccal cell,,,after glucocorticoid exposure,Not reported,buccal cell
Initial,850K,30,0.33,18,58,25.6,7.7,buccal cell,,,before glucocorticoid exposure,Not reported,buccal cell
Initial,850K,302,0.46,null,null,44.3,3.7,whole blood,CARDIA,Coronary Artery Risk Development in Young Adults,,African American or Afro-Caribbean,whole blood
Initial,850K,32,0.59,0,0,0,0,cord blood,,,spontaneous preterm birth,East Asian,cord blood
Initial,850K,32,0.59,0,0,0,0,placenta,,,spontaneous preterm birth,East Asian,placenta
Initial,850K,36,0.56,null,null,19.8,0.9,whole blood,,,,East Asian,whole blood
Initial,850K,4,0.25,20,33,26,null,right lower lobe,,,controls,Not reported,right lower lobe
Initial,850K,4,0.25,20,33,26,null,right upper lobe,,,controls,Not reported,right upper lobe
Initial,850K,4,0.5,18,28,21,null,right lower lobe,,,CF subjects,Not reported,right lower lobe
Initial,850K,4,0.5,18,28,21,null,right upper lobe,,,CF subjects,Not reported,right upper lobe
Initial,850K,4,0.75,34,44,null,null,synovial fibroblast,BEACON,Birmingham early arthritis cohort,non-arthritic patients,Not reported,synovial fibroblast
Initial,850K,448,0.53,0,0,0,0,placenta,Gen3G,Gestation and Growth prospective cohort,,European,placenta
Initial,850K,45,0.25,null,null,42.3,12.1,peripheral blood mononuclear cell,,,MS-affected MZ co-twins,Not reported,peripheral blood mononuclear cell
Initial,850K,45,0.25,null,null,42.3,12.1,peripheral blood mononuclear cell,,,Non-affected MZ co-twins,Not reported,peripheral blood mononuclear cell
Initial,850K,455,0.515,null,null,45.9,3.3,whole blood,CARDIA,Coronary Artery Risk Development in Young Adults,,European,whole blood
Initial,850K,470,0.44,null,null,43.6,6.8,whole blood,ECRHS,,time point 1,European,whole blood
Initial,850K,470,0.44,null,null,54.5,6.8,whole blood,ECRHS,,time point 2,European,whole blood
Initial,850K,611,0.45,null,null,46.3,0.4,whole blood,NFBC1966,,time point 2,European,whole blood
Initial,850K,658,0.42,null,null,54.3,12.7,leukocyte,,,,European,leukocyte
Initial,850K,7,0.43,23,43,null,null,CD4+ T cell,,,6 months treatment,Not reported,CD4+ T cell
Initial,850K,7,0.43,23,43,null,null,CD4+ T cell,,,prior to the first dose of DMF,Not reported,CD4+ T cell
Initial,850K,74,0,null,null,32.4,6,saliva,,,mother,African American or Afro-Caribbean,saliva
Initial,850K,74,0.35,null,null,3.7,0.7,saliva,,,Child,African American or Afro-Caribbean,saliva
Initial,850K,78,1,null,null,25.9,null,CD14+ monocyte,,,European descent,European,CD14+ monocyte
Initial,850K,78,1,null,null,30.9,null,CD14+ monocyte,,,African descent,African unspecified,CD14+ monocyte
Initial,850K,8,0,35,62,43.5,null,urine,,,IC/BPS Cases,European;Not reported,urine
Replication,27K,10,0.6,73,78,75,null,subcutaneous adipose tissue,,,,Not reported,subcutaneous adipose tissue
Replication,27K,108,0,52,78,null,null,whole blood,UKOPS,United Kingdom Ovarian Cancer Population Study,Healthy women,Not reported,whole blood
Replication,27K,122,0,49,91,null,null,whole blood,UKOPS,United Kingdom Ovarian Cancer Population Study,Ovarian cancer after treatment,Not reported,whole blood
Replication,27K,124,0.59,null,null,55,3,peripheral blood,,,,Not reported,peripheral blood
Replication,27K,146,0.5,27,74,null,null,whole blood,,,Type-1 diabetics,Not reported,whole blood
Replication,27K,152,0,19,55,25,null,uterine cervix,,,,Not reported,uterine cervix
Replication,27K,154,0.37,7,82,42.5,16.3,tumor tissue,ENS@T,European Network for the Study of Adrenal Tumors,,European,tumor tissue
Replication,27K,16,1,1,60,25,null,occipital cortex,,,,Not reported,occipital cortex
Replication,27K,177,0,24,88,null,null,ovarian cancer cell,,,Women with ovarian cancer,Not reported,ovarian cancer cell
Replication,27K,188,0.49,24,74,null,null,whole blood,,,Type-1 diabetics,Not reported,whole blood
Replication,27K,191,0.49,24,74,43,null,whole blood,,,,Not reported,whole blood
Replication,27K,198,0.65,33,86,60,null,kidney,,,,Not reported,kidney
Replication,27K,20,1,1,60,22,null,cerebellar,,,,Not reported,cerebellar
Replication,27K,22,0.45,53,78,66,null,vastus lateralis muscle,,,,Not reported,vastus lateralis muscle
Replication,27K,24,0.25,16,69,35,null,CD4+ T cell,,,,Not reported,CD4+ T cell
Replication,27K,25,0.2,16,68,35.2,12.4,CD14+ monocyte,,,,Not reported,CD14+ monocyte
Replication,27K,25,0.2,16,68,35.2,12.4,CD4+ T cell,,,,Not reported,CD4+ T cell
Replication,27K,26,0.27,16,69,36.5,null,CD14+ monocyte,,,,Not reported,CD14+ monocyte
Replication,27K,262,0,49,91,67,null,whole blood,,,,Not reported,whole blood
Replication,27K,269,0,52,78,64,null,whole blood,,,,Not reported,whole blood
Replication,27K,27,0,35,88,51,null,breast,,,,Not reported,breast
Replication,27K,33,0.52,9,74,50.9,18.1,tumor tissue,ENS@T,European Network for the Study of Adrenal Tumors,,European,tumor tissue
Replication,27K,355,0.52,2,61,28,null,leukocyte,MRCA,,,African American or Afro-Caribbean;European,leukocyte
Replication,27K,386,1,3.6,18,9.3,null,peripheral blood mononuclear cell,,,,Not reported,peripheral blood mononuclear cell
Replication,27K,405,1,null,null,null,null,whole blood,,,control,Not reported,whole blood
Replication,27K,415,1,null,null,null,null,whole blood,,,ASD,Not reported,whole blood
Replication,27K,44,0.59,0,83,71,null,various tissues,,,,Not reported,various tissues
Replication,27K,44,1,25,25,25,0,vastus lateralis muscle,,,,Not reported,vastus lateralis muscle
Replication,27K,44,null,20,61,28,null,whole blood,,,MZ twins discordant for psychosis,Not reported,whole blood
Replication,27K,48,0,26,43,null,null,cervix,,,LBC samples,Not reported,cervix
Replication,27K,48,0.98,0,0,0,0,cord blood,,,,Not reported,cord blood
Replication,27K,507,0,49,91,null,null,whole blood,,,"262 healthy women, 120 ovarian cancer cases before treatment and 125 ovarian cancer cases after treatment",Not reported,whole blood
Replication,27K,52,0.08,21,55,27,null,saliva,,,,Not reported,saliva
Replication,27K,53,0.55,0,0,0,0,cord blood,,,,Not reported,cord blood
Replication,27K,6,1,55,71,60,null,heart,,,,Not reported,heart
Replication,27K,8,0,21,85,null,null,mesenchymal stem cell,,,Bone marrow from healthy donors,Not reported,mesenchymal stem cell
Replication,27K,84,0.48,0,0,0,0,cord blood,,,,Not reported,cord blood
Replication,27K,92,null,24,45,33,null,peripheral blood mononuclear cell,,,,Not reported,peripheral blood mononuclear cell
Replication,27K,93,0,49,74,63,null,whole blood,,,,Not reported,whole blood
Replication,27K,93,0,49,74,null,null,whole blood,,,,Not reported,whole blood
Replication,27K,95,0.57,null,null,55,3,peripheral blood,,,Heavy smoker: smoking >= 20 cigarettes per day at ages 30 and 40 and at enrollment,Not reported,peripheral blood
Replication,27K,97,0.63,null,null,55,3,peripheral blood,,,,Not reported,peripheral blood
Replication,450K,101,0.4,null,null,15.7,1.6,whole blood,Karelia,,,European,whole blood
Replication,450K,1011,0,null,null,64.6,7.1,whole blood,WHI-EMPC,,,European,whole blood
Replication,450K,103,0.54,0,0,0,0,cord blood,,,Normal pregnancy,East Asian,cord blood
Replication,450K,1052,0.41,null,null,39,19,peripheral blood mononuclear cell,,,,European,peripheral blood mononuclear cell
Replication,450K,1058,null,null,null,59.8,5.4,leukocyte,ARIC,Atherosclerosis Risk in Communities,,European,leukocyte
Replication,450K,108,0.51,null,null,74.7,13.3,whole blood,BASICMAR_ 2,,control,European,whole blood
Replication,450K,1092,0,null,null,64.7,7.1,blood,WHI-EMPC,Women‚Äôs Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD,,European,blood
Replication,450K,111,null,null,null,47.2,4.9,whole blood,SYS adults,Saguenay Youth Study,,European,whole blood
Replication,450K,112,null,20,73,null,null,blood,,Danish Family Study,Danish Family Study,Not reported,blood
Replication,450K,115,0,null,null,null,null,whole blood,KORA F3,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers,Not reported,whole blood
Replication,450K,116,0,null,null,null,null,whole blood,KORA F3,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers,Not reported,whole blood
Replication,450K,117,1,null,null,null,null,whole blood,KORA F3,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers,Not reported,whole blood
Replication,450K,12,1,null,null,45.3,16.2,CD3+ T cell,,,Controls,Not reported,CD3+ T cell
Replication,450K,12,1,null,null,null,null,buccal epithelium,,,6 FASD children and 6 matched controls,European,buccal epithelium
Replication,450K,120,0.6,null,null,53.6,8.5,gastric mucosa,,,Controls,East Asian,gastric mucosa
Replication,450K,120,1,null,null,null,null,whole blood,KORA F3,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers,Not reported,whole blood
Replication,450K,126,0.52,null,null,8.7,0.3,whole blood,Robbic-Bologna,Rome and Bologna Birth Cohorts,,European,whole blood
Replication,450K,1261,0.4,null,null,64.8,9,buffy coat,FHS,Framingham Heart Study,,Not reported,buffy coat
Replication,450K,127,0.49,4,4,4,0,whole blood,INMA-GIP,Infancia y Medio Ambiente,,European,whole blood
Replication,450K,128,null,null,null,null,null,CD14+ monocyte,,,,Not reported,CD14+ monocyte
Replication,450K,13,0.46,6,null,5,8,nasal epithelial cell,,,,African unspecified;European;Other admixed ancestry,nasal epithelial cell
Replication,450K,13,0.69,null,null,52.2,5.6,gastric mucosa,,,self-comparison validation Unsuccessful eradication,East Asian,gastric mucosa
Replication,450K,13,0.69,null,null,52.2,5.6,leukocyte,,,self-comparison validation Unsuccessful eradication,East Asian,leukocyte
Replication,450K,13,1,null,null,50.9,9.1,CD3+ T cell,,,post-treatment alcohol dependent patients,Not reported,CD3+ T cell
Replication,450K,13,1,null,null,50.9,9.1,CD3+ T cell,,,pre-treatment alcohol dependent patients,Not reported,CD3+ T cell
Replication,450K,131,0.37,null,null,38,11.6,whole blood,,,Cases,European,whole blood
Replication,450K,131,0.6,null,null,73.4,10.2,whole blood,BASICMAR_1,,type 2 diabetes mellitus,European,whole blood
Replication,450K,131,0.85,null,null,70.2,8.7,carotid plaque,AEMS450K2,Athero-Express Biobank Study,Former or Never Smokers,Not reported,carotid plaque
Replication,450K,137,0,null,null,57.3,5.9,whole blood,,,,Not reported,whole blood
Replication,450K,14,0.21,null,null,37.2,12.5,whole blood,,,Case Group II,European;Not reported,whole blood
Replication,450K,142,0.51,null,null,62.6,7.2,whole blood,BLITZ,Evaluierung innovativer Testverfahren zur Darmkrebsfr‚Ç¨uherkennung,,European,whole blood
Replication,450K,149,0.52,21,null,18,30,leukocyte,PAPA,,,African American or Afro-Caribbean;European,leukocyte
Replication,450K,149,1,null,null,63.3,2.7,whole blood,HBCS,Helsinki Birth Cohort,,European,whole blood
Replication,450K,15,0.29,null,null,52.1,9.3,CD19+ B cell,,,Cases,Hispanic or Latin American,CD19+ B cell
Replication,450K,15,0.33,null,null,52.5,11.4,CD19+ B cell,,,Controls,Hispanic or Latin American,CD19+ B cell
Replication,450K,15,0.4,null,null,42.5,5,whole blood,KHTS,Korean Healthy Twin Study,AT siblings,Not reported,whole blood
Replication,450K,15,null,null,null,null,null,aorta,,,,Not reported,aorta
Replication,450K,159,0.73,16.1,84.8,59.5,null,tumor tissue,TCGA,The Cancer Genome Atlas,,Not reported,tumor tissue
Replication,450K,16,0.38,17,60,32,null,blood,,,,Not reported,blood
Replication,450K,160,0.5,5,79,29,null,leukocyte,SLSJ,,,African American or Afro-Caribbean;European,leukocyte
Replication,450K,1622,0.57,null,null,46.7,10.8,whole blood,Lifelines,,time point 1,European,whole blood
Replication,450K,166,0.64,null,null,43.9,12,whole blood,,,,African American or Afro-Caribbean;European,whole blood
Replication,450K,169,0.28,null,null,38,7.2,whole blood,,,Controls,European,whole blood
Replication,450K,17,null,null,null,null,null,cartilage,,,knee OA patients,Not reported,cartilage
Replication,450K,171,0,null,null,null,null,breast,,,,Not reported,breast
Replication,450K,172,0.78,null,null,70,17,whole blood,BAsicMAR,,Current Smokers,Not reported,whole blood
Replication,450K,173,0.36,null,null,26.2,7,whole blood,EGCUT Asthma,Estonian Genome Centre University of Tartu,,European,whole blood
Replication,450K,1789,0.49,null,null,60.9,8.9,whole blood,KORA F4,Cooperative Health Research in the Region of Augsburg,Second replication cohort,European,whole blood
Replication,450K,18,0,13,80,49,null,breast,NDRI,National Disease Research Interchange,ductal carcinoma,Not reported,breast
Replication,450K,18,0.389,null,null,88.5,5.2,prefrontal cortex,,,Braak III-IV,Not reported,prefrontal cortex
Replication,450K,18,0.78,8.4,12.8,11.7,null,leukocyte,PICTS,Paediatric-onset IBD Cohort and Treatment Study,patients,Not reported,leukocyte
Replication,450K,18,0.78,8.6,12.9,11.3,null,leukocyte,BISCUIT,Scottish Children Undergoing Investigation before Treatment study,controls,Not reported,leukocyte
Replication,450K,181,0.75,null,null,60.7,8.7,whole blood,LOLIPOP,The London Life Sciences Prospective Population Study,Incident T2D,European,whole blood
Replication,450K,187,0,null,null,50.5,4.8,whole blood,,National Institute of Environmental Health Sciences (NIEHS) Sister Study,,Not reported,whole blood
Replication,450K,187,0.07,null,null,48.8,14.9,whole blood,,,Controls,Not reported,whole blood
Replication,450K,19,null,null,null,null,null,carotid plaque,,,,Not reported,carotid plaque
Replication,450K,192,null,null,null,46.3,13.6,whole blood,Amish,The Amish Complex Disease Research Studies,family,European,whole blood
Replication,450K,196,0.54,null,null,57.6,8.9,whole blood,KORA,Kooperative Gesundheitsforschung in der Region Augsburg,controls,European,whole blood
Replication,450K,196,0.54,null,null,57.8,8.9,whole blood,KORA,Cooperative Health Research in the Region of Augsburg,Incident T2D,European,whole blood
Replication,450K,20,0.7,null,null,68.3,9.6,tumor tissue,,,Obese,Not reported,tumor tissue
Replication,450K,201,0.13,null,null,48.7,14.8,whole blood,,,Patients,Not reported,whole blood
Replication,450K,202,1,57,67,62,null,whole blood,ESTHER,,,European,whole blood
Replication,450K,205,0.28,null,null,79,9,whole blood,BAsicMAR,,Never Smokers,Not reported,whole blood
Replication,450K,207,0.56,null,null,16.4,0.2,nasal epithelial cell,PIAMA,Prevention and Incidence of Asthma and Mite Allergy,Atopy,European,nasal epithelial cell
Replication,450K,2096,null,null,null,null,null,whole blood,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,whole blood
Replication,450K,2097,0.36,null,null,56.2,5.7,whole blood,ARIC,Atherosclerosis Risk in Communities Study,,African American or Afro-Caribbean,whole blood
Replication,450K,2097,null,47,70,null,null,leukocyte,ARIC,Atherosclerosis Risk in Communities,,African American or Afro-Caribbean,leukocyte
Replication,450K,213,0.53,null,null,10.9,0.8,whole blood,ECA,Environment and Childhood Asthma study in Oslo,,European,whole blood
Replication,450K,214,0.51,null,null,7.8,0.5,whole blood,Robbic-Rome,Rome and Bologna Birth Cohorts,,European,whole blood
Replication,450K,22,0.41,0,0,0,0,placenta,,,early-onset preeclampsia,African unspecified;Asian unspecified;European;Other,placenta
Replication,450K,221,0.38,null,null,65.1,10.2,peripheral blood mononuclear cell,,,Parkinson's disease,Not reported,peripheral blood mononuclear cell
Replication,450K,221,null,null,null,31.2,4.3,cord blood,BAMSE,,,European,cord blood
Replication,450K,221,null,null,null,31.2,4.3,cord blood ,BAMSE,,,European,cord blood 
Replication,450K,225,0.44,null,null,16.3,0.2,nasal epithelial cell,PIAMA,Prevention and Incidence of Asthma and Mite Allergy,No atopy,European,nasal epithelial cell
Replication,450K,2297,0.37,null,null,56.1,5.7,whole blood,ARIC,,,African unspecified,whole blood
Replication,450K,230,1,18,18,18,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Replication,450K,2316,null,0,103,54,null,whole blood,MARMAL‚ÄêAID,,,Not reported,whole blood
Replication,450K,232,0.5,34,83,53.2,null,whole blood,KORA F3,Kooperative Gesundheitsforschung in der Region Augsburg,Never smokers,Not reported,whole blood
Replication,450K,236,0.51,35,80,52.8,null,whole blood,KORA F3,Kooperative Gesundheitsforschung in der Region Augsburg,Current smokers,Not reported,whole blood
Replication,450K,236,null,null,null,60.6,9.2,monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,African American or Afro-Caribbean,monocyte
Replication,450K,2377,0.44,null,null,67,null,whole blood,FHS Offspring,Framingham Heart Study Offspring Cohort,,European,whole blood
Replication,450K,238,0,null,null,51.7,11.7,whole blood,,,,Not reported,whole blood
Replication,450K,239,0.28,null,null,41,13,leukocyte,GTP,Grady Trauma Project,,African American or Afro-Caribbean,leukocyte
Replication,450K,24,null,null,null,null,null,whole blood,AWHS,Aragon Workers‚Äô Health Study,,Not reported,whole blood
Replication,450K,247,0.76,null,null,35,null,whole blood,,,Cases,European,whole blood
Replication,450K,249,null,null,null,44.1,4.1,whole blood,BHS,Bogalusa Heart Study,MetS+,European,whole blood
Replication,450K,25,0.48,null,null,null,null,gastric mucosa,,,case-control validation H. pylori positive,East Asian,gastric mucosa
Replication,450K,25,0.48,null,null,null,null,leukocyte,,,case-control validation H. pylori positive,East Asian,leukocyte
Replication,450K,25,0.56,null,null,null,null,gastric mucosa,,,case-control validation H. pylori negative,East Asian,gastric mucosa
Replication,450K,25,0.56,null,null,null,null,leukocyte,,,case-control validation H. pylori negative,East Asian,leukocyte
Replication,450K,250,0.76,null,null,35.1,null,whole blood,,,Controls,European,whole blood
Replication,450K,2515,0.46,null,null,66.2,8.9,whole blood,FHS Offspring,Framingham Offspring Study,,Not reported,whole blood
Replication,450K,259,0.56,null,null,68.8,9.7,saliva,PEG,Parkinson's Environment and Genes Study,,European;Not reported,saliva
Replication,450K,26,0.54,42,86,66,null,lung,,,,Not reported,lung
Replication,450K,27,0.41,null,null,46.2,6.1,whole blood,KHTS,Korean Healthy Twin Study,BT siblings,Not reported,whole blood
Replication,450K,279,null,null,null,37.3,5.2,cord blood,OW F1,,,European,cord blood
Replication,450K,279,null,null,null,37.3,5.2,cord blood ,OW F1,,,European,cord blood 
Replication,450K,28,0,35,90,62,null,uterus,,,,Not reported,uterus
Replication,450K,28,0.53,null,null,74.5,4.2,adipose tissue,,,Type 2 diabetes,Not reported,adipose tissue
Replication,450K,28,0.54,null,null,74.3,4.3,adipose tissue,,,normal glucose tolerance,Not reported,adipose tissue
Replication,450K,29,0.448,null,null,77.6,12.8,prefrontal cortex,,,Braak 0-II,Not reported,prefrontal cortex
Replication,450K,293,0.53,null,null,49,17,CD4+ T cell,GOLDN,,,European,CD4+ T cell
Replication,450K,300,null,null,null,null,null,whole blood,,,,European,whole blood
Replication,450K,3018,null,70,79,null,null,whole blood,LBC,Lothian Birth Cohort,,European,whole blood
Replication,450K,315,0,null,null,61.6,6.2,blood,WHI-EMPC,Women‚Äôs Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD,,Hispanic or Latin American,blood
Replication,450K,32,0.45,null,null,59.3,4.2,cord blood,REGARDS,REasons for Geographic and Racial Differences in Stroke,MetS-,African American or Afro-Caribbean,cord blood
Replication,450K,324,0.23,null,null,44.1,14.3,whole blood,MARTHA,MARseille Thrombosis Association Study,,Not reported,whole blood
Replication,450K,326,0.48,null,null,48.8,16.9,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Replication,450K,327,1,null,null,54.6,6.8,whole blood,,,,Not reported,whole blood
Replication,450K,327,null,null,null,null,null,gastric tissue,TCGA,The Cancer Genome Atlas,,Not reported,gastric tissue
Replication,450K,33,1,25,50,null,null,sperm,,,nonsmoker,Not reported,sperm
Replication,450K,331,0.492,null,null,47.7,16.2,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Replication,450K,333,0,null,null,62.3,6.8,blood,WHI-BAA23,Women‚Äôs Health Initiative ‚Äì Broad Agency Award 23,,Hispanic or Latin American,blood
Replication,450K,338,0,null,null,54.6,8.9,whole blood,TwinsUK,,,European,whole blood
Replication,450K,339,0.22,null,null,43.8,14.2,whole blood,MARTHA,MARseille THrombosis Association,Primary replication cohort,European,whole blood
Replication,450K,354,null,null,null,43.1,4.6,whole blood,BHS,Bogalusa Heart Study,MetS-,European,whole blood
Replication,450K,355,0.52,2,61,28,null,leukocyte,MRCA,,,Not reported,leukocyte
Replication,450K,356,0,34,84,60.1,8.8,peripheral blood,EPITWIN,,,Not reported,peripheral blood
Replication,450K,358,0.35,null,null,49.3,12.1,leukocyte,EPIC-Italy,,,European,leukocyte
Replication,450K,359,0.49,4,4,4,0,whole blood,INMA-MEN,Infancia y Medio Ambiente,,European,whole blood
Replication,450K,36,0.44,null,null,46.5,11.5,adipose tissue,,,Type 2 diabetes,Not reported,adipose tissue
Replication,450K,36,0.47,null,null,10.9,0.9,nasal epithelial cell,,,Non-atopic controls,African American or Afro-Caribbean,nasal epithelial cell
Replication,450K,36,0.53,null,null,11.1,0.8,nasal epithelial cell,,,Atopic asthma,African American or Afro-Caribbean,nasal epithelial cell
Replication,450K,36,1,null,null,40.4,7.3,sperm,,,Current smokers,Not reported,sperm
Replication,450K,36,null,0,0,0,0,cord blood,NEST,Newborn Epigenetics Study,,European,cord blood
Replication,450K,367,0.33,18,18,18,0,leukocyte,IOW,,,Not reported,leukocyte
Replication,450K,369,0.36,null,53,47.5,7.1,whole blood,EOCOPD,Early-Onset COPD,,Not reported,whole blood
Replication,450K,37,0.45,null,null,59.7,4.8,buffy coat,REGARDS,REasons for Geographic and Racial Differences in Stroke,MetS+,African American or Afro-Caribbean,buffy coat
Replication,450K,37,0.62,0,0,0,0,cord blood,,,,East Asian,cord blood
Replication,450K,37,0.65,20,81,68,null,liver,,,,Not reported,liver
Replication,450K,37,0.65,null,null,51.9,6.4,gastric mucosa,,,self-comparison validation Successful eradication,East Asian,gastric mucosa
Replication,450K,37,0.65,null,null,51.9,6.4,leukocyte,,,self-comparison validation Successful eradication,East Asian,leukocyte
Replication,450K,38,0.26,0,100,44,null,peripheral blood mononuclear cell,,,,Not reported,peripheral blood mononuclear cell
Replication,450K,38,0.55,40,90,72,null,colon,,,,Not reported,colon
Replication,450K,381,null,null,null,59,9.5,monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,Hispanic or Latin American,monocyte
Replication,450K,389,0.5,null,null,16.3,0.2,whole blood,PIAMA,Prevention and Incidence of Asthma and Mite Allergy,,European,whole blood
Replication,450K,39,0.33,null,null,63,null,whole blood,ESTHER,,"Diabetic, poorly controlled",Not reported,whole blood
Replication,450K,390,0,53,53,53,0,buccal cell,NSHD,National Survey of Health and Development,,Not reported,buccal cell
Replication,450K,390,null,70,80,null,null,whole blood,Prospective Investigation of the Vasculature in Uppsala Seniors,PIVUS,,European,whole blood
Replication,450K,40,0.85,null,null,36.6,13.5,whole blood,,,pairs of monozygotic (MZ) twins highly discordant for aggression,Not reported,whole blood
Replication,450K,40,null,0,0,0,0,placenta,,,,Not reported,placenta
Replication,450K,40,null,0,103,null,null,peripheral blood mononuclear cell,,,,Not reported,peripheral blood mononuclear cell
Replication,450K,41,0,null,null,null,null,whole blood,,,spontaneous PTB,African American or Afro-Caribbean,whole blood
Replication,450K,42,1,null,null,38.4,8.3,sperm,,,Never smokers,Not reported,sperm
Replication,450K,422,0.51,null,null,53.2,9.6,whole blood,KORA F3,,,Not reported,whole blood
Replication,450K,43,0,null,null,31.3,null,peripheral blood mononuclear cell,,,,African American or Afro-Caribbean;European,peripheral blood mononuclear cell
Replication,450K,43,0.44,null,null,59.7,8.1,buccal mucosa,COPDGene,,Current Smokers,African American or Afro-Caribbean;European,buccal mucosa
Replication,450K,440,0.39,null,null,62,null,whole blood,ESTHER,,Nondiabetic,Not reported,whole blood
Replication,450K,446,0.42,null,null,null,null,whole blood,NTR,Netherlands Twin Register,,Not reported,whole blood
Replication,450K,449,0.53,null,null,69.6,0.9,whole blood,LCB1936,,time point 1,European,whole blood
Replication,450K,449,0.53,null,null,76.3,0.7,whole blood,LCB1936,,time point 2,European,whole blood
Replication,450K,45,1,25,50,null,null,sperm,,,smoker,Not reported,sperm
Replication,450K,474,0.53,null,null,44,14,whole blood,HAPI,Phenotype Intervention Heart Study,,Not reported,whole blood
Replication,450K,48,0.4,null,null,64,null,whole blood,ESTHER,,"Diabetic, controlled",Not reported,whole blood
Replication,450K,48,null,0,1,0.5,null,CD4+ T cell,,,,Not reported,CD4+ T cell
Replication,450K,498,0.52,50,75,62,null,whole blood,ESTHER,,,Not reported,whole blood
Replication,450K,50,0.52,null,null,55.5,6.3,adipose tissue,,,Type 2 diabetes,Not reported,adipose tissue
Replication,450K,500,0.51,50,75,null,null,whole blood,ESTHER,,,Not reported,whole blood
Replication,450K,51,0.55,0,1.5,0,null,buccal cell,,,,Not reported,buccal cell
Replication,450K,521,0.53,null,null,4.3,0.3,whole blood,Rhea,Mother-Child Cohort in Crete,,European,whole blood
Replication,450K,53,0.21,28,79,45,null,tumor tissue,,,,Not reported,tumor tissue
Replication,450K,535,0.47,null,null,55.1,16,whole blood,NSPHS,,time point 1,European,whole blood
Replication,450K,54,0,null,null,null,null,whole blood,,,control,African American or Afro-Caribbean,whole blood
Replication,450K,55,0.33,10.9,12.2,11.4,null,whole blood,,,B12 with multiple micronutrients supplementation,Not reported,whole blood
Replication,450K,55,0.47,null,null,55.7,16.5,whole blood,TCGA,The Cancer Genome Atlas,Validation group,African unspecified;Asian unspecified;European;Not reported,whole blood
Replication,450K,55,0.55,11,12,11.3,null,whole blood,,,Control,Not reported,whole blood
Replication,450K,552,0,null,null,53.45,0.5,buccal cell,NSHD,National Survey of Health and Development,,Not reported,buccal cell
Replication,450K,556,0,null,null,62.8,7,blood,WHI-EPMC,Women‚Äôs Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD,,African American or Afro-Caribbean,blood
Replication,450K,56,0.8,null,null,65.2,9,carotid plaque,AEMS450K2,Athero-Express Biobank Study,Current Smokers,Not reported,carotid plaque
Replication,450K,566,null,null,null,60.8,9.6,monocyte,MESA,Multi-Ethnic Study of Atherosclerosis,,European,monocyte
Replication,450K,568,0.73,null,null,60.4,9.7,whole blood,LOLIPOP,The London Life Sciences Prospective Population Study,control,European,whole blood
Replication,450K,57,null,null,null,null,null,bone marrow,,,ETV6-RUNX1,Not reported,bone marrow
Replication,450K,582,0.48,null,null,62.6,11.7,whole blood,REGICOR,,control,European,whole blood
Replication,450K,583,null,null,null,30.9,3.7,cord blood,PIAMA,,,European,cord blood
Replication,450K,583,null,null,null,30.9,3.7,cord blood ,PIAMA,,,European,cord blood 
Replication,450K,59,0.48,null,null,75,11,whole blood,BASICMAR_ 2,,type 2 diabetes mellitus,European,whole blood
Replication,450K,59,0.53,null,null,7.5,0.2,whole blood,INMA-VAL,Infancia y Medio Ambiente,,European,whole blood
Replication,450K,592,0.46,null,null,43,5,whole blood,BHS,Bogalusa Heart Study,,European,whole blood
Replication,450K,6,0.67,0,0,0,0,placenta,,,Pre-term Control,African unspecified;Asian unspecified;European;Other,placenta
Replication,450K,60,0.6,null,null,53.5,9.7,gastric mucosa,,,Gastric Cancer patients (normal gastric mucosa ),East Asian,gastric mucosa
Replication,450K,61,0.56,0,0,0,0,cord blood,,,insulin-treated GDM,European,cord blood
Replication,450K,628,0.47,null,null,53.6,4.5,whole blood,KORA,,time point 1,European,whole blood
Replication,450K,628,0.47,null,null,60.1,4.5,whole blood,KORA,,time point 2,European,whole blood
Replication,450K,63,0.57,null,null,69.1,10,whole blood,REGICOR,,type 2 diabetes mellitus,European,whole blood
Replication,450K,63,0.65,41,69,60.4,7.2,gastric mucosa,,,healthy individuals with gastric atrophy,Not reported,gastric mucosa
Replication,450K,64,0.39,0,0,0,0,cord blood,,,dietetically treated GDM,European,cord blood
Replication,450K,641,0.52,0,0,0,0,leukocyte,,Generation R Study,,European,leukocyte
Replication,450K,642,0.48,null,null,59,6.5,whole blood,Leiden Longevity,,,European,whole blood
Replication,450K,648,0,null,null,60,null,adipose tissue,MuTHER,Multiple Tissue Human Expression Resource cohort,"97 MZ pairs, 162 DZ pairs and 130 singletons",European,adipose tissue
Replication,450K,656,0,18,18,18,0,leukocyte,ALSPAC,Avon Longitudinal Study of Parents and Children,,Not reported,leukocyte
Replication,450K,656,0.43,null,null,53.8,10.2,whole blood,LOLIPOP,The London Life Sciences Prospective Population Study,,South Asian,whole blood
Replication,450K,66,null,null,null,null,null,bone marrow,,,high hyperdiploidy,Not reported,bone marrow
Replication,450K,666,0,null,null,62.8,6.7,blood,WHI-BAA23,Women‚Äôs Health Initiative ‚Äì Broad Agency Award 23,,African American or Afro-Caribbean,blood
Replication,450K,667,0.44,null,null,31,0.3,whole blood,NFBC66,Northern Finland Birth Cohort 1966,,European,whole blood
Replication,450K,67,0.5,50,75,61,null,whole blood,ESTHER,,Longitudinal,Not reported,whole blood
Replication,450K,689,0.29,17,70,54,null,whole blood,,,,Not reported,whole blood
Replication,450K,70,0.46,null,null,53.4,7.4,adipose tissue,,,normal glucose tolerance,Not reported,adipose tissue
Replication,450K,701,0,null,null,47.8,4.3,whole blood,ALSPAC,Avon Longitudinal Study of Parents and Children,,European,whole blood
Replication,450K,709,0.5,null,null,8.3,0.4,whole blood,PIAMA,Prevention and Incidence of Asthma and Mite Allergy,,European,whole blood
Replication,450K,711,null,null,null,67.5,6,whole blood,RS-III,Rotterdam Study,,European,whole blood
Replication,450K,719,0.43,51.5,79.9,67.5,null,whole blood,RS,,40 hepatic steatosis patients,European,whole blood
Replication,450K,731,0.46,null,null,59.9,8.2,whole blood,RS-III,Rotterdam Study,,European,whole blood
Replication,450K,734,null,null,null,29.1,5.8,cord blood,RAINE,,,European,cord blood
Replication,450K,734,null,null,null,29.1,5.8,cord blood ,RAINE,,,European,cord blood 
Replication,450K,752,0.42,null,null,45.5,13.3,whole blood,LifeLines Deep,,,European,whole blood
Replication,450K,760,0.42,null,null,67.7,5.9,leukocyte,,,,Not reported,leukocyte
Replication,450K,762,0.43,null,null,67.7,5.9,whole blood,RS-BIOS,Rotterdam study-Biobank-based Integrative Omics Studies,,European,whole blood
Replication,450K,78,1,null,null,55.4,3.3,whole blood,ETS,Emory Twin Study,,European,whole blood
Replication,450K,79,0.56,25,72,51,13.5,whole blood,DILGOM,,,Not reported,whole blood
Replication,450K,8,0.63,null,null,69.7,13.1,tumor tissue,,,Non-obese,Not reported,tumor tissue
Replication,450K,8,null,null,null,null,null,gastric mucosa,,,successfully eradicated,East Asian,gastric mucosa
Replication,450K,8,null,null,null,null,null,gastric mucosa,,,unsuccessfully eradicated,East Asian,gastric mucosa
Replication,450K,8,null,null,null,null,null,leukocyte,,,successfully eradicated,East Asian,leukocyte
Replication,450K,8,null,null,null,null,null,leukocyte,,,unsuccessfully eradicated,East Asian,leukocyte
Replication,450K,81,0,28,90,55,null,breast,,,,Not reported,breast
Replication,450K,82,0.44,23,85,58,null,tumor tissue,,,,Not reported,tumor tissue
Replication,450K,82,0.89,47,68,62.2,4.7,gastric mucosa,,,gastric cancer patients,Not reported,gastric mucosa
Replication,450K,87,0.47,null,null,65.3,8.1,buccal mucosa,COPDGene,,Former Smokers,African American or Afro-Caribbean;European,buccal mucosa
Replication,450K,877,0,null,null,null,null,whole blood,,,,European,whole blood
Replication,450K,88,0.69,62,72.2,67,null,lung,TCGA,,Heavy smoking,Not reported,lung
Replication,450K,91,0.51,10.5,10.8,10.6,null,leukocyte,GENOI,Grupo Navarro de Obesidad Infantil,,European,leukocyte
Replication,450K,93,0.53,22,97,69,null,whole blood,,,,Not reported,whole blood
Replication,450K,93,0.53,null,null,30.4,3.8,whole blood,FTC,,time point 1,European,whole blood
Replication,450K,95,1,null,null,55.5,10.5,whole blood,,,,Not reported,whole blood
Replication,450K,96,0.5,null,null,53,23.7,whole blood,EGCUT CTG,Estonian Genome Centre University of Tartu,,European,whole blood
Replication,450K,965,0,null,null,68.4,6.2,blood,WHI-BAA23,Women‚Äôs Health Initiative ‚Äì Broad Agency Award 23,,European,blood
Replication,450K,967,null,null,null,null,null,whole blood,PIVUS,Prospective Investigation of the Vasculature in Uppsala Seniors,,European,whole blood
Replication,450K,97,0,28,90,57.57,null,breast,TCGA, The Cancer Genome Atlas,invasive ductal carcinoma,Not reported,breast
Replication,450K,97,0.56,59,72,66,null,lung,TCGA,,Light smoking,Not reported,lung
Replication,450K,971,0.39,null,null,60.9,8.8,whole blood,KORA F4,,,Not reported,whole blood
Replication,450K,991,0.48,null,null,49,null,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network Study,,European,CD4+ T cell
Replication,450K,992,null,null,null,null,null,CD4+ T cell,GOLDN,Genetics of Lipid Lowering Drugs and Diet Network,,European,CD4+ T cell
Replication,850K,10,null,null,null,null,null,brain,,,after glucocorticoid exposure,Not reported,brain
Replication,850K,10,null,null,null,null,null,brain,,,before glucocorticoid exposure,Not reported,brain
Replication,850K,13,null,null,null,null,null,buccal cell,,,after glucocorticoid exposure,Not reported,buccal cell
Replication,850K,13,null,null,null,null,null,buccal cell,,,before glucocorticoid exposure,Not reported,buccal cell
Replication,850K,18,null,null,null,null,null,whole blood,,,after glucocorticoid exposure,Not reported,whole blood
Replication,850K,18,null,null,null,null,null,whole blood,,,before glucocorticoid exposure,Not reported,whole blood
Replication,850K,21,null,null,null,null,null,saliva,,,after glucocorticoid exposure,Not reported,saliva
Replication,850K,21,null,null,null,null,null,saliva,,,before glucocorticoid exposure,Not reported,saliva
Replication,850K,220,1,null,null,48.3,9.2,leukocyte,,,Non-smokers,African American or Afro-Caribbean,leukocyte
Replication,850K,309,1,null,null,48,6.55,leukocyte,,,smokers,African American or Afro-Caribbean,leukocyte